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Abstract 
Observational studies on the association between birth weight and adult blood 
pressure provide suggestive evidence that exposures during fetal development can 
have lasting impacts on health. The effect of maternal nutrition during pregnancy 
on offspring blood pressure has been demonstrated in animal models, but data 
from cohort studies in humans have proven inconclusive. The follow-up of 
randomised controlled trials of nutritional supplementation during pregnancy can 
add high quality data to this research field; this thesis focuses on the effects in 
three separate trials. 
Protein energy supplementation provided to pregnant women in rural Gambia was 
unrelated to offspring blood pressure at 11-17 years old (n=1267). Again in The 
Gambia, maternal calcium supplementation compared to placebo was also 
unrelated to offspring blood pressure at 5-10 years old (n=350). 
In rural Bangladesh there was no effect of maternal food or multiple micronutrient 
supplementation on offspring systolic blood pressure at 4.5 years old (n=2335). The 
micronutrient intervention was also unrelated to offspring diastolic blood pressure, 
but there was evidence that an early invitation to enter a governmental food 
supplementation programme was associated with marginally lower diastolic blood 
pressure: 0.58mmHg (95% Cl: 0.06,1.11; P: 0.03). In this setting, randomisation to 
receive counselling to promote exclusive breast feeding was not associated with 
offspring blood pressure at 4.5 years of age and none of the interventions were 
associated with offspring kidney function, assessed as ultrasound-obtained volume 
and glomerular filtration rate calculated from plasma Cystatin C. 
These data suggest that the maternal diet during pregnancy, at least those aspects 
of intake that can be altered during supplementation trials, may not be directly 
relevant for the determination of offspring blood pressure. Nutritional exposures 
during other stages of the life course may prove to be more important. 
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Chapter 1 Introduction 
1.1 Cardiovascular disease 
Chronic non-communicable diseases, including cardiovascular diseases (CVDs), are 
responsible for the largest share of death and disability worldwide [1]. CVDs, 
encompassing coronary heart disease and cerebrovascular disease, contribute the 
greatest burden of non-communicable diseases and accounted for 17.5 million 
deaths worldwide in 2005, equating to 30% of global deaths [1]. Traditionally 
viewed as diseases of the affluent, there is now recognition of the increasing 
burden of chronic diseases in low and middle income countries as highlighted by 
two Lancet series [2,3] and a WHO report [1], each of which called for urgent global 
action. Indeed, it is currently estimated that 80% of chronic disease deaths occur in 
low and middle-income countries [4]. The burden of chronic diseases in these 
countries is projected to increase rapidly, surpassing morbidity and mortality 
attributed to infectious communicable diseases in even the lowest income 
countries by 2015 (Figure 1.1) [5]. 
Figure 1.1 Death rates for World Bank country income groups, 2005 and 2015 
(reproduced from Strong et al [5]) 
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Intermediate risk factors for cardiovascular disease include overweight or obesity, 
raised blood pressure (hypertension), raised blood glucose and blood lipids. These 
are potentially modifiable and thus lend themselves to public health prevention 
strategies. This thesis focuses on blood pressure, which is responsible for a large 
burden of death and disability worldwide. In 2000, a WHO analysis attributed 7.1 
million deaths and 64.3 million disability-adjusted life years worldwide to non- 
optimal blood pressure [6]. After a brief discussion of the general determinants of 
blood pressure this chapter will highlight the role of early-life exposures, 
particularly prenatal nutrition, which form the basis of this PhD research. 
1.2 Definition of blood pressure 
Blood pressure refers to the force exerted by the blood against the area of the 
vessel wall. It is conventionally measured as arterial pressure described in 
millimetres of mercury (mmHg) [7]. The heart pumps blood into the arteries in a 
continuous but pulsatile manner; the peak of this pulse is termed systolic pressure, 
whilst the lowest point is the diastolic pressure [7]. The blood pressure system is 
highly regulated both in the short-term by the autonomic nervous system and in 
the long-term by the action of the kidneys. This regulation is vital as even small rises 
in arterial pressure have important consequences for morbidity and mortality. Over 
time, raised blood pressure can lead to congestive heart failure, stroke and renal 
failure [7]. 
In adults, hypertension is currently defined by the World Health Organisation as a 
systolic blood pressure greater than or equal to (>) 140mmHg and a diastolic blood 
pressure ? 90mmHg [8]. It has been proposed that a cut-off of 120/80 should be 
termed 'pre-hypertension' as these levels are also associated with increased risk of 
disease [9]. Blood pressure has been shown to track from childhood into adult life 
so that early elevations in blood pressure may have important consequences for 
later health [10,11]. The definition of high blood pressure in childhood is 
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complicated by the influence of changing body size. One commonly-applied 
definition utilises population distributions of blood pressure, split by age and height 
centiles, compiled by the US National High Blood Pressure Education Program 
(NHBPEP) and last updated in 1996 [12]. Using these distributions, hypertension in 
childhood is defined as average systolic or diastolic blood pressure above the 95th 
percentile for age, height and sex [12]. 
1.3 Concurrent determinants of blood pressure 
Blood pressure is related to age, sex, ethnicity, body size and to some extent diet, 
each of which will be described briefly in this section. Blood pressure is positively 
associated with age. Data from the Framingham Heart Study for example, 
demonstrated that systolic blood pressure rose steadily from 30 to 85 years of age, 
whilst diastolic blood pressure rose initially and then began to fall after 50 years; 
both changes have been interpreted as a consequence of increasing arterial 
stiffness [13]. The association between age and blood pressure is less clear for 
children and adolescents, due to the impact of growth and development, with some 
studies reporting no association [14,15]. At a given age, men generally have higher 
blood pressure than pre-menopausal women and are at higher risk of hypertension 
[16]. In a Danish study, 24 hour blood pressure was on average 6-10mmHg higher 
for men than for women between the ages of 20-70 years, after which the 
differences were no longer apparent [17]. It has been hypothesised that androgens 
operating on the renin-angiotensin system explain the gender difference in blood 
pressure, which becomes less apparent after menopause [16]. Sex differences are 
also apparent in adolescents, with boys demonstrating a higher ambulatory 
(continually monitored) blood pressure than girls [18,19]. 
Body size is an important predictor of blood pressure in children and adolescents 
[12], with both height and weight independently and positively associated with 
blood pressure [14,15,20,21]. Few studies have been able to characterise body 
composition in greater detail than simple anthropometry, but data from the Avon 
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Longitudinal Study of Pregnancy and Childhood (ALSPAC) demonstrated a positive 
independent association between systolic blood pressure and both fat and lean 
mass assessed by dual-energy X-ray absorptiometry (DXA) at nine years of age [21]. 
In a smaller US study of children and adolescents aged 5-18 years, He et a! reported 
an inverse association between fat mass (assessed by DXA and by skinfold thickness 
measurements) and systolic blood pressure in boys and a positive association 
between fat mass and blood pressure for girls only, assessed by skinfold thickness 
measurements [22]. Possible associations with lean mass were not assessed by this 
study. The importance of fat distribution remains unclear; Brion et a!, using the 
ALSPAC cohort, report a potential positive association between trunk fat and 
systolic blood pressure that was stronger for girls than boys [21], whilst He et a! 
report a positive association between trunk fat and both systolic and diastolic blood 
pressure, but only for boys [22]. At present it is therefore difficult to draw firm 
conclusions about the association between body composition and blood pressure. 
The effect of ethnic background on blood pressure has been suggested by a number 
of studies, generally reporting higher blood pressure for individuals of African 
compared to European decent [23-26]. A recent systematic review of UK studies, 
revealed that the majority reported higher blood pressure for adults of African 
descent compared to white Europeans [26]. A second review reported similar blood 
pressure levels for white Europeans and Asian adults living in the UK [27]. However, 
it should be noted that confounding by socio-economic class and by other factors 
such as body composition and diet are often not taken into account in these 
studies, and there is very little data from native African or Asian populations. The 
existence of ethnic differences in children is less well established; in one US study 
the observation that blood pressure was higher for black compared to white girls at 
10 years of age was entirely explained by the difference in sexual maturation [28]. 
In a separate study, recruiting children and adolescents aged 1-17 years, no ethnic 
differences were observed for girls but blood pressure was higher for normal 
weight black boys compared to normal weight white boys, although no difference 
was observed for overweight individuals [29]. A systematic review of studies in 
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children in the UK found that blood pressure levels in the five identified studies 
were similar across the different ethnic groups studied [30]. 
The association between dietary factors and blood pressure has been most 
extensively researched for alcohol and salt intake. High alcohol consumption has 
been consistently shown to be related to high blood pressure [31-34]. At the lower 
end of the consumption spectrum however, there has been debate over a possible 
protective effect of moderate alcohol intake compared to individuals who do not 
drink [31,32,35]. These observational associations have been criticised for 
confounding by a variety of factors such as diet and smoking status, and a meta- 
analysis of 15 randomised controlled trials confirmed that a reduction in alcohol 
consumption resulted in a reduction in blood pressure [36]. In addition, a recent 
meta-analysis utilising the technique of Mendelian randomisation revealed a dose 
response effect between low, moderate and high alcohol consumption (defined by 
genotype) and systolic blood pressure in adulthood [37]. The authors used an 
individual's genotype for the alcohol dehydrogenase 2 (ALDH2)*2 allele as a 
randomly allocated lifetime alcohol exposure to investigate the association 
between alcohol consumption and blood pressure that is not confounded by other 
factors; individuals homozygous for the ALDH2*2 allele have a reduced ability to 
process alcohol and therefore drink considerably less [37]. 
Law et al conducted meta-analyses of both observational and randomised 
controlled trial data on the impact of salt intake on blood pressure [38,39]. The 
authors conclude that there is a strong positive association and that a reduction in 
salt intake of around 50mmols per day would be associated with a reduction in 
systolic blood pressure of 5mmHg [38,39]. Data on the impact of other dietary 
factors on blood pressure is less well established; high fibre intake may be 
associated with a reduced risk of developing hypertension in men [34] and a 
vegetarian diet has been associated with lower blood pressure [40], although issues 
of confounding remain important in these types of dietary association studies. 
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1.4 Early-life determinants of blood pressure 
Exposures throughout the life course are increasingly recognised as playing an 
important role in the aetiology of chronic diseases [41-43]. The impacts of the 
prenatal and early postnatal environment in particular, have been highlighted by 
the Developmental Origins of Health and Disease Hypothesis (DOHaD) [44], which 
has grown into a multidisciplinary research area. This section of the introduction 
will outline the current evidence for the impact of the early-life nutritional 
environment on the development of the blood pressure system. For both pre- and 
early post-natal stages of the life course, the evidence will be presented first from 
human observational data, then from animal studies and finally human intervention 
trials as this follows the historical pattern of how the data has emerged in the 
literature. 
1.4.1 Prenatal nutrition 
1.4.1.1 Observational data 
Work by David Barker and colleagues from the MRC's Environmental Epidemiology 
Unit in Southampton in the late 1980s provided some of the first evidence that the 
fetal environment may be related to blood pressure in later life [45]. Using records 
that had been routinely collected at birth in various centres around the UK, 
including a hospital in Preston [46] and midwife records in Hertfordshire [47], 
individuals were traced to their current residence for recruitment into studies 
investigating cardiovascular disease risk factors. The analysis revealed an inverse 
association between birth weight and blood pressure that was apparent in 
childhood but became stronger with age [48]. Subsequently a number of 
epidemiological studies have replicated this finding, but the topic has not been 
without controversy. In a systematic review of 34 studies published up to 1996, Law 
and Sheill reported that the majority of studies in children and adults showed an 
inverse association between birth weight and blood pressure, although the 
association for adolescents was less consistent [49]. However, when Huxley et al 
updated the review in 2002 they highlighted some concern with the literature; only 
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just over half of the published studies had reported a regression coefficient and the 
strength of the association between birth weight and blood pressure became 
weaker as study size increased [50]. The authors concluded that this suggested 
publication bias in the research topic and that previous claims about the strength of 
the association had been overstated [50]. Subsequently, an informal review of the 
literature conducted by Adair and Dahly again provided support for an inverse 
association between birth weight and adult systolic blood pressure and/or an 
increased risk of hypertension in adults born smaller at birth [51]. Adair and Dahly 
reported a range of regression coefficients (-0.55, -6. OmmHg) for the difference in 
systolic blood pressure associated with a 1kg increase in birth weight and 
concluded that the often quoted 2mmHg difference was in general supported by 
the literature [51]. 
In addition to the issue of publication bias outlined above, past studies have been 
criticised for the predominantly retrospective design (prone to selection bias) 
employed in most studies [52], inappropriate adjustment for social economic status 
[52] and the use of statistical methods that may not be appropriate for the research 
question, such as adjusting for current size [53]. Large prospective birth cohorts can 
go some way to addressing these concerns but tend to be relatively young in age at 
present. The ALSPAC cohort has provided conflicting evidence to date; size at birth 
was inversely related to blood pressure at three years of age [54] but not at nine 
years [21]. The impact of birth weight on later blood pressure may arguably be 
more relevant for less developed countries where there is a greater prevalence of 
low birth weight [55], but very few data are available from these settings. In one 
comparison study, birth weight and length were found to be inversely related to 
blood pressure at 3-6 years of age after adjusting for current size in Guatemala City 
and Santiago but not for cities in China or Nigeria [56]. 
Beyond birth weight: maternal diet 
The impact of fetal growth restriction on the development of chronic disease in 
later life has mainly been attributed to the action of nutritional insufficiency [45, 
57]. Birth weight is therefore used as a proxy measurement of fetal nutrition, which 
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is itself multifactorial in origin, comprising maternal body composition and size 
(determined partly by her own fetal experience), maternal diet and nutrient stores 
and the placental transport of nutrients [45]. Relatively few studies have 
investigated the direct effect of the maternal diet during pregnancy on health 
outcomes in the offspring. 
The Dutch Hunger Winter, 1944-45, has been extensively studied as an example of 
a relatively defined exposure to a period of reduced food intake. Between 
November 1944 and May 1945 there was a severe shortage of food in the western 
Netherlands as a result of German occupation, and harsh weather conditions, 
disrupting supply routes. Rations fell to between 400-800 calories a day during this 
period but were quickly restored with the Allied liberation in May 1945 [58]. 
Individuals born or conceived during the famine have been compared to those born 
before or conceived just after this period of food shortage as 'controls' [58]. Despite 
an inverse association between birth weight and blood pressure in the Dutch 
famine birth cohort, there was no relationship between famine exposure and blood 
pressure at 50 years of age [59]. In a study of a different group of survivors 
however, Stein et a/ (2006) did find that those exposed to the famine (at any time 
during gestation) had higher blood pressure and a higher rate of hypertension at 59 
years of age compared to 'controls' born before or conceived after the famine [60]. 
Using record data on the rations available during this time, Roseboom et al 
investigated the association between macronutrient availability and blood pressure 
in adulthood [61]. Although there was no association with total macronutrient 
availability, the authors observed an inverse association between the 
protein/carbohydrate ratio in late gestation and offspring blood pressure in 
adulthood, both for individuals exposed and unexposed to the famine [61]. 
Similar studies have been conducted on individuals born during the Leningrad siege 
revealing no differences in blood pressure (at around 50 years of age) compared to 
those exposed to the siege during infancy [621. Interestingly both groups exposed 
to the Leningrad siege in early life (infancy and in utero), demonstrated raised 
diastolic blood pressure and a non-significant tendency to raised systolic blood 
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pressure compared to individuals born outside of the city [62]. Whilst these findings 
are intriguing, one of the main drawbacks with these studies is a lack of individual 
data on actual intakes. 
Some of the observational studies that have directly assessed diet during pregnancy 
were reviewed by Brion et al, concluding that there was no strong evidence that 
any component of the maternal diet influenced blood pressure in the offspring [63]. 
This data, and a few additional studies not covered by the review, will be briefly 
summarised below. The heterogeneity of exposure measures prevents any 
meaningful tabulation of the results but the methodological designs of the various 
studies are summarised in Tables 1.1 and 1.2 to give an indication of the variety of 
studies involved. 
The impact of protein and energy intake during pregnancy has been investigated in 
five observational studies [64-68], mostly reporting no main effect in relation to 
offspring blood pressure. In Filipino adolescent boys, but not girls, low percentage 
energy from protein in the maternal diet was related to higher blood pressure at 16 
years of age [66]. In contrast, high meat consumption (interpreted as high protein) 
during pregnancy was associated with higher systolic blood pressure in the 
offspring of individuals who followed severe dietary advice during pregnancy in a 
Scottish hospital in the 1960s [67]. In a separate Scottish study in the 1950s, no 
single nutrient intake during pregnancy was associated with offspring blood 
pressure 40 years later [65]. However, at intakes of animal protein under 50g a day 
a high carbohydrate intake was associated with higher offspring blood pressure, 
whereas the reverse pattern was seen for women with intakes of animal protein 
over 50g a day [65]. An issue raised by this analysis is the importance of pre- 
specifying hypotheses to be tested prior to conducting the analysis; it is not clear if 
this particular analysis would have been conducted for a priori reasons. In two 
contemporary birth cohort studies, one from the US [68] and one from the UK [64], 
no association was observed between protein intake during pregnancy and 
offspring blood pressure at six months and seven years respectively. 
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Chapter 1: introduction 
Maternal intake of calcium during pregnancy has been the focus of a number of 
studies due to the potential reduction in pre-eclampsia risk associated with 
increased calcium intake [74]. In turn, the association between calcium intake in 
pregnancy and offspring blood pressure has also been investigated and reported by 
three observational studies (Table 1.2), albeit with conflicting results [69-71]. 
Gilman et al reported that calcium intake in the second trimester of pregnancy, 
although not the first trimester, was inversely related to blood pressure in the 
offspring at six months of age in a large American birth cohort known as Project 
Viva [71]. Interestingly this association was only observed with calcium intake from 
supplements and was not apparent for calcium intake from food sources; mean 
supplement intake was 264mg/d. After adjusting for confounders, a 500mg 
increase in calcium intake during pregnancy was associated with a 3mmHg decrease 
in systolic pressure in infancy [71]. McGarvey et a/ also observed an inverse 
association between maternal calcium intake (from food and personal 
supplements) and offspring systolic blood pressure at one month, a borderline 
association at six months but no association at twelve months of age, although only 
33% of the cohort were recruited at this time [69]. No association was observed 
between maternal calcium supplementation use during pregnancy (no data on 
dietary intake was recorded) and child blood pressure at nine years of age in 
Tasmania, Australia [70]. It should be noted that both the latter two studies relied 
on post-partum questionnaires, which are likely to suffer from recall bias. 
The impact of other nutrients during pregnancy has received little attention in 
relation to offspring blood pressure. In the Philippines, fat intake in pregnancy was 
associated with reduced blood pressure for girls but not boys [66]. In the ALSPAC 
cohort, omega-3 fatty acid intake was weakly inversely associated with offspring 
blood pressure, although this association was no longer apparent after adjustment 
for confounders [64]. Again in ALSPAC, anaemia during pregnancy (haemoglobin 
<11g/di) was associated with lower systolic blood pressure in the offspring at seven 
years of age, although once again the relationship was lost after adjustment for 
confounders [73]. No other nutrients in the ALSPAC study were associated with 
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offspring blood pressure [64]. In the Scottish study reporting on women who had 
followed a high meat diet during pregnancy, high intake of fruit and vegetables was 
weakly associated with reduced offspring blood pressure [67]. Belfort et al reported 
a positive association between maternal iron intake from supplements during 
pregnancy and offspring systolic blood pressure at three years of age in Project Viva 
[72]. Interestingly there was no association between measures of maternal iron 
status (either haemoglobin or mean cell volume) and offspring blood pressure in 
the same study [72]. In addition to an association of calcium intake highlighted 
above, McGarvey et al, reported an inverse association between maternal intake of 
magnesium and systolic blood pressure at one month of age and an inverse 
association between potassium intake and offspring diastolic blood pressure at six 
and twelve months of age [69]. As stated previously, the heterogeneity of study 
design in terms of nutrients assessed, the method of assessment and the age of the 
subjects at follow-up make any meaningful combined analysis of these results 
impossible and the picture that emerges from these various studies is unclear and 
somewhat contradictory. 
1.4.1.2 Animal studies 
Methodological issues have plagued the human data in this field from the outset 
and, as a result, evidence from animal studies has been extremely important for 
advancing understanding of the impact of the maternal diet during pregnancy on 
offspring health. There is now a wealth of animal data in this field, which will be 
briefly summarised below, but which is extensively reviewed elsewhere [75-80]. 
Hypertensive offspring have been produced by a variety of nutrient restrictions 
during pregnancy in a variety of species, including rats, sheep and pigs [79,81]. 
Global food restriction (15-30% of normal food intake), either during part or all of 
pregnancy, has been shown to lead to raised blood pressure in both sheep and rat 
offspring [79]. One of the most commonly studied exposures in the literature is a 
low protein diet provided to pregnant rats, followed by a normal postnatal diet. 
Researchers at the University of Southampton have modelled the low protein diet 
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as 9% casein compared to a control diet containing 18% casein [82]. This 
experimental model has consistently been shown to produce offspring with raised 
blood pressure [82]. The balance of amino acids may be an important feature, as 
low protein diets of different compositions have not induced hypertension in the 
offspring [80]. One proposed explanation is that rats on the Southampton low- 
protein diet are provided with additional methionine in their diet, which in turn 
leads to high levels of homocysteine and may therefore result in changes in DNA 
methylation effecting organogenesis [80]. Supplementation of the diet with folate 
reduces plasma homocysteine and results in normotensive offspring [83]. Recently 
the animal data relating to hypertension in rats has been criticised for certain 
common methodologies, particularly the measurement of blood pressure using a 
single tail-cuff reading compared to 24 hour continuous recording by telemetry; the 
former has been shown to give higher readings due to the stress associated with 
this technique [84]. 
There has been some debate about the existence of sex differences in fetal 
response to nutrient restriction during pregnancy, as recently reviewed by Grigore 
et al [85]. In rat models at least, the existence or absence of sex differences is 
potentially explained by the nature of the nutritional insult and the method of 
measuring blood pressure; gender differences are generally reported in studies 
utilising methods other than the tail cuff [79]. Moderate protein restriction during 
pregnancy results in male offspring with raised mean arterial pressure but no effect 
in female offspring, whilst severe restriction leads to raised blood pressure in both 
males and females [86-88]. Females may therefore be more resistant to the effect 
of dietary manipulation during in utero development, only developing disease 
outcomes under extreme conditions. However, the existence of sex differences in 
response to early life nutritional insults in other species is unclear at present [79]. 
Other dietary exposures that have been studied in animal models include fat, 
sodium and iron. Rat models of iron deficiency during pregnancy result in pups with 
higher blood pressure than controls, despite being cross-fostered at birth to control 
dams [89]. Further experiments utilising the same design have demonstrated 
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increased expression of placental cytokines in response to iron deficiency, which 
the authors suggest may partly explain the differences in growth rates in 
experimental and control pups [90]. A diet deficient in omega-3 fatty acids provided 
during gestation and early postnatal life has also been shown to promote high 
blood pressure in rats [91]. High sodium diets provided during pregnancy, lactation 
and early weaning have been shown to produce lasting hypertension in rat 
offspring [92], although exposure only during pregnancy does not have the same 
effect [93]. 
The relevance of the animal data outlined above, to human populations can be 
questioned for a number of reasons, particularly the appropriateness of 
extrapolating between species. Human reproduction requires only incremental 
increases in nutrients on a daily basis compared to other species (because humans 
have evolved to have very slow pre- and post-natal growth rates), and the 
developing fetus is protected by a number of evolved adaptations [94]. In addition, 
the majority of animal studies involve interventions that are at the extreme end of 
nutrient restriction, representing situations that are unlikely to occur in human 
populations. 
1.4.1.3 Human intervention trials 
Returning to the human situation we are reminded of the paucity of the data and of 
the issues with those that are available. The majority of evidence is derived from 
cohort studies which suffer either from a retrospective design and/or from large 
losses to follow-up, insufficient adjustment for confounding (especially for social 
economic status) and potential errors associated with the measurement of the 
maternal diet. It is therefore unsurprising that the evidence base is conflicting and 
dogged by criticism. One solution to obtain higher quality data in this area is to 
utilise intervention studies to answer the research question "does the maternal diet 
during pregnancy affect offspring blood pressure? ". Intervention studies, 
particularly those that have utilised randomised double-blind placebo-controlled 
designs have the advantage of providing the highest quality data of all 
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epidemiological designs and, provided the sample size is large and randomisation 
successful, confer a greater degree of validity on the observed result due to a 
reduced potential for bias [95]. Although there are no trials that have been 
published that specifically test this hypothesis, trials of nutritional supplementation 
during pregnancy for other primary outcomes have been conducted and are 
available for follow-up. A comprehensive review of the published literature in this 
area revealed that to date, the only exposures that have been studied are protein- 
energy, multiple micronutrient and calcium supplementation. These will be 
sumarised on the following pages. 
Protein-energy 
Two community-based interventions of protein-energy provision for pregnant 
women and their children have so far been followed-up to investigate any impact 
on later blood pressure, amongst other outcomes (Table 1.3). The first was a trial 
conducted by the Institute of Nutrition of Central America and Panama (INCAP) in 
rural Guatemala in the 1960s [96]. Two villages received the 'Atole' supplement, a 
protein and energy dense drink, whilst two control villages received the 'Fresco' 
supplement, a drink which contained no protein and around one third of the energy 
[96]. A follow-up study was conducted when the offspring were 20 - 29 years old, 
recruiting only those who had been exposed to the intervention during gestation 
and for their first three years of life [97]. There was no difference in systolic or 
diastolic blood pressure for adults born in the intervention compared to the control 
villages [97] (Table 1.4). A major limitation of this study in relation to the research 
question under investigation is that it is not possible to distinguish between pre- 
and post-natal enhanced nutrition in the intervention analysis. Furthermore, due to 
the small number of villages, the cluster design of the original trial could not be 
accounted for in the analysis. Another factor to consider is that although this study 
is often viewed as a trial of protein supplementation the two drinks also provided 
different levels of certain micronutrients (calcium, phosphorus, zinc, folic acid and 
vitamin B12), which may affect interpretation of the results [98]. 
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A comparable follow-up study was recently published from India investigating the 
impact of a community-based intervention, which provided a cereal meal to 
pregnant and lactating women and children up to age six, on cardiovascular disease 
risk factors in the offspring [99]. The intervention was rolled-out in a stepwise 
manner as part of a national public health programme and the researchers were 
able to compare individuals born into areas covered by the programme with 
'control' areas, which did not yet have that provision. The authors report that there 
was no difference in systolic or diastolic blood pressure between individuals from 
intervention compared to control areas at 15 years old [99]. However, there was a 
difference in augmentation index (viewed as a marker of global arterial stiffness 
with lower values suggesting a healthier vascular tree [100]) between the two 
groups; adolescents in the intervention area had a percentage augmentation index 
that was 3.16% lower than individuals in control areas [99]. Again, it is important to 
note that this study involved a community-level intervention that provided 
supplements to pregnant women and to their children up to 6 years of age, 
hampering conclusions regarding the importance of prenatal compared to 
postnatal nutrition. In addition, the roll-out of the intervention had not been 
conducted in a random manner, which should add caution to the interpretation of 
its results. 
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Multiple micronutrients 
In recent years there has been considerable interest in the potential of maternal 
micronutrient supplementation during pregnancy to provide important benefits for 
both the mother and infant. Two trials have to date published findings of follow-up 
beyond infancy, both of which were based in Nepal [101,102] (Table 1.5). The trials 
had different designs: one conducted by Osrin et a/ investigated the impact of a 
supplement containing 15 micronutrients compared to one containing iron and 
folate only [101], whilst the trial by Christian et al compared five arms of 
supplementation: vitamin A only; vitamin A plus folic acid; vitamin A, folic acid and 
iron; vitamin A plus folic acid, iron and zinc; a multiple micronutrient tablet that 
also contained vitamin A [102]. The follow-up studies of both of these trials have 
been published recently with conflicting results (Table 1.6 and 1.7). The follow-up 
of the first trial recruited 2-3 year old children and reported that those born to 
mothers who received the multiple micronutrients had lower systolic blood 
pressure (2.5mmHg) than those born to 'control' women receiving only iron and 
folic acid [103]. In contrast, the follow-up of the second trial recruited offspring 
who were 6-8 years old and found no difference in blood pressure between the five 
different trial arms [104]. 
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Chapter 1: introduction 
Calcium 
A number of maternal calcium supplementation trials have been conducted on 
pregnant women in recent years, primarily to investigate the potential for reducing 
the risk of pre-eclampsia [74,105], and to date three of these trials [106-108] have 
published follow-up data on offspring blood pressure (Table 1.8 and 1.9). All three 
trials enrolled only nulliparous women as this has been shown to be a risk factor for 
developing pre-eclampsia [74], and all were randomised double-blind placebo- 
controlled trials, which represent the highest epidemiological individual study 
design [95]. One of the trials was conducted by Levine et al in the US providing 2g/d 
of calcium [109], a second also providing 2g/d was conducted by Belizan et a/ in 
Argentina [110] and the third conducted by Crowther et a/ in Australia provided 
1.8g/d [111]. 
The follow-up of the US study reported that maternal calcium supplementation 
during pregnancy was associated with lower systolic blood pressure in the offspring 
at two years, although only 10% of eligible participants were recruited into the 
follow-up study and a previous follow-up at three months of age had revealed no 
difference [107] (Table 1.10). Data from Australia [108] and Argentina [106] showed 
no association between maternal calcium supplementation and offspring blood 
pressure at 4-7 years and 5-9 years respectively. Despite no overall association with 
mean blood pressure, in Argentina the intervention was associated with a reduced 
risk of having high systolic blood pressure (defined by age and height specific cut- 
offs) [106]. In this same study, there was also an interaction between childhood 
BMI and maternal calcium supplementation on offspring blood pressure. For 
children with BMI above the mean at follow-up, the intervention was associated 
with lower blood pressure [106]. 
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Chapter 1: introduction 
Dietary counselling 
One additional study should be mentioned in this section although it is not a trial of 
nutritional supplementation but of dietary advice. This is a small trial conducted in 
Finland where women were randomised to three different arms: dietary 
intervention plus probiotics, dietary intervention plus placebo and a control plus 
placebo arm. Women in the dietary intervention arms received detailed counselling 
at 24 and 34 weeks gestation, encouraging them to achieve intake that complied 
with healthy eating recommendations. Specifically, the counselling highlighted the 
amount and type of fat in the diet and the importance of fibre intake [112]. 
Subjects were also provided with conventional food products with favourable fat 
and fibre content to facilitate adherence to the advice given [112]. There were 256 
women recruited into the trial and 216 infants recruited into the follow-up study at 
six months of age where blood pressure was estimated [113]. The intervention was 
associated with changes in food habits; participants in the dietary intervention arms 
consumed higher quality fats as a result of reduced butter and increased margarine 
and vegetable oil consumption [113]. However, there was no difference in infant 
blood pressure between the dietary intervention and control groups at six months 
of age [113]. 
1.4.2 Early postnatal nutrition 
Lucas et al propose that the apparent association between size at birth and chronic 
disease in later life may be explained by the relative change in size experienced 
postnatally for individuals born small for their gestational age [53]. The majority of 
birth weight - blood pressure associations published in the literature either are only 
apparent after adjusting for current size or are substantially stronger after this 
adjustment, suggesting that change in size may be the important exposure rather 
than fetal growth restriction per se [50]. Whilst more recent data has demonstrated 
robust associations between restricted fetal growth and blood pressure in later life 
[51], and the animal data outlined in Section 1.4.1.2 demonstrates the proof of 
principle that fetal exposures can influence hypertension risk [76,77,79], there is a 
growing interest in the importance of exposures early in postnatal life. The field of 
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research encompassed by DOHaD has now expanded to include early postnatal 
influences such as differential patterns of growth, nutrition or infection on the 
susceptibility to disease in later life [44]. 
1.4.2.1 Observational data 
Growth 
The importance of growth patterns for the development of disease risk has 
received the most attention in this field, and underlying this concept are a range of 
nutritional exposures that in turn influence growth. The highest risk for 
hypertension is usually observed for individuals who were born small but are 
relatively large as adults, suggesting that catch-up growth may be aetiologically 
important and some authors have suggested that coronary heart disease can be 
conceptualised as a "disorder of growth" [114]. There has however been substantial 
controversy about the specific patterns of growth which may confer greatest risk, 
partly stemming from methodological issues relating to characterising an exposure 
that is fundamentally associated with later size and, by implication, later blood 
pressure. Data from the Helsinki birth cohort has been influential in this area and 
appears to implicate catch-up growth between birth and seven years of age; in this 
cohort hypertensive adults had been born relatively small and by age seven had 
caught up to average size before surpassing this by age 15 [115]. Many studies have 
investigated the impact of rapid postnatal growth on blood pressure in later life 
with the majority reporting the crossing of weight centiles in childhood to be an 
important exposure [116-120], although there is great heterogeneity in the 
definition of growth across studies. 
Cole has suggested a method for visualising the impact of growth during childhood 
on blood pressure in later life, termed life course plots [1211. The regression 
coefficient for the association between weight SD score at different time points and 
final blood pressure are plotted against age to give an indication of the shape of the 
relationship. The individual data points represent the strength of the association at 
a given age and the change from one age to the next represents the effect of 
-47- 
growth [121]. Date from the Pelotas birth cohort in Brazil was used to illustrate this 
method, showing a negative effect of birth weight on systolic blood pressure and a 
strong positive effect of weight at 15 years of age. In addition the graphs revealed 
an essentially linear association between weight centile crossing from birth to 15 
years of age and systolic blood pressure at this later age point [121] (Figure 1.2). 
Figure 1.2 Life course plot for the association between weight in childhood and 
blood pressure in adolescence in the Pelotas cohort, Brazil 
(reproduced from Cole [121]) 
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As the interest in the impact of early life has grown, a number of more 
sophisticated analysis techniques have emerged. Ben-Shlomo et al have suggested 
modeling individual growth trajectories, which by necessity requires multiple 
measurements, in order to gain a more complete understanding of the pattern of 
growth that may be associated with raised blood pressure [122]. Their analysis of 
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the Barry Caerphilly Growth Study in Wales has demonstrated that rapid postnatal 
weight and length gains in the first five months of life are positively associated with 
systolic and diastolic blood pressure at 25 years of age, [122]. In contrast, a recent 
pooled analysis of cohort data from Brazil, Guatemala, India, the Philippines and 
South Africa reported that larger size in early childhood was associated with later 
blood pressure mainly through its association with greater BMI, and that the rate of 
growth in early life did not affect later blood pressure [123]. 
Feeding 
The impact of infant feeding behavior on the development of high blood pressure in 
later life was reviewed systematically by Owen et al [124] in 2003 and again by 
Martin et a/ in 2005, with this second review focusing only on studies with follow- 
up beyond the first year of life [125]. Both reviews found some evidence of lower 
systolic blood pressure for exclusively breast fed compared to exclusively bottle fed 
individuals. However, they also both reported a stronger effect in smaller studies, 
with only a very borderline effect in studies recruiting over 1000 individuals, 
suggesting some publication bias in the literature [124,125]. The most recent 
review and meta-analysis was conducted by Horta et al for the WHO in 2007 as part 
of a wider summary of the long-term health effects of breast feeding [126]. This 
review included 28 observational studies and one randomised controlled trial. The 
meta-anlaysis revealed a pooled estimate of systolic blood pressure that was - 
1.21mmHg (95% Cl: -1.72, -0.7) lower for breast fed compared to bottle fed 
individuals and a smaller effect for diastolic blood pressure of -0.49mmHg (95% Cl: - 
0.87, -0.11) [126]. Again the authors reported evidence for publication bias with 
smaller sample sizes revealing larger effects, and some evidence that any effect of 
breast feeding may be attributed to issues of residual confounding [126]. 
Infections 
The impact of infectious diseases in early postnatal life on the risk of chronic 
diseases in later life could be one interpretation of the observed association 
between infant mortality rates and death rates from coronary heart disease, which 
form the foundations of the DOHaD research field [45,127]. There is little evidence 
-49- 
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exploring any link between infectious diseases in early life and blood pressure 
development. However, some suggestive data were provided by the ALSPAC 
cohort; hospital admissions for dehydration in infancy were associated with higher 
diastolic blood pressure at seven years of age, which the authors suggest could 
reveal a link between diarrhoea in infancy and later blood pressure [128]. Although 
this finding was replicated in a similar study in Brazil, the more detailed data 
available in this study failed to show an association between frequency of 
dehydrating diarrhoea in infancy and blood pressure at a mean age of 5.6 years 
[129], lending uncertainty to the explanation of the original observation. 
1.4.2.2 Animal studies 
The majority of animal studies in the DOHaD field have concentrated on the 
manipulation of the diet during pregnancy and only a few have focussed on the 
impact of the postnatal diet, recently summarised by Symonds [130]. If a low 
protein diet is continued from pregnancy throughout lactation in rats, the offspring 
have blood pressure that is no different from control animals, even if they are given 
a standard diet after weaning [131]. Interestingly, the offspring exhibit lower blood 
pressure than controls as adults if they are continued on the low protein diet after 
weaning [132]. The importance of diet during lactation, at least in rat models, has 
been highlighted by work by Ozanne and Hales [133]. Male rat pups exposed to 
reduced nutrition during in utero development but cross-fostered at birth to dams 
on a normal diet show rapid catch-up growth and a reduced lifespan compared to 
those born to normal dams and cross-fostered to dams on a reduced diet [133]. 
1.4.2.3 Human intervention trials 
Very few studies have investigated the impact of nutritional interventions in early 
post-partum life on subsequent blood pressure. One of the widely cited examples 
pertains to an intervention conducted in preterm individuals to investigate the 
impact of breast vs formula milk on health and development. Preterm infants 
randomly assigned to receive banked breastmilk for the first few weeks of life had 
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lower diastolic and mean arterial blood pressure at 13-16 years compared to infants 
given preterm formula [134], although no difference had been observed in an 
earlier study when the offspring were 7.5-8 years old [135]. In a separate trial of 
term infants born small for gestational age, individuals randomised to receive 
protein-enriched formula had increased diastolic and mean arterial pressure 
compared to those on standard formula at age 6-8 [136]. The authors suggest that 
the lower risk in these studies relates to slower postnatal growth experienced by 
breast-fed vs formula-fed or standard vs enriched formula-fed infants [136]. One 
additional intervention study provides useful data in this field. A large multicentre 
cluster-randomised controlled trial promoting breastfeeding in the Republic of 
Belarus using the steps of the WHO and UNICEF-developed Baby-Friendly Hospital 
Initiative was conducted between 1996 and 1997 and termed the 'Promotion of 
Breastfeeding Intervention Trial' (PROBIT) [137]. The trial was successful at 
increasing the rate of breast feeding; infants in intervention sites were more likely 
to be breastfed exclusively at three and six months compared to infants in control 
areas [137]. However, a follow-up study when the children were 6.5 years of age 
found no difference in blood pressure between the children from intervention and 
control sites [138]. 
1.4.3 Other early-life exposures 
Stress 
The effect of stress during pregnancy on birth weight and subsequent disease risk 
has been proposed as an alternative explanation for the impact of the fetal 
environment on the development of the blood pressure system [139]. Animal 
evidence has supported this hypothesis; administration of the synthetic corticoid 
stress hormone dexamethasone to pregnant rats results in hypertensive offspring 
who are born low birth weight [139-141]. Observational studies of human preterm 
infants have reported that prenatal exposure to corticoids is associated with raised 
offspring blood pressure [142], although a recent RCT of the corticosteroid 
betamethasone vs placebo provided during pregnancy has shown no adverse effect 
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on offspring blood pressure [143]. In the US birth cohort Project Viva, a higher ratio 
of cortisol to cortisone in umbilical venous cord blood (representing increased fetal 
exposure to cortisol) was found to be associated with increased systolic blood 
pressure at three years of age [144]. At present, little other data from human 
studies is available to test this intriguing hypothesis. Moreover, it has been 
suggested that the mechanism through which stress impacts on the development of 
offspring blood pressure is through a reduction in maternal dietary intake during 
pregnancy, a pathway that has been observed in rat models [145]. 
Seasonality 
Season of birth in settings where there is a marked seasonality of farming activities 
and of food availability has been used by some research groups as a marker of sub- 
optimal conditions experienced during in utero development. In The Gambia, 
individuals born during the annual hungry season running from July to December 
have been shown to have a 10-fold increased risk of death in young adulthood, 
predominantly from infectious causes [146]. This has led researchers to speculate 
that the development of the immune system may be impaired in individuals born in 
the hungry season [147]. Interestingly, there is no evidence from the same 
population that season of birth is related to cardiovascular risk factors in young 
adulthood, including blood pressure [148]. Data from the Pune Maternal Nutrition 
study in India has further highlighted the effects of seasonality; marked changes in 
activity and energy intake correspond with the seasonal changes in farming 
patterns and in turn are associated with maternal weight fluctuations and with 
birth weight [149]. 
1.4.4 Summary of early-life literature 
The importance of fetal nutrition for the optimal development of the blood 
pressure system has been inferred from studies showing a consistently inverse 
association between birth weight and blood pressure in later life. Direct evidence of 
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the role of the maternal diet has been demonstrated by a large number of animal 
experiments, but data on the impact of diet during pregnancy in humans is 
conflicting, partly due to the heterogeneity of the data collected in observational 
studies investigating this hypothesis. Follow-up studies of intervention trials of 
maternal supplementation can provide a useful resource with which to investigate 
the impact of the maternal diet, which should be free from confounding, but to 
date very few have been published. 
Recent research attention has focused on the postnatal period as another key stage 
in the life course that may affect later blood pressure. The impact of growth in the 
first few years of life has been inferred from the inverse associations between birth 
weight and blood pressure that often are only apparent after adjustment for 
current size. Again direct evidence of the role of nutrition during the first few years 
of life on later blood pressure is lacking. One exception is the predominantly 
observational data on the impact of breast feeding compared to formula feeding, 
but again the results are conflicting. 
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1.5 Potential mechanisms 
Despite the paucity and conflicting findings from some of the human data, the 
evidence does appear to suggest that environmental influences, potentially 
nutritional, operating in early life can affect an individual's susceptibility to 
developing chronic disease. It is therefore necessary to consider which mechanisms 
may be operating during development that impact on the blood pressure system; 
possibilities are outlined below. 
1.5.1 Structural changes 
The kidneys (Figure 1.3) are the major organ in the blood pressure system and act 
as the regulator of long-term arterial pressure [150,151]. Waste products produced 
by body cells are excreted in urine formed by the kidneys, a process that maintains 
the normal volume, electrolyte composition and pH balance of the blood and thus 
the maintenance of normal blood pressure [152]. Due to the pivotal role the 
kidneys play in maintaining body fluid composition they are thought to be 
important in the development of hypertension. Other evidence implicating the 
kidneys in the development of hypertension is that all known single gene mutations 
associated with hypertension are characterised by altered expression of kidney 
proteins [153] and that transplant recipients exhibit blood pressures that reflect 
those of their donors [154]. 
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Figure 1.3 Cross-sectional image of a kidney with major vessels and the 
microcirculation surrounding a single nephron 
(reproduced from Guyton and Hall [7]) 
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Nephrons are the functional unit of the kidney and the site of urine formation 
(Figure 1.3 and 1.4). The first sections of the nephron are located in the kidney 
cortex, these are the glomerulus capillary network, which is surrounded by the 
expanded end of the renal tubule known as Bowman's capsule (Figure 1.4) [152]. 
Blood pressure forces plasma, and associated dissolved substances, out of the 
glomeruli and into Bowman's capsule where it is known as renal filtrate. As the 
filtrate passes through the remainder of the nephron (the connecting tubule, 
proximal tubule and loops of Henle), the majority is reabsorbed and only around 1% 
eventually enters the renal pelvis to be lost as urine [152]. The kidney filtration 
surface area is therefore dependent on the number of functioning nephrons, and a 
reduced number is thought to confer a susceptibility to developing hypertension 
[155]. A figure of roughly 1 million nephrons is often quoted as the average number 
per kidney [152]. Hoy et a/ describe studies from as long ago as the 1930s that 
report inverse associations between systolic blood pressure and nephron number 
[156]. 
Figure 1.4 Structure of a single nephron, not drawn to scale 
(reproduced from Guyton and Hall [7]) 
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The rate of filtration into the Bowman's capsule is known as the glomerular 
filtration rate (GFR). Estimation of the GFR is often used by clinicians to measure 
kidney function and in the detection of chronic kidney disease [157]. GFR declines 
with age from an average of around 130 ml/min/1.73m2 in young men and 120 
ml/min/1.73m2 in young women; a cut-off of 60 ml/min/1.73m2 is used to detect 
chronic kidney disease in both men and women [157]. The gold standard 
measurement of GFR is the plasma clearance rate of injected substances that are 
exclusively excreted by the kidneys, such as chromium-EDTA, but these techniques 
are expensive and difficult to perform routinely [157]. As an alternative, serum 
creatinine has been widely used for the estimation of GFR but the marker has come 
under recent criticism for its variation in response to other factors than renal 
function, particularly its association with muscle mass [158]. Recently, Cystatin C 
(CysC) has been proposed as an alternative estimator of GFR that may be more 
accurate than creatinine, particularly amongst children [158,159]. 
It has been suggested that a reduction in nephron number as a result of inadequate 
fetal nutrition may explain the association between low birth weight and 
hypertension [150]. In humans, nephrogenesis occurs between weeks 8 and 36 of 
gestation with the majority forming in the third trimester and no potential for 
increase after birth [160]. Brenner et al postulate that a reduction in nephron 
number would cause the remaining glomeruli to undergo hypertrophy and 
hyperfiltration in compensation, ultimately leading to a loss of functioning 
glomeruli through glomerulosclerosis and the subsequent development of 
hypertension in response to this decline in kidney function [155]. There is support 
for this hypothesis from animal experiments; a low protein diet during pregnancy 
has consistently been shown to result in a reduced number of nephrons (of around 
30%) in rat models [79,161-164], whilst in the sheep the same effect has been 
induced by exposure to a global undernutrition diet [165,166]. However, there 
remains some debate about the link between reduced nephron number and 
hypertension; in one rat model combined pre- and postnatal protein restriction 
resulted in a deficit in nephron number but a lower rather than higher mean 
arterial pressure [132]. 
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There are few studies in humans investigating the hypothesis that inadequate 
nutrition in utero is associated with structural changes to the kidney, and 
particularly a reduction in nephron number. In a very small study of stillborn 
infants, those who were severely growth retarded had a reduced nephron number 
[167]. Autopsy data have also provided supportive evidence, reporting positive 
associations between nephron number and birth weight [168,169]. In vivo 
assessments of kidney function range from structural parameters such as 
ultrasound assessed volume to estimates of glomerular filtration rate and tubular 
function via surrogate markers. At autopsy, kidney volume has been shown to 
correlate well with the number of functioning nephrons, suggesting that this 
parameter may be used as a proxy indicator of nephron number [170]. 
Konje et al report that small for gestational age fetuses, assessed by ultrasound, 
have smaller kidneys after 26 weeks of gestation than those appropriate for their 
gestational age [171]. Australian Aborigines have a high prevalence of both 
hypertension and low birth weight and a study of children and adolescents 
demonstrated that low birth weight individuals had a lower kidney volume, 
assessed by ultrasound, than those of normal birth weight [172]. A study of US 
adults also reported a strong correlation between glomerular number and birth 
weight [173]. A larger comparison study involving over 300 people from Australia 
and the USA reported that Aborigines and US whites with hypertension had fewer 
nephrons than those groups without hypertension, but the same relationship was 
not significant for US blacks [156]. Japanese individuals appear to have smaller 
kidneys than Caucasians, which has been postulated to partly explain the greater 
prevalence of hypertension in this population [150]. White et al recently reviewed 
the observational data linking low birth weight to chronic kidney disease in later life 
and their meta-analysis provided some evidence for an association between low 
birth weight and albuminuria, end-stage renal disease and low estimated 
glomerular filtration rate, although it should be noted that half of the studies 
reported a null association [174]. 
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Postnatal growth maybe an important factor to consider in the association between 
reduced nephron number and raised blood pressure in later life. Bagby postulates 
that at birth nephron number and body size should be aligned for individuals born 
small for their gestational age [160]. If however, accelerated growth is experienced 
postnatally the excretory demand (body mass) exceededs the excretory capacity 
(nephron number) and it is this imbalance that confers susceptibility to 
hypertension in later life [160]. 
Microalbuminuria is one of the first symptoms of renal disease, even before a 
decrease in glomerular filtration rate (GFR) [175]. In Australian Aborigines, low birth 
weight was associated with high albumin-creatinine ratio (ACR) (_34g/mol) in 
adulthood, which is indicative of renal disease although there was no difference in 
blood pressure [176]. A study in the Netherlands reported that in individuals born 
before 32 weeks gestation (and therefore before nephrogenesis is completed) high 
ACR was related to low birth weight [175]. Evidence for a raised ACR was also 
observed for individuals exposed to the Dutch Hunger Winter during mid-gestation 
compared to those who were un-exposed, when individuals were measured at 
around 50 years of age [177]. However, there was no corresponding difference in 
blood pressure at this age [59]. 
It has also been proposed that fetal growth restriction is associated with structural 
changes of the vasculature. Some authors have suggested that the laying down of 
elastin in utero is impaired in low birth weight individuals and the resulting blood 
vessels have reduced compliance, thus resulting in raised blood pressure [45]. Small 
studies of low birth weight individuals have found some evidence of altered 
function of the microvasculature [178], whilst there is also suggestive evidence 
from rat and sheep models [80]. However, further evidence on the role of vascular 
structure in the programming of blood pressure in humans is limited at present. 
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1.5.2 Hormonal changes 
Renin (mainly released by the kidneys) stimulates the conversion of angiotensin I 
(ANG I) to angiotensin II (ANG II) by angiotensin-converting enzyme (ACE), which 
acts through a variety of mechanisms to increase blood pressure [179]. In addition, 
the renin-angiotensin system (RAS) is important for nephron development during 
gestation [180]. Therefore, the programming of the RAS may represent a 
mechanism whereby nephrogenesis is affected or an alternative mechanism linking 
fetal nutrition to later blood pressure. In rats, nutrient restriction has been 
associated with increased activity of ACE [78]. Human data is very limited, although 
higher ANG II concentrations have been reported amongst growth restricted infants 
in Glasgow, compared to those who were appropriate weight for their gestational 
age [181]. In contrast, lower plasma renin levels were reported for adults in the 
Sheffield birth cohort who had been born small for gestational age [182]. 
Insulin-like growth factor (IGF) also plays an important role in kidney development; 
IGF is expressed at high levels in the developing kidney and knock-out animals 
without IGF-I have impaired renal development [180]. IGF has been shown to be 
altered in many of the diseases associated with low birth weight and growth 
retarded humans have elevated IGF-I [45]. The role of IGF in the programming of 
hypertension is unclear. Sheep exposed to a 50% reduction in energy requirements 
during the last trimester produced offspring with upregulated IGF-l receptors but 
no difference in kidney size [180]. Interestingly, sheep exposed to reduced energy 
requirements throughout pregnancy showed no effect on IGF-I receptors [180]. 
1.5.3 Epigenetics 
If, as is suggested, there are critical periods of development that respond to cues or 
stresses in the environment and in turn influence the blood pressure system 
(amongst others), how are these cues translated into the proposed mechanistic 
changes outlined above? The role of epigenetics has been highlighted as a likely 
linking mechanism and the data relating to DOHaD has been recently summarised 
by Waterland and Michels [183]. Epigenetics refers to heritable changes in gene 
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expression potential, of which changes in DNA methylation patterns is one of the 
best characterised examples [183]. DNA methylation patterns are established 
during fetal and early postnatal development and are thus susceptible to 
environmental stimuli, such as dietary supply, at this time [183]. One line of 
evidence that epigenetic mechanisms can be influenced by the maternal diet has 
been derived from studies in the agouti mouse. In this model, diets rich in methyl 
donors provided periconceptually and throughout pregnancy were associated with 
changes in offspring coat colour that operated via altered epigenetic expression 
[184]. Altered methylation patterns have also been described in the angiotensin 
receptor gene of rats born to dams fed a low protein diet during pregnancy [185], 
again implicating epigenetics in the explanation of the effect of nutritional 
programming of hypertension. There is little data yet published that investigates 
epigenetic changes in response to fetal nutrition in humans. However, a recent 
small follow-up study of the Dutch Hunger Winter revealed less DNA methylation of 
the insulin-like growth factor 2 (IGF2) gene for individuals conceived during the 
famine compared to unexposed same-sex siblings, providing suggestive evidence of 
genetic changes in response to environmental exposures during fetal development 
[186]. 
1.6 DOHaD theories 
Since its inception, the field of DOHaD has stimulated a lively discussion on the 
possible explanations for the observed inverse association between birth weight 
and later disease. These have often focused on whether the postulated mechanistic 
changes, as a consequence of sub-optimal early nutrition, reflect a purely 
pathogenetic process or whether there could be adaptive advantages. This section 
will briefly summarise three of the influential theories in this field, in chronological 
order of their appearance in the literature. 
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1.6.1 Thrifty genes 
The term the 'thrifty genotype' was first used by Neel in 1962 to describe the 
potential for genes that allow metabolically frugal processes, which would confer 
advantages in times of food shortages but which in today's environment result in an 
increased susceptibility to metabolic diseases [187]. Prentice has argued in support 
of this theory that much of human evolution has been characterised by periods of 
extreme famine, providing an evolutionary pressure to select genes that allow 
increased survival in these conditions, in other words a pressure for genes that are 
'thrifty' [188]. In modern society, where there is predominantly an abundance of 
food, these genes are no longer advantageous and may instead render individuals 
susceptible to disease [189]. The majority of discussions around the concept of the 
thrifty genotype have focused on genes involved with metabolic functions or with 
behavioural adaptations that conserve fuel [189], the applicability of this theory to 
the blood pressure system is thus debatable. 
1.6.2 Thrifty phenotypes 
Hales and Barker proposed the 'thrifty phenotype' hypothesis in the early 1990s in 
an effort to explain the observed inverse association between birth weight and 
impaired glucose tolerance and the metabolic syndrome [190]. They postulated 
that fetal malnutrition led to changes in body systems, such as poor pancreatic 0- 
cell development and insulin resistance, which in turn reduced growth and 
preserved resources for brain development [191]. The resulting reduced capacity 
for insulin secretion may become detrimental in later life leading to a greater risk of 
developing glucose intolerance, particularly if an individual were to become 
overweight or obese [191]. Metabolic adaptations lend themselves to the thrifty 
phenotype hypothesis as intuitive mechanisms for preserving fuel; the 
extrapolation of the theory to the development of hypertension is less obvious. 
However, the potential structural changes in the kidneys outlined in Section 1.5 
could also be viewed as 'brain sparing' mechanisms in as far as resources are 
diverted away from peripheral organs, resulting in a smaller size and functional 
capacity. Although a necessary adaptation for short term survival, these changes 
-62- 
Chapter 1: introduction 
may confer increased susceptibility to hypertension in later life, particularly in 
environments of nutritional excess (Figure 1.5). 
Figure 1.5 Development of hypertension explained by the thrifty phenotype 
hypothesis 
(adapted from Hales and Barker [191]) 
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1.6.3 Mismatch hypothesis 
In essence the thrifty phenotype hypothesis outlined above is a form of 
'developmental plasticity', which is an observed phenomenon throughout the 
animal kingdom. There is a clear survival advantage to an organism that is able to 
adjust its development optimally in response to the prevailing environmental 
exposures, a phenomenon that has been observed for many species [192]. 
Gluckman and Hanson have defined the concept of developmental plasticity within 
the framework of DOHaD in what they term the 'Predictive Adaptive Response' or 
'Mismatch' hypothesis, by which they propose that the developing fetus utilises 
cues (potentially nutritional) from the uterine environment to predict the 
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environment that will be experienced postnatally, and thus takes the appropriate 
developmental pathway [193]. Provided that these cues do accurately predict the 
future environment there is no increase in disease risk, but if there is a substantial 
'mismatch' between the early and later environments a greater risk of disease is 
incurred [193]. Currently many populations could be experiencing a mismatch 
between predicted and experienced environments due to the rapidity by which 
food preferences, consumption patterns and energy expenditure are changing over 
time, particularly in developing countries undergoing rapid nutrition transitions. 
Indeed, Gluckman and Hanson have suggested that the epidemic of type II diabetes 
currently witnessed on the Indian sub-continent may be a consequence of 
improved postnatal nutrition for individuals born small as a consequence of 
intergenerational poor nutrition and corresponding maternal constraint [193]. 
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1.7 Study aim and design 
The primary research aim of this thesis is to investigate the impact of the maternal 
diet during pregnancy on offspring blood pressure. The adopted approach is the 
follow-up of randomised controlled trials (RCTs) of maternal nutritional 
supplementation. These trials represent a valuable resource with which to 
investigate this research question, providing two main advantages over 
observational studies in this field: 
1) The RCT design allows us to be less concerned about issues of confounding 
and therefore more confident that observed effects are due to the 
treatment regime 
2) The diet has been changed by a known amount and therefore, provided 
compliance data is available, it is not necessary to rely on observational 
dietary intake data, which has well-documented measurement errors. 
To investigate this research question, three intervention studies were chosen (Table 
1.11): one of protein-energy supplementation, one of calcium supplementation and 
one multifaceted design including food and micronutrient supplementation as well 
as an intervention to promote exclusive breastfeeding. 
As a secondary research aim, observational analysis was also conducted for each of 
the trial 'cohorts' to investigate the impact of other early life factors in the 
development of blood pressure including, birth weight, season of birth and infant 
growth. 
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1.8 Candidate's involvement 
I defined the topic of this thesis and main research question in close collaboration 
with my supervisor Dr Sophie Moore. The two large follow-up studies (one in The 
Gambia and one in Bangladesh) were conducted in close collaboration with the 
original study principal investigators who gave full permission to use data from the 
original trials in this thesis. For clarity, I have outlined my specific involvement in 
the different aspects of this thesis below. 
Chapter 2: Gambian methods 
Description of the original Gambian follow-up study and statistical analysis. The 
fieldwork component did not take place in the timeframe of the PhD and is merely 
described here to allow for the interpretation of results in their appropriate 
context. 
Chapters 3 and 4: protein-energy and calcium results 
Presentation of the impact of maternal protein-energy (Chapter 3) and calcium 
(Chapter 4) supplementation on offspring blood pressure. All aspects of the data 
analysis from defining the research questions to presenting the data were 
conducted by me with expert guidance, where appropriate, from Dr Sophie Moore 
and Dr Tony Fulford (statistician). 
Chapter 5: Bangladesh methods 
Description of fieldwork conducted in Bangladesh to follow-up a large multifaceted 
nutritional intervention. I was a co-PI on this large project, in collaboration with 
staff from Uppsala University, Sweden and the International Centre for Diarrhoeal 
Disease Research, Bangladesh. I was heavily involved from the beginning of the 
project with the design and implementation of the follow-up study as well as the 
staff training and monitoring of data collection. 
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Chapter 6: Bangladesh results 
Presentation of the impact of maternal food, micronutrient supplementation and 
breast feeding counselling on offspring blood pressure and kidney function. Again, I 
performed all aspects of the analysis, receiving expert advice where appropriate. 
-68- 
Chapter 2: Gambian methods 
Chapter 2 Gambian study methods 
2.1 Forward 
In 2005 the UK Medical Research Council International Nutrition Group (ING), in 
collaboration with MRC Human Nutrition Research, Cambridge, participated in a 
large European Union Consortium to investigate the early life nutritional 
determinants of disease. The project was funded by the European Union Sixth 
Framework Programme for Research and Technical Development of the European 
Union Community and was known as the 'Early Nutrition Programming Project' 
(FOOD-CT-2005-007036) or 'EARNEST' (Early nutrition programming - long term 
follow up of efficacy and safety trials and integrated epidemiological, genetic, 
animal, consumer and economic research). The role of the ING was to investigate 
the impact of two maternal supplementation trials in The Gambia on cardiovascular 
disease risk factors in the offspring. A description of the original supplementation 
trials and the follow-up study is given in this chapter, with particular emphasis on 
the statistical methodology that has been used in the analysis of the data. The 
results of the analysis of the effect of maternal protein-energy supplementation will 
be described and explored in Chapter 3 and the effect of maternal calcium 
supplementation in Chapter 4. 
2.2 Field site 
2.2.1 The Gambia 
The Gambia is a small country in West Africa, surrounded on three sides by Senegal 
and on the fourth by the Atlantic Ocean (Figure 2.1). The country is 11,295km2 and 
in 2006 the population was reported to be 1.6 million [196]. Islam is the main 
religion and English is the official language, although there are many indigenous 
languages spoken [197]. World Bank statistics for 2007 estimate life expectancy as 
69 years and under five mortality rate as 68 per 1000 [196]. The vegetation is 
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tropical savannah and the climate is characterised by a hot rainy season that runs 
from June to November and a dry season which covers the remaining months [197]. 
2.2.2 West Kiang 
The majority of fieldwork conducted by the ING is concentrated in the rural region 
of West Kiang, 80km from the more urbanised coastal areas (Figure 2.1) and with a 
population of over 14,000 as of 2009 (Fulford, pers. comm. ). The majority of people 
in the West Kiang region speak the Mandinka language and extended families live 
together in compounds, the average size of which is 15 people (Fulford, pers. 
comm. ). The region is characterised by subsistence agriculture and the cereal crops 
are rice (Oryza sativa), millet (Pennisetum glaucum), and sorghum (Sorghum 
bicolour), which are predominately tended to by the women in the community. 
Farming activities and the availability of food show marked variation over the year 
in response to the seasonality of the rains. The months from June to October, when 
the majority of farming work is conducted and next year's harvest has yet to come 
in, have been termed the 'hungry season', whilst November to May is known as the 
'harvest season' [194]. This seasonal pattern of energy expenditure and nutrient 
intake is associated with marked changes in maternal weight gain and in birth 
weight [198]. 
2.2.3 MRC Keneba 
The MRC has run a research station in the village of Keneba within West Kiang since 
1974, previously as part of the MRC Dunn Nutrition Unit and now as part of the 
ING. In parallel to their international research agenda, the MRC provides a clinical 
service and over the years has established strong links with the local community. 
More than 120 staff are employed at MRC Keneba; the fieldworkers have a wealth 
of experience of working in the area and are a key component of any successful 
project. 
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Figure 2.1 Map of The Gambia, located within West Africa 
(reproduced from West Africa Crossroads (regional map) and University of Missouri 
(Gambian map) [199,200]) 
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2.3 Original supplementation trials 
A follow-up study of two supplementation trials forms the basis of this PhD 
research. These trials were conducted when MRC Keneba was part of the MRC 
Dunn Nutrition Unit and the original Principal Investigators (Protein-energy: 
Andrew Prentice; Calcium: Ann Prentice and Landing Jarjou) gave permission to use 
the pre-existing trial data and gave their full support to the follow-up study 
described below. 
2.3.1 Protein-energy supplementation trial 
Between 1989 and 1994, pregnant women in the rural West Kiang region of The 
Gambia were invited to take part in a food supplementation trial to improve birth 
weight [194]. Using a cluster design with 28 villages, all consenting pregnant 
women were randomised to receive two protein-energy dense biscuits a day, either 
from 20 weeks gestation until delivery (intervention villages) or for 20 weeks post- 
partum (control villages). The biscuits were made locally from local ingredients 
including roasted groundnuts, rice flour, sugar and ground nut oil. Women received 
two biscuits a day and were asked to consume them in the presence of a traditional 
birth attendant so that intake could be recorded [194]. The maximum daily intake 
from two biscuits is displayed in Table 2.1 together with the average requirements 
for pregnant women in this region. In line with the original trial, throughout this 
thesis the offspring of women who received protein-energy biscuits during 
pregnancy will be referred to as 'intervention' whilst those whose mothers received 
biscuits post-partum will be referred to as 'control'. 
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Table 2.1 Nutrient intake provided by protein-energy biscuit supplement 
Nutrient Daily requirementa Maximum daily 
intake from two 
biscuits 
Energy (kJ) 11840 4250 
Protein (g) 74` 22 
Fat (g) 62.8d 56 
Calcium (mg) 800e 47 
Iron (mg) N/Af 1.8 
aAverage requirement for third trimester of pregnancy, based on the average age of 24y and weight 
of 53kg of women in the original trial. 
bCalculated from FAO/WHO/UNU Expert Consultation [201] 
`The safe level (meeting 95% of the population) calculated from the WHO Technical Report [202] 
dBased on the minimal requirement of 20% of energy from fat and assuming a conversion factor of 
37.7KJ=lg of fat [203] 
e Theoretical allowance reported in FAO/WHO Expert Consultation [204] 
fNo recommend intake is given in the FAO/WHO Expert Consultation for iron [204] 
Birth weight was the primary outcome of the original trial and was measured using 
a portable spring balance and tared sling (CMS Weighing Equipment, London) to the 
nearest 20g and within 48 hours of birth [194]. Birth length was measured using 
neonatal length mats (TALC Teaching Aids, St Albans, England) to the nearest 5mm. 
Maternal height was measured at baseline (20 weeks gestation) and maternal 
weight was measured within 48 hours of delivery to the nearest 200g [194]. 
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The randomisation process of the trial was successful in producing two groups 
which did not differ in the distribution of measured characteristics known to 
influence birth weight (Table 2.2). 
Table 2.2 Characteristics of rural Gambian women enrolled into the protein-energy 
supplementation trial 
(adapted from Ceesay et al [194]) 
Control groups Intervention group 
No of live singleton births 1037 1010 
Male births (%) 50.4 49.5 
Maternal age (y) 23.7 (6.4) 24.0 (6.2) 
Maternal parity 4.2 (2.4) 4.3 (2.6) 
Maternal height (m) 1.59 (0.06) 1.59 (0.06) 
No days of prenatal 0 82 (31) 
supplementation 
Values are means (SD), unless otherwise stated 
'Control group received supplementation during lactation 
There were 2047 live singleton births during the five years of the trial and the 
intervention was found to improve birth weight, by 136g overall and with a greater 
increase (201g) during the nutritionally poor hungry season (June - October) (Table 
2.3) [194]. The odds of neonatal mortality (up to day 28, including stillbirths) was 
also improved by the administration of the supplement during pregnancy with an 
odds ratio of 0.57 (95% Cl: 0.38,0.88) [194]. 
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Table 2.3 Effect of protein-energy supplementation to pregnant women on 
offspring birth anthropometry in The Gambia 
(reproduced from Ceesay et al [194]) 
Regression coefficient 
(95% Cl) 
P-value 
Birth weight (g) All year 136 (79,193) <0.001 
(n=1751)a Harvest seasonb 94 (31,157) <0.001 
Hungry season 201 (132,270) <0.001 
Birth length (cm) All year 0.16 (-0.24,0.56) >0.2 
(n=1746)a Harvest seasonb -0.01 (-0.41,0.39) >0.2 
Hungry season 0.41 (-0.09,0.91) >0.05 
Results are the mean difference in birth anthropometry between individuals born to intervention 
compared to control women, derived from three stage random effects modelling, adjusted for sex, 
primiparity and gestational age as Parkin score 
'Missing Parkin scores for gestational age reduced sample size of analysis from 2047 
bHarvest season defined as November - May, hungry season as June - October 
2.3.2 Calcium supplementation trial 
Between 1995 and 2000, staff from MRC Human Nutrition Research in Cambridge 
conducted a prenatal calcium supplementation trial in The Gambia to reduce pre- 
eclampsia. All pregnant women from 16 villages in the rural West Kiang region were 
invited to participate in a double-blind, randomised, placebo-controlled trial of 
calcium supplementation [195]. Women were randomised using published tables to 
receive the intervention (1500mg Ca/d as calcium carbonate) or placebo (cellulose- 
lactose), from 20 weeks gestation until delivery. This is well above the level of 
200mg Ca/d recommended as a requirement during pregnancy [205]. Both the 
calcium supplement and placebo were provided daily in three identical chewable 
tablets. Study participants were randomised in blocks of four to ensure that women 
were enrolled from different seasons. Maternal antenatal care was stratified by 
three clinic blocks, which corresponded to different areas under the responsibility 
of the three midwives involved in the trial. Fieldworkers delivered the tablets to 
participating women on a daily basis between 5-7pm and recorded their 
consumption as a measure of compliance. 
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The primary outcome of the study was maternal blood pressure at 36 weeks 
gestation, measured in triplicate using the DINAMAP PRO 400 automated monitor 
(Critikon Ltd, UK) under standard techniques. Maternal weight was measured to the 
nearest 0.1kg whilst wearing light clothing but no shoes (Wylux scales: CMS 
Weighing Equipment Ltd, London, United Kingdom) and height was measured using 
a stadiometer, also whist wearing no shoes, to the nearest 0.1cm (Magnimetre 
stadiometer: CMS Weighing Equipment Ltd). Birth weight and length were 
measured by traditional birth attendants but there were a large number of missing 
data (34% of live singleton births), therefore for the analysis presented in this 
thesis, infant anthropometry at two weeks of age has been used as an estimate of 
birth anthropometry. At this later time point trained fieldworkers took the 
measurements; naked weight was measured to the nearest 0.01kg (Seca baby- 
weighing scale: CMS Weighing Equipment Ltd) and supine crown-heel length was 
measured using a length-board to the nearest 1cm (Kiddimate: Raven Equipment 
Ltd, Dunmow, United Kingdom). 
Blood pressure at 36 weeks gestation was measured in 536 women, and 546 live 
singleton infants were deemed to have been delivered at term and retained in the 
cohort. Maternal calcium supplementation was shown to have no effect on breast 
milk calcium concentrations, birth weight or infant bone mineral status in a sub-set 
of the participants who were enrolled in a more detailed sub-study [195]. Analysis 
of the main outcome, maternal blood pressure at 36 weeks gestation, is ongoing. 
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2.4 Follow-up study, methodology 
2.4.1 Subjects 
The EU-funded follow-up study was conducted between November 2005 and 
August 2006, and the same protocol was used for the offspring of both trials. 
Children born to women who had participated in the protein-energy trial were 11- 
17 years old at follow-up, whilst those born to women who had participated in the 
calcium trial were 5-10 years old. For logistical reasons, recruitment was restricted 
to individuals who were still resident in West Kiang and to those who had moved to 
urban/perl-urban areas at the coast, provided they were within one hour drive from 
the MRC Laboratories. From the protein-energy trial, data were missing for 44 
individuals, 207 had died in the intervening years and 254 had moved outside of the 
study area, thus reducing the potential sample size for follow-up to 1542 (Figure 
2.2). For the calcium trial, 452 children were known to be still alive and to be living 
within the study area and thus represented the number of children that were 
eligible for the follow-up (Figure 2.3). 
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Figure 2.2 Flow diagram of progression of offspring from protein-energy trial until 
time of current follow-up 
1460 women delivered during trial 
1010 births 1037 births 
INTERVENTION ARM CONTROL ARM 
(16 villa es (12 villages) 
23 missing 21 missing 
details details 
95 deaths 112 deaths 
Excluded: 134 Excluded: 120 
living outside living outside 
study area study area 
758 potential 784 potential 
children in children in 
follow-up follow-up 
(16 villages) (12 villages) 
Follow-up study was restricted to individuals still living in West Kiang or within an hour drive from 
MRC laboratories in the coastal area 
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Figure 2.3 Flow diagram of progression of offspring from calcium trial until time of 
current follow-up 
662 women 
randomised 
Calcium Placebo 
330 332 
10 dropout 7 dropout 
8 fetal death 14 fetal death 
2 multiple 
9 multiple 
birth birth 
39 delivered 27 delivered 
before date before date 
L 
271 Live singleton births 275 
3 dropout 3 dropout 
20 died 19 died 
10 missing data 7 missing data 
cluded: 15 Excluded: 17 
e 
En8outsid 
living o utside 
study area study area 
223 Eligible for follow-up 229 
Follow-up study was restricted to individuals still living in West Kiang or within an hour drive from 
MRC laboratories in the coastal area 
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Scientific approval for the study was granted by MRC The Gambia Scientific 
Coordinating Committee (SCC), and ethical permission was granted by the joint 
Gambian Government and MRC Ethical Committee as well as the London School of 
Hygiene and Tropical Medicine Ethics Committee. Full informed consent was 
obtained from the parents or guardians of the children and community support was 
sought through meetings with village elders and school head teachers. 
2.4.2 Study protocol 
In West Kiang, measurements were conducted in the subject's village of residence 
as far as this was possible, to minimise disruption to their day. At the coastal areas, 
local clinics were used as study sites. All fieldworkers were trained and were 
unaware of which treatment group the child's mother had belonged to. Subjects 
were asked to attend the study visit early in the morning (lam) in a fasted state and 
were provided with breakfast once all of the measurements had been obtained. 
Data collected in the field were recorded onto paper copies of subject-specific data 
recording forms, which contained the subject's unique identifier details such as 
date of birth and maternal and paternal names. These details were used to check 
that the correct subject was recruited into the study and to ensure that the 
measurements were recorded on the correct form. Data was double-entered by 
data entry clerks at MRC Keneba within a few days of collection and any 
inconsistencies were checked in the field. 
2.4.3 Measurements 
2.4.3.1 Blood pressure 
Blood pressure was measured in triplicate using the automated Omron 7051T 
oscillometric device (Morton Medical Ltd, London, United Kingdom) and following 
the manufacturer's instructions. Children were seated at rest for five minutes 
before the initial measurement was taken and for two minutes between each 
subsequent measurement. The appropriate cuff size was chosen from 
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measurement of the mid-arm circumference and then was placed on the upper 
right arm with the arm resting on a flat table at chest height. In an effort to improve 
the accuracy of the readings, fieldworkers were asked to continue taking 
measurements until three were within 5mmHg of each other, a protocol amended 
from recommendations of the American Heart Association [206]. Children with 
unusually high blood pressure readings, as defined by the United States National 
Heart, Lung and Blood Institute guidelines [12], were seen again on a different day 
and referred to a physician if readings remained high. If the blood pressure readings 
on the second visit were within the normal range, these new values were entered 
into the database and used in the analysis. 
2.4.3.2 Anthropometry and body composition 
Height, weight, mid-upper arm circumference (MUAC) and triceps skinfold 
thickness were measured by a single fieldworker in the majority (99%) of cases to 
minimise observer bias. Standard techniques were used for each measurement. 
Weight was measured to the nearest 0.1kg using daily calibrated, digital scales 
(Tanita digital scales: Chasmors Ltd, London, United Kingdom) whilst height was 
measured using a daily calibrated stadiometer (Seca Leicester stadiometer: 
Chasmors Ltd) to the nearest 0.1cm. Triceps skinfold thickness was measured in 
triplicate on the left arm using Holtain callipers (Chasmors Ltd) and the mean 
reading to the nearest 0.2mm was recorded. MUAC was measured on the left arm 
to the nearest 0.1cm using a waxed measuring tape (Teaching Aids at Low Cost 
(TALC): Hertfordshire, UK) whilst the subject's arm was hanging by their side. 
Body composition was assessed by bioelectrical impedance analysis (BIA) using the 
Tanita BC-418MA (Chasmors Ltd) segmental analyser; measurements were 
conducted after an overnight fast and at a similar time point each day (between 8 
and 10am). This analyser uses eight electrodes to measure the impedance (z) to an 
alternating electric current as it passes through the body and inbuilt prediction 
equations convert this into an estimate of body fat. These equations are based on 
Caucasian populations, and in a validation study they were found to not be accurate 
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for this population [207]. Percentage fat-free mass (%FFM) was therefore predicted 
from a population-specific equation that had been derived previously in this 
population using deuterium oxide dilution as a reference method [207]. 
Prediction equation: 
%FFM = exp(7.659 + 0.709*In(ht) - 0.311*In(z) - 0.402*In(wt) - 0.044*In(triceps) + 
0.024*sex + 0.007*age) where z is impedance (0), ht is height (m), wt is weight (kg) 
and triceps is triceps skinfold thickness (mm). 
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2.5 Statistical analysis 
All statistical analysis was conducted using Stata 10 (Stata Corporation, College 
Station, Texas, USA). The analysis initially focused on the effect of the intervention 
(intention-to-treat followed by an as-treated analysis) before going on to explore 
some of the relevant observational data relating early exposures to later blood 
pressure. Due to the different nature of the two original trials the statistical analysis 
will be described separately for each, in the sections below. 
2.5.1 Data manipulation, both trials 
Outcome variables and continuous covariates were assessed for the normality of 
their distribution using histograms and quantile-quantile plots. For the primary 
outcome measure the mean of three measurements was taken as the estimate of 
systolic and diastolic blood pressure. Pulse pressure was defined as systolic - 
diastolic pressure, whilst mean arterial pressure (MAP) was defined as diastolic + 
(1/3 * pulse pressure). 
Body mass index (BMI) was calculated as weight(kg)/height(m)2. Percentage fat-free 
mass (%FFM) was derived from bioelectrical impedance analysis, using the 
population specific equation quoted previously (Section 2.4.3.2), and was used to 
calculate percentage fat mass (%FM=100-%FFM). Impedance data were missing for 
nine subjects from the protein-energy trial and six subjects from the calcium trial 
due to a short circuit in the analyser, which was fixed at a later date. Log-log 
regression analysis, described by Wells et al [208], was used to assess the 
relationship of FM and FFM with height (Ht). FM/Ht and FFM/Ht indices that were 
uncorrelated with height were generated by using the value of the slope parameter 
from the regression equation (Table 2.4). The relationship between fat and lean 
tissues and height was different for individuals whose mothers had participated in 
the two trials, reflecting the different age of the two groups of offspring. It was not 
possible to create prediction equations for the segmental impedance readings and 
therefore the Tanita system's inbuilt prediction equations were used for percentage 
trunk fat, which is reported as an indication of central fat distribution. 
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Table 2.4 Body composition indices created for analysis of offspring of the maternal 
protein-energy supplementation and calcium supplementation trials 
Trial Body composition Calculations 
estimate 
Protein-energy Fat-mass index I)b FM/Ht4'2 
Lean mass index (LMI)` FFM/Ht2.8 
Calcium FMI FM/Ht1'6 
LMI FFM/Ht2.3 
a Denotes the equation used to generate each index 
bindex of fat mass independent of height 
`Index of lean mass independent of height 
The association between body composition and blood pressure was assessed by 
linear regression analysis with models adjusted for age and sex. The relative 
contribution of fat and lean mass was also assessed by fitting a simultaneous model 
containing both FMI and LMI. 
2.5.2 Protein-energy trial analysis 
The analysis of the protein-energy trial was restricted to individuals born at term by 
excluding those that were assessed as less than 37 weeks gestation by their Parkin 
score [209]. Independent t-tests were used to assess any differences in 
characteristics from the original trial between individuals who were recruited and 
those lost to follow-up. 
2.5.2.1 Intention-to-treat analysis 
An intention-to-treat analysis was used to assess the effect of maternal protein- 
energy supplementation (during pregnancy vs during lactation) on offspring blood 
pressure. Generalised estimating equations [210] were used to take the cluster 
design of the original trial into account in the analysis. Variables that were potential 
correlates of blood pressure were assessed by simple linear regression and those 
statistically associated with the outcome were included in the adjusted regression 
models. There were three different stages of regression models used to investigate 
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the impact of the maternal intervention: unadjusted (model 1), adjusted for 
covariates unrelated to the maternal intervention but related to blood pressure 
(model 2), as model 2 but additionally adjusted for height, FMI and LMI (as 
continuous variables) (model 3). 
Model 2 was first conducted as a simple main effects model, and then any 
interaction of the intervention effect with age, sex, location, season of birth 
(defined as Fourier terms [211], see Section 2.5.2.4) and current body composition 
was assessed by fitting interaction terms in a sequential manner. 
Children were defined as having high blood pressure if their systolic blood pressure 
was above the 95th centile for their age and height defined by NHBPEP reference 
values [12]. The impact of the maternal intervention on the odds of having high 
blood pressure was assessed using generalised estimating equations fitted with a 
binomial family. 
2.5.2.2 As-treated analysis 
Data on the number of biscuits consumed was available for women in the 
intervention arm of the protein-energy trial but was not available for women in the 
control arm. Women in the intervention arm were divided into those who 
consumed more than the median number of biscuits and those who consumed less. 
An as-treated analysis was then conducted comparing blood pressure in these two 
groups of offspring with the offspring of control women; generalised-estimated 
equations were used, adjusted for the same covariates as before. 
2.5.2.3 Size at birth and infant growth analysis 
The association between birth weight and later blood pressure was assessed using 
linear regression. A number of different models were fitted: firstly the unadjusted 
association, then adjusting for confounders (sex, age and season of birth), the final 
model was also adjusted for current weight. A similar analysis was conducted using 
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birth length as the explanatory variable and fitting height instead of weight in the 
final model. 
For a proportion of the subjects, weight data were available for 3,6,9,12 and 36 
months of age. It had not been possible to recruit the entire cohort during these 
studies and some individuals were present at one time point but not others. As a 
result, records were available for 80% of the current follow-up subjects at 3 months 
of age, falling to 71-73% between 6 and 12 months and to 43% at 36 months. Small 
proportions of length data were also available from the 12 (45%) and 36 (18%) 
month time points. Within-population standard deviation scores (SD score: value - 
mean / standard deviation) were calculated for these age points as well as for the 
birth anthropometric variables. Magnitude of growth was defined by the change in 
weight SDS from birth to 3 months, 3 months to 6 months and so on. The impact of 
early growth on later blood pressure was assessed using linear regression analysis 
adjusted for confounders (age, sex and season of birth). In addition, the growth 
data were visualised by using life-course plots suggested by Cole [121]. For these 
plots the regression coefficient for the association between weight SD score at 
different time points and final blood pressure are plotted against age to give an 
indication of the shape of the relationship [121]. 
2.5.2.4 Season of birth analysis 
A further analysis was conducted to investigate the effect of season of birth on 
blood pressure in adolescence. Season of birth was defined by fitting Fourier terms 
(sin, cos, sinn, cos) which are smooth linear functions whose terms are 
approximately orthogonal to one another and inherently cyclic, making them ideal 
models for seasonality [211]. The impact of season of birth on blood pressure was 
investigated using likelihood ratio tests to assess whether a linear regression model 
containing season of birth terms was a better fit than a simple model containing 
only factors relating to current blood pressure (age, sex, height, FMI and LMI). 
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2.5.3 Calcium trial analysis 
The analysis of the calcium trial was also restricted to infants judged to be born at 
term, this time by excluding those who had been assessed as under 37 weeks 
gestation by their Duboviz score [212] at delivery. Independent t-tests were used to 
assess any differences in characteristics from the original trial between those 
recruited and those lost to follow-up. Again for the primary outcome measure, the 
mean of three measurements was taken as the estimate of systolic and diastolic 
blood pressure, pulse pressure was defined as systolic - diastolic pressure, and 
mean arterial pressure (MAP) was defined as diastolic + (1/3 * pulse pressure). 
2.5.3.1 Intention-to-treat analysis 
An intention-to-treat analysis using linear regression was used to assess the effect 
of supplementation during pregnancy (calcium vs placebo) on blood pressure in the 
offspring. Variables that were potential correlates of blood pressure were assessed 
by simple linear regression and those that were associated were included in the 
adjusted regression models. There were four different stages of regression models 
used to investigate the impact of the maternal intervention: unadjusted (model 1), 
adjusted for covariates unrelated to the maternal intervention but related to blood 
pressure (model 2), as model 2 but additionally adjusted for height, FMI and LMI 
(model 3), as model 3 but additionally adjusted for maternal compliance (defined as 
number of observed tablets consumed/number of expected tablets) and length of 
time spent in the supplementation trial (model 4). 
Model 2 was first conducted as a simple main effects model, then any interaction of 
the intervention effect with age, sex, maternal baseline blood pressure, maternal 
baseline BMI and child body composition were assessed by fitting interaction terms 
in a sequential manner. 
Children were defined as having high blood pressure if their systolic blood pressure 
was above the 95 `h centile for their age and height [12]. The impact of the 
intervention on the odds of having high blood pressure was assessed using logistic 
regression adjusted for the same covariates as above. 
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2.5.3.2 As-treated analysis 
An as-treated analysis was conducted relating the number of tablets a woman 
consumed during pregnancy to her offspring's blood pressure in childhood. The 
total number of tablets consumed was affected by the amount of time a woman 
spent in the study and her compliance with treatment. Compliance was defined as 
the number of observed tablets consumed/number expected over the study period. 
The as-treated analysis was controlled for the effects of compliance and of length of 
time in the study (their interaction was also fitted but the term was dropped as it 
was not significant). The calcium dose consumed by women in the original trial was 
regarded as the interaction between compliance, time in study and treatment 
group (calcium vs placebo). The association between calcium dose and offspring 
blood pressure was assessed using linear regression analysis. Different models were 
fitted: unadjusted (model 1), adjusted for covariates unrelated to the maternal 
intervention but related to blood pressure (model 2), as model 2 but additionally 
adjusted for height, FMI and LMI (model 3). 
2.5.3.3 Size at birth and infant growth analysis 
Weight (and length) at two weeks of age (adjusted for the actual age at 
measurement) was used as a proxy measure of birth weight, because 
measurements at this age were more complete and were deemed to be of greater 
accuracy. The association between weight at two weeks and later blood pressure 
was assessed using linear regression analysis. A number of different models were 
fitted: firstly a simple unadjusted analysis, then adjusted for confounders (age, sex, 
maternal weight and maternal blood pressure), the final model was also adjusted 
for current weight. A similar analysis was conducted using length at two weeks as 
the explanatory variable and fitting height rather than weight in the final model. 
Anthropometric data were also available from 52 weeks of age, these data were 
adjusted for the actual date of measurement and then within-population standard 
deviation scores (SD score: value - mean / standard deviation) were calculated for 
the 2 week and 52 week timepoints. Growth was defined by the change in weight 
SDS from 2 to 52 weeks and the impact of this early growth on later blood pressure 
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was assessed using linear regression analysis adjusted for confounders (age, sex, 
maternal weight and maternal blood pressure). In addition, the growth data were 
visualised by using life course plots [121]. 
2.5.3.4 Season of birth analysis 
A further analysis was conducted to investigate the effect of season of birth on 
blood pressure in childhood. Season of birth was defined by fitting Fourier terms as 
before [211]. Linear regression models were fitted with factors relating to current 
blood pressure (age, sex, height, FMI and LMI) and this model was then compared, 
using a likelihood ratio test, to one also containing season of birth terms. 
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Chapter 3 Follow-up of protein-energy supplementation trial 
3.1 Forward 
This chapter will describe in detail the results of the statistical analysis investigating 
the impact of maternal protein-energy supplementation on offspring blood 
pressure at 11-17 years of age in The Gambia. The main findings have already been 
published [213], although this chapter will display and explore the data in greater 
detail. A review of the statistical methods has been covered in Chapter 2 (Section 
2.5) and should be referred to when interpreting the analysis. Regression 
coefficients appear as ß in the text, standard deviations are denoted by SD, the chi- 
squared test statistic by X2 and confidence intervals by Cl. 
3.2 Study participants 
3.2.1 General characteristics 
The follow-up study recruited 1317 children, representing 64% of individuals born 
during the original trial and 85% of those who were eligible to participate in the 
follow-up (Figure 3.1). Eligible subjects were offspring still living in West Kiang or 
those who had moved to coastal areas that were within an hour drive from MRC 
facilities (see Section 2.4.1). Recruitment rates were similar between the two arms 
of the trial: 630 children from the intervention arm (62% of original births) and 687 
children from the control arm (66%) were recruited. The main reason for non- 
recruitment (13% of intervention subjects and 8% of control subjects) was due to 
family movement within The Gambia, resulting in eligible subjects being unavailable 
during the study period. Eight subjects were excluded from the study: six due to a 
reported mental illness, one who was handicapped from polio and one who had 
suffered a trauma to the leg. Three percent of parents refused to give consent for 
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their children to take part, primarily because they were not happy for their children 
to give blood. 
Figure 3.1 Flow diagram of offspring eligible for protein-energy trial follow-up and 
those recruited 
1542 eligible subjects 
758 
INTERVENTION ARM 
(16 villages) 
24 refused 
3 excluded 
101 missed 
through 
movement 
630 children measured 
at follow-up 
(16 villages) 
784 
CONTROL ARM 
27 refused 
5 excluded 
65 missed 
through 
movement 
687 children measured 
at follow-up 
(12 villages) 
There were no differences in the available characteristics between those recruited 
and those lost to follow-up, with the exception that recruited children were on 
average almost three months younger (Table 3.1). 
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Table 3.1 Differences between individuals recruited into protein-energy trial follow- 
up and those lost to follow-upa 
Lost to follow-up 
Nb Mean (SD) or 
percentage 
Recruited 
N Mean (SD) or 
percentage 
P-value` 
Age at start of 686 14.0 (1.5) 1317 13.8 (1.5) 0.001 
follow-up (y) 
% male 686 49.3 1317 52.1 0.23 
Birth weight (g) 686 2921 (415) 1317 2896 (436) 0.21 
Birth length (cm) 575 49.4 (2.1) 1179 49.4 (2.3) 0.72 
Maternal weight 685 53.2 (7.1) 1315 53.0 (7.0) 0.52 
(kg) 
Maternal height 524 1.6 (0.1) 1060 1.6 (0.1) 0.21 
(m) 
% term infants 568 97.4 1168 96.1 0.17 
% primiparous 637 11.8 1257 12.3 0.76 
mothers 
a Lost to follow-up defined as all live, singleton children born into the original trial who were not 
recruited into follow-up (ie: includes those ineligible for current follow-up) 
bdata were missing on 44 children from the original study 
`P-value refers to t-tests for continuous data or chi-squared tests for categorical data 
Forty-six individuals (19 intervention, 27 control) with a gestational age less than 37 
weeks (preterm) were excluded from the analysis. Three further individuals had 
implausible blood pressure readings, which were removed from the analysis: two of 
the blood pressure readings were more than four standard deviations from the 
mean and one individual had identical systolic and diastolic readings, which were 
interpreted as a recording error. One further individual was excluded because they 
had ambiguous treatment allocation, resulting in a sample size of 1267 that was 
used as the basis for all of the following analyses. 
Of this sample, 48% were girls and 22% were living in urban/semi-urban coastal 
areas at the time of the study. Urban subjects were on average older than their 
rural counterparts (mean difference: 0.7y; 95%Cl: 0.5,0.9; p<0.001), which is to be 
expected as children move to the urban areas to attend senior school. A greater 
proportion of the urban subjects were girls, 57% compared to 45% in the rural area 
(X2 test: 12.05; P: 0.001), which may reflect that they were also moving to the urban 
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areas for marriage. A greater proportion of urban subjects belonged to the 
intervention (55%) rather than control (46%) arm of the original trial (X2 test: 7.07; 
P: 0.01). 
3.2.2 Anthropometry, body composition and age of menarche 
Table 3.2 displays the anthropometric and body composition data for the analysed 
sample. Mean height for girls was 152.3cm (SD: 9.3) and the mean height-for-age Z- 
score (HAZ), compared to UK reference data [214], was -0.92 (SD: 1.03). Mean 
height for boys was 150.4cm (SD: 10.8) and the mean HAZ was -1.47 (SD: 1.10). A 
relatively high proportion (24%) of the children was classified as stunted, defined as 
a HAZ 5-2 Z-scores of the reference population. At the other end of the spectrum, 
mean BMI for girls was 17.5kg/m2 (SD: 2.8) and for boys was 16.2kg/m2 (SD: 1.8). 
Using International Obesity Taskforce cut-offs for childhood BMI [215], 2.6% of girls 
and 0.3% of boys would be classified as overweight. All anthropometric and body 
composition variables increased with age, with the exception of percent trunk fat 
which was unrelated to the age of the individual (data not shown). 
Table 3.2 Anthropometry and body composition of offspring born during Gambian 
protein-energy supplementation trial 
Mean (SD) 
Girls Boys 
N 608 659 
Height (cm) 152 (9) 150 (11) 
Weight (kg) 41.2 (10.1) 37.2 (8.5) 
Height-for-age Z-scores -0.9 (1.0) -1.5 (1.1) 
BMI (kg/m2) 17.5 (2.8) 16.2 (1.8) 
BMI Z-scores -1.0 (1.2) -1.5 (1.0) 
Body fat (%) 19.4 (4.5)#n-2 12.6 (2.9) #n-7 
Trunk fat (%) 15.0 (4.8) #n-4 12.0 (2.9) #n-' 
Fat mass index (FMI) 1.4 (0.4)#n_2 0.8 (0.3)"". 7 
(kg/ra. z) 
Lean mass index (LMI) 10.0 (1.0)#n. 2 10.2 (0.8)"n-' 
(kg/m2. s) 
'Compared to UK reference data[214] 
""Denotes sample size which differs from the column header due to missing data 
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3.2.3 Blood pressure 
Mean systolic blood pressure is shown in Table 3.3. The variance in blood pressure 
was similar for boys and for girls and the analysis was therefore conducted for the 
sexes combined, although adjusted for sex where appropriate. Blood pressure was 
normally distributed as assessed by quantile-quantile plots and the Shapiro-Wilk 
test for normal data (systolic P: 0.002; diastolic P: <0.001) 
Table 3.3 Blood pressure of subjects recruited into protein-energy trial follow-up 
Mean (SD) 
Girls Boys 
N 608 659 
Systolic (mmHg) 111.1(8.8) 109.9 (9.2) 
Diastolic (mmHg) 65.5 (7.2) 63.9 (8.0) 
Pulse pressure (mmHg)' 45.5 (6.5) 46.0 (7.2) 
Mean arterial pressure (mmHg)b 80.7 (7.1) 79.2 (7.7) 
Hvoertension (%)` 6.4 4.6 
'Calculated as systolic - diastolic blood pressure bMean arterial pressure calculated as diastolic + (1/3*pulse pressure) 
`Hypertension defined as systolic blood pressure above the NHBPEP 95% centile for height and age 
[12] 
In simple linear regression analysis, offspring systolic and diastolic blood pressures 
were unrelated to maternal height or parity (data not shown). Systolic blood 
pressure increased with child age (ß: 0.9mmHg; 95% Cl: 0.5,1.2; P: <0.001) and was 
higher for girls compared to boys (mean difference: 1.1mmHg; 95% Cl: 0.1,2.1; P: 
0.03). Diastolic blood pressure was also higher in girls (mean difference: 1.58mmHg; 
95% Cl: -2.42, -0.74; P: <0.001) but there was no association with age (ß: 
0.18mmHg; 95% Cl: -0.10,0.46; P: 0.21). The location of the individual at follow-up 
(rural vs urban) was not associated with systolic or diastolic blood pressure (data 
not shown). Variables included in the adjusted models were therefore restricted to 
age, sex and season of birth. In addition, the location of the individual (rural vs 
urban) was included as a covariate because this variable was associated with the 
intervention (see Section 3.2.1). 
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Both systolic and diastolic blood pressures were positively associated with height, 
weight, and BMI (Table 3.4). Systolic blood pressure was positively associated with 
LMI, but not with FMI or percent trunk fat. In simultaneous models including both 
LMI and FMI this association remained; the association with LMI was 0.95mmHg 
(95% Cl: 0.24,1.66; P: 0.01) and with FMI was -0.74mmHg (95% Cl: -2.41,0.93; P: 
0.38). In contrast, diastolic blood pressure was positively associated with FMI, 
percent body and trunk fat but not associated with LMI. Again this association 
remained in simultaneous analysis (data not shown). BMI and height in this group 
of children are highly correlated (Pearson correlation coefficient: 0.5; P: <0.001) and 
BMI is therefore a poor index of relative weight (independent of height) in these 
individuals. 
Table 3.4 Association between blood pressure and anthropometry/body 
composition for individuals in protein-energy trial follow-up 
Systolic blood pressure Diastolic blood pressure 
(mmHg) (mmHg) 
Regression P-value Regression P-value 
coefficient coefficient 
(95% Cl) (95% Cl) 
Height (cm) 0.29 (0.22,0.35) <0.001 0.14 (0.09,0.20) <0.001 
Weight (kg) 0.30 (0.23,0.37) <0.001 0.19 (0.14,0.25) <0.001 
BMI (kg/m2) 0.68 (0.44,0.92) <0.001 0.57 (0.36,0.77) <0.001 
Body fat (%) 0.13 (-0.01,0.26) 0.06 0.36 (0.25,0.47) <0.001 
FMI (kg/m4.2) 0.67 (-0.57,1.90) 0.29 2.83 (1.69,3.97) <0.001 
LMI (kg/m2'8) 0.76 (0.19,1.34) 0.01 0.35 (-0.14,0.84) 0.16 
Trunk fat (%) 0.07 (-0.05,0.20) 0.25 0.27 (0.16,0.38) <0.001 
Results are the effect on blood pressure of a one unit increase in explanatory variable, derived from 
linear regression analysis, adjusted for age and sex 
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3.3 Maternal protein-energy supplementation and offspring blood 
pressure 
3.3.1 Results of intention-to-treat analysis 
There was no effect of prenatal compared to postnatal maternal protein-energy 
supplementation on offspring systolic, diastolic or mean arterial blood pressure in 
adolescence (Table 3.5). There was a suggestion that pulse pressure was related to 
maternal supplementation, with higher pulse pressure for individuals whose 
mothers received the intervention during pregnancy compared to individuals born 
to control mothers, although the association was borderline in all but the final 
model (Table 3.5). 
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Only 5% of individuals had a systolic blood pressure above the NHBPEP 95% centile 
for their height and age [12]. There was no difference in the proportion of 
individuals with high systolic blood pressure in the intervention or control groups 
(adjusted odds ratio: 1.19; 95% Cl: 0.73,1.95; P: 0.48). 
A potential source of bias in the results is the method chosen to measure blood 
pressure: using three measurements of blood pressure that were within 5mmHg of 
each other rather than taking the first three measurements. From the study records 
it was possible to compare the chosen method with the results that would have 
been obtained if only the first three blood pressure measurements had been taken. 
Using the first three measurements only produced a higher estimate of mean 
systolic (mean difference between the two methods: 0.72mmHg; 95% Cl: 0.58, 
0.86; P: <0.001) and diastolic (mean difference: 0.35mmHg; 95% Cl: 0.24,0.46; P: 
<0.001) blood pressure than the method chosen in this study. However, there was 
no difference in the conclusions drawn from the analysis of the effect of the 
maternal intervention on offspring blood pressure (Table 3.6). Therefore in all 
subsequent analysis the original protocol has been used to generate an estimate of 
blood pressure (ie: the mean of three blood pressure measurements which were 
within 5mmHg). It was deemed unnecessary to repeat this extra analysis for the 
calcium intervention reported in Chapter 4. 
Table 3.6 Effect of maternal protein-energy supplementation on offspring blood 
pressure when using the first three measurements as an estimate of blood pressure 
Unadjusted regression 
coefficient (95% Cl) 
P-value 
Systolic BP (mmHg) 0.42 (-1.27,2.11) 0.63 
Diastolic BP (mmHg) 0.09 (-1.18,1.37) 0.89 
Pulse pressure (mmHg) 0.63 (0.11,1.15) 0.02 
Mean arterial pressure -0.03 (-1.40,1.34) 0.97 
(mmHg) 
Results are the difference in mean blood pressure (95% Cl) for individuals born to women receiving 
protein-energy supplements during pregnancy (coded 1) compared to during lactation (coded 0), 
derived from unadjusted generalised estimating equations (gee) with original village of residence 
(cluster) modelled as a random effect 
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Another potential source of error is the incorrect inclusion of preterm individuals 
due to the fact that Parkin scores were missing for 148 individuals (70 intervention, 
78 control), making it impossible to classify their gestational age. However, 
conducting the analysis of the effect of maternal supplementation on offspring 
blood pressure on only those individuals for whom Parkin scores were available 
does not alter the conclusions of the analysis, with the exception that any effect on 
pulse pressure is no longer apparent (Table 3.7). 
Table 3.7 Effect of maternal protein-energy supplementation on offspring blood 
pressure for individuals with known gestational age (n=1119) 
Unadjusted regression 
coefficient (95% Cl) 
P-value 
Systolic BP (mmHg) 0.44 (-1.20,2.08) 0.60 
Diastolic BP (mmHg) -0.10 (-1.31,1.10) 0.87 
Pulse pressure (mmHg) 0.70 (-0.17,1.58) 0.12 
Mean arterial pressure 0.09 (-1.20,1.39) 0.89 
(mmHg) 
Results are the difference in mean blood pressure (95% Cl) for individuals born to women receiving 
protein-energy supplements during pregnancy (coded 1) compared to during lactation (coded 0), 
derived from unadjusted generalised estimating equations (gee) with original village of residence 
(cluster) modelled as a random effect 
The possibility of the intervention effect being modified by covariates was assessed 
by fitting interaction terms into the generalised estimating equations. There were 
no interactions between treatment group and age, sex, location (rural or urban), 
season of birth or any of the body composition variables (height, FMI, LMI or % 
trunk fat) (data not shown). 
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3.3.2 Results of as-treated analysis 
For most of the blood pressure outcomes, there remained no association with the 
intervention when investigated using an as-treated analysis model (Table 3.8). 
There was a suggestion however, that children whose mothers had consumed less 
than the median number of biscuits during the trial had a higher pulse pressure 
compared to control children. The difference in pulse pressure between the low 
biscuit category and control group was 0.99 mmHg (95% Cl: 0.31,1.67; P: 0.004). 
This association was not reflected in the intervention children whose mothers had 
consumed more than the median number of biscuits. For these individuals there 
was no difference in blood pressure compared to control individuals (ß: 0.16; 95% 
Cl: -0.78,1.10; P: 0.74). 
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3.4 Early life exposures: observational analysis 
3.4.1 Birth weight and later blood pressure 
There was no overall association between birth weight and systolic blood pressure 
(adjusted for age, sex and season of birth) in this cohort (ß: -0.52mmHg; 95%Cl: - 
1.72,0.68; P: 0.39), even after adjustment for current body weight (ß: -1.13mmHg; 
95%Cl: -2.31,0.04; P: 0.06). There was also no association between birth weight 
and diastolic blood pressure, both without (ß: -0.004mmHg; 95%Cl: -1.03,1.02; P: 
0.99) and with adjustment for current body weight (ß: -0.40mmHg; 95%Cl: -1.41, 
0.62; P: 0.44). Adjusting birth weight for gestational age did not alter the lack of 
association between birth weight and systolic or diastolic blood pressure (data not 
shown). 
Birth length was also unrelated to systolic (ß: 0.19mmHg; 95%Cl: -0.06,0.43; P: 
0.13) and diastolic (ß: 0.11mmHg; 95%Cl: -0.10,0.32; P: 0.31) blood pressure. After 
adjustment for current height there remained no association between birth length 
and systolic (ß: 0.06mmHg; 95%Cl: -0.18,0.30; P: 0.63) or diastolic (ß: 0.05mmHg; 
95%Cl: -0.16,0.26; P: 0.64) blood pressure. There was no association between birth 
weight or length and either pulse pressure or mean arterial pressure (data not 
shown). 
The data presented in this analysis are derived from the follow-up of an 
intervention trial and are therefore not strictly a cohort study. Although maternal 
supplementation was unrelated to blood pressure it was associated with birth 
weight and the analysis was therefore also conducted for the different 
supplementation groups separately (Table 3.9). For individuals in the intervention 
arm of the trial only, birth weight was negatively associated with systolic blood 
pressure and pulse pressure. The association became more negative once the 
equations were adjusted for current weight (Table 3.9). 
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3.4.2 Season of birth and later blood pressure 
Season of birth was associated with systolic blood pressure in adolescence 
(Likelihood Ratio (LR) test XZ: 6.69, P: 0.04). Individuals who had been born in June 
and July had lower systolic blood pressure than individuals born during the 
remainder of the year (Figure 3.2) after adjustment for age, sex, current height, 
current FMI and current LMI. There was no association between season of birth and 
diastolic blood pressure (LR test XZ: 4.51; P: 0.10), although the pattern was similar 
(Figure 3.3). Season of birth was also unrelated to pulse pressure and mean arterial 
pressure (data not shown). 
Figure 3.2 Variation of systolic blood pressure in Gambian adolescents aged 11-17 
in relation to their month of birth 
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Bold middle line represents the fitted line for the variation in systolic blood pressure with month of 
birth. Upper and lower lines represent fitted 95% confidence interval. 
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Figure 3.3 Variation of diastolic blood pressure in Gambian adolescents aged 11-17 
in relation to their month of birth 
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Bold middle line represents the fitted line for the variation in diastolic blood pressure with month of 
birth. Upper and lower lines represent fitted 95% confidence interval. 
3.4.3 Growth in infancy and later blood pressure 
In the original trial, the protein-energy supplement was found to increase birth 
weight by 136g overall [194], and within the sample of individuals included in this 
follow-up study there remained a difference in birth weight between intervention 
and control children of 97.6g (95% Cl: 6.8,188.4; P: 0.04). However, these 
differences did not correspond to differences in attained size in infancy for those 
individuals for whom there were data available (Figure 3.4) [216] 
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Figure 3.4 Effect of protein-energy supplementation to pregnant women on their 
offspring's attained size in infancy, represented by internal standard-deviation- 
score. 
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Regression coefficient and error bars (±2 x SE) are displayed for the effect of the intervention on 
offspring weight SDS (calculated internally) at different age points. The sample size at different age 
points differs (n = 2003 (birth), 840 (3mo), 870 (6mo), 848 (9mo), 874 (12mo), 527 (36mo) and 1029 
(168mo)). 
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Growth in infancy, defined as the change in weight SD score between two time 
points, was unrelated to blood pressure in adolescence (Table 3.10). 
Table 3.10 Relationship between growth in infancy and blood pressure at 11-17 
years in Gambian adolescents 
Growth time 
perioda 
Systolic blood pressure 
(mmHg) 
Regression P-value 
coefficient 
(95% Cl) 
Diastolic blood pressure 
(mmHg) 
Regression P-value 
coefficient 
(95% CI) 
Birth -3 0.30 0.21 0.07 0.73 
months (-0.17,0.77) (-0.33,0.47) 
(n=1017) 
3-6 months -0.07 0.82 0.06 0.82 
(n=897) (-0.61,0.48) (-0.41,0.52) 
6-9 months 0.55 0.07 0.42 0.10 
(n=911) (-0.03,1.12) (-0.08,0.93) 
9- 12 months 0.56 0.05 0.17 0.49 
(n=926) (0.00,1.12) (-0.31,0.65) 
12 - 36 months -0.59 0.10 -0.27 0.38 
(n=534) (-1.31,0.12) (-0.89,0.34) 
Results are the effect on blood pressure of a one unit increase in weight standard deviation score 
between two time points, derived from linear regression analysis adjusted for sex, age and season of 
birth 
a Exposure is change in within-sample weight standard deviation score between specified time points 
Using change in weight SD score from birth to one year as a single measure of 
growth over the first year, an association with blood pressure emerged; increased 
growth was associated with higher systolic blood pressure in adolescence after 
adjusting for age, sex and season of birth (ß: 0.73mmHg; 95% Cl: 0.27,1.19; P: 
0.002). There was a similar association for pulse pressure (ß: 0.42mmHg; 95% Cl: 
0.06,0.77; P: 0.02) and mean arterial pressure (ß: 0.46mmHg; 95% Cl: 0.07,0.84; P: 
0.02). Diastolic blood pressure however, was unrelated to change in weight SD 
score from birth to one year (ß: 0.32mmHg; 95% Cl: -0.08,0.72; P: 0.12). Change in 
length SD score between birth and one year was not related to systolic (ß: 
-107- 
Chapter 3: protein-energy results 
0.27mmHg; 95% Cl: -0.39,0.92; P: 0.43) or diastolic (ß: 0.36mmHg; 95% Cl: -0.22, 
0.93; P: 0.22) blood pressure in adolescence. Pulse pressure and mean arterial 
pressure were also not associated with change in length SD score (data not shown). 
A potential source of bias in the growth data is that a number of records were 
missing. However, there was no difference in mean systolic blood pressure for 
individuals who had a weight measurement at 12 months of age and those who did 
not (mean difference: -1.1mmHg; 95% Cl: -2.4,0.3; P: 0.12). 
Cole recommends a method for visualising the impact of growth during childhood 
on blood pressure in later life, termed life course plots [121]. The regression 
coefficient for the association between weight SD score at different time points and 
final blood pressure are plotted against age to give an indication of the shape of the 
relationship. The individual data points represent the strength of the association at 
a given age and the change from one age to the next represents the effect of 
growth [121]. For the current study, the life course plot (Figure 3.5) shows the 
strong association between current weight and blood pressure for both systolic and 
diastolic blood pressure. In infancy the association between weight and later blood 
pressure is less clear although there is a generally linear trend for systolic blood 
pressure from birth to one year, indicating that weight centile crossing at this time 
point has a positive effect on blood pressure in adolescence. 
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Figure 3.5 Life course plot of the association between growth at different ages and 
blood pressure in adolescence in rural Gambia 
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Points are regression coefficient (±2 x SE plotted as error bars) for association between weight 
internal SD score at different ages and blood pressure at 168 months, for systolic (black line, circle) 
and diastolic (grey line, square) blood pressure 
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3.5 Discussion 
3.5.1 Maternal protein-energy supplementation 
3.5.1.1 Summary of findings 
These results show that in a rural area of The Gambia maternal protein-energy 
supplementation, compared to supplementation during lactation, was not 
associated with offspring blood pressure at 11-17 years of age. 
3.5.1.2 Study strengths and limitations 
The current study has a large sample size and as a consequence there are relatively 
tight confidence intervals around the effect estimate. The rates of recruitment were 
relatively high (64%) for a follow-up of a community intervention study with such a 
long time-lag [217]. There was no differential loss to follow-up between the two 
arms of the trial and, with the exception of a slight difference in age, loss to follow- 
up was not associated with any of the available characteristics from the original 
trial. The recruited sample is therefore representative of the trial offspring as a 
whole. 
The main weakness of the current study is that the 'control' group received the 
protein-energy supplement during lactation. The current analysis could therefore 
be regarded as comparing the effects of improved nutrition during pregnancy with 
improved nutrition during lactation (Table 3.11). 
Table 3.11 Study design of original protein-energy supplementation trial 
Time point at which supplement provided 
Study arm Pregnancy Lactation 
Prenatal supplement x --- 
('intervention') 
Postnatal supplement --- x 
('control') 
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For this analysis it has been assumed that the improved nutrition of the 'control' 
group would not have affected the infants, who may therefore be regarded as a 
true control group. To support this view there is little evidence that providing 
supplements to lactating women improves their breast milk quality and thus the 
nutrition of the growing infant. Data from a previous trial in The Gambia found no 
evidence that providing protein-energy and multivitamin supplements to lactating 
women affected their breast milk quantity or quality [218,219]. Furthermore, the 
lack of an association between supplementation group and size in infancy [216] 
argues against an impact of supplementation during lactation; at least one that 
affects growth. 
The age of the individuals in the current study is a limitation of the follow-up study 
design. Subjects were undergoing puberty at the time of recruitment, which could 
potentially obscure a relationship between early-life exposures and blood pressure. 
It is noticeable for example that the inverse association with birth weight 
commonly apparent in the literature is often much weaker at this age [220]. 
A further limitation is the setting of the study in a rural area of The Gambia where 
nutritional intakes tend to be marginal. Gluckman and Hanson have proposed a 
new paradigm to explain the DOHaD phenomenon, which has been termed the 
'predictive adaptive response' [193,221]. They suggest that the developing 
organism utilises cues from their current environment to predict the environment 
that will be faced in later life, and in response, takes the appropriate developmental 
pathway. If conditions in later life are mismatched to those predicted in early-life 
there will be a greater risk of disease [221]. Subjects in the current study were 
relatively lean (mean BMI: 16.2 kg/m2 (boys) and 17.5 kg/m2 (girls)), and it may be 
that their prevailing nutritional exposure remains within the confines of that 
programmed by their early-life experiences. It is possible that any adverse 
outcomes will only become apparent if individuals are exposed to a more 
obesogenic environment in later life. 
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A final limitation is the lack of data on maternal nutritional status at baseline 
making it impossible to investigate any interaction of the intervention with pre- 
pregnancy BMI. However, season of birth could be viewed as a proxy for maternal 
nutritional status in this study because in this population seasonality has a marked 
impact on maternal weight and on birth weight [198]. Furthermore, the 
supplement had a greater impact on birth weight when it was consumed during the 
hungry season [194]. Season of birth did not modify the effect of the maternal 
intervention on offspring blood pressure, which suggests that maternal nutritional 
status may have been similarly unimportant for this outcome. 
3.5.1.3 Comparison with literature 
The overall lack of association between pregnancy supplementation and offspring 
blood pressure reflects the findings of a Guatemalan community-based intervention 
where a balanced protein-energy supplement, provided during pregnancy and in 
early-life, was not associated with blood pressure at 20-29 years of age [97]. 
Similarly, follow-up studies of the Dutch hunger winter and the Lenningrad siege, 
which have been considered 'natural experiments', have shown no association 
between exposure to famine during in utero development and blood pressure in 
adulthood [58,62]. Although both of these examples are of reduced, rather than 
supplemented, nutrition during pregnancy. 
A recently published follow-up from India investigated the impact of a community- 
based intervention, which provided a cereal meal to pregnant and lactating women 
and children up to age seven years, on cardiovascular disease risk factors in the 
offspring [99]. The intervention was rolled-out in a stepwise manner as part of a 
national public health programme and the authors were able to compare 
individuals born into areas covered by the programme with 'control' areas which 
did not yet have that provision. Although there was no effect of the early-life 
intervention on blood pressure in adolescence, a measure of global arterial stiffness 
(the augmentation index) was found to be lower in individuals born into 
intervention compared to control areas [99]. It is important to acknowledge that 
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both the Guatemalan and Indian studies involved community-level interventions 
that provided supplements to pregnant women and to their children up to seven 
and six years of age, respectively. Thus, it is not possible to distinguish between the 
prenatal and postnatal interventions, making them not directly comparable to the 
study being presented here. In addition, the roll-out of the Indian intervention had 
not been conducted in a random manner, which should also add caution to the 
interpretation of its conclusions. 
The effect of the Indian intervention on arterial stiffness is a finding which warrants 
further discussion as increased arterial stiffness, as a consequence of fetal growth 
restriction, has been proposed as one of the mechanisms linking early-life 
exposures to blood pressure in adulthood [222]. From the data presented in this 
thesis there was a suggestion that the maternal intervention was associated with 
lower pulse pressure in adolescence. Pulse pressure is determined in part by the 
compliance of the arteries and could therefore be viewed as a surrogate marker of 
arterial stiffness [223]. There should be caution on overemphasising this finding 
however, as there was no effect of the intervention on systolic blood pressure, 
which should also be affected by arterial compliance [223]. The observed 
association may reflect that the non-significant effects on systolic and diastolic 
blood pressure were operating in opposite directions; positive for systolic and 
negative for diastolic. As pulse-pressure is calculated by subtracting diastolic from 
systolic blood pressure the pulse pressure effect may be an artificial consequence 
of this. In addition, the effect was not observed when the analysis was restricted to 
those individuals for whom known gestational age was available, despite the fact 
that the sample size remained large. The clinical importance of pulse pressure in 
this age group can also be questioned, especially as the subjects are undergoing 
puberty and therefore experiencing different growth rates. In the Framingham 
cohort, pulse pressure has been shown to be an important predictor of congestive 
heart failure in older people [224], but its importance as a predictor of risk in 
younger adults is less clear [225]. 
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The as-treated analysis also suggested a putative association between consumption 
of biscuits during pregnancy and pulse pressure in the offspring, although 
interestingly the association was only apparent in offspring whose mothers had 
consumed less than the median number of biscuits, compared to control children, 
and not in those who had consumed more. It is therefore likely that this represents 
a chance finding or one which reflects an inherent issue with conducting as-treated 
analysis: loss of randomisation. It could be that there is an unmeasured 
characteristic which makes these women less likely to adhere to the study protocol 
and which is also associated with higher blood pressure in their children. 
Returning to the concept that the experimental design compared improved 
pregnancy nutrition with improved lactation nutrition, there are comparable 
experiments in mice conducted by Ozanne and Hales [226]. Pups born to dams 
provided with normal nutrition (20% protein) during pregnancy and suckled by 
dams fed a protein-restricted diet (8% protein) during lactation experienced greater 
longevity than pups born to protein-restricted dams but suckled by dams fed a 
normal diet during lactation [226]. Unfortunately there is no blood pressure data on 
these pups but using the same experimental design, Tarry-Adkins et al observed 
nephroprotective effects in rats suckled by dams fed a protein-restricted diet 
compared to controls [227]. 
3.5.1.4 implications of findings 
One interpretation of the null result of this analysis is that the maternal diet during 
pregnancy does not directly affect the development of the fetus in a way that 
impacts on body systems. Although birth weight was directly influenced by the 
maternal diet in the original trial [194], the supply of nutrients to the fetus is also 
influenced by placental sufficiency and maternal nutrient stores [45]. The protein- 
energy supplement was provided after 20 weeks gestation [194], which may be too 
late to have an impact on organ development, and therefore blood pressure, but at 
a time where it may still influence fetal size. As stated previously, an alternative 
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explanation is that in an environment where the prevailing exposures remain 
relatively frugal any effect of the intervention may not become apparent. 
3.5.2 Observational analysis 
3.5.2.1 Summary of findings 
Birth weight was unrelated to blood pressure in adolescence overall. However, 
amongst individuals in the intervention arm of the trial, birth weight was negatively 
associated with systolic blood pressure, pulse pressure and mean arterial pressure. 
For every 1kg increase in birth weight, systolic blood pressure decreased by 
2.17mmHg for intervention children only. Season of birth also influenced systolic 
blood pressure, which was lowest for individuals who were born in June and July. 
Increased growth during the first year of life was positively associated with systolic 
blood pressure, pulse pressure and mean arterial pressure, but not with diastolic 
blood pressure. For each unit increase in weight SD score over the first year of life, 
systolic blood pressure increased by 0.73mmHg at follow-up, although current 
weight was a much more important predictor of current blood pressure. 
3.5.2.2 Study strengths and limitations 
Although the study being presented in this thesis was not designed as a cohort 
study it still provides a useful resource with which to investigate observational 
associations, particularly as the intervention did not have an effect on the outcome 
of interest (blood pressure). The dataset can therefore be regarded as a prospective 
cohort who were enrolled at birth and characterised by their birth anthropometry. 
The impact of the intervention on birth weight makes the interpretation of birth 
weight effects on blood pressure challenging; hence the analysis was explored for 
the intervention groups separately, as well as combined. The loss to follow-up rate 
is fairly low for a cohort study and loss to follow-up is not associated with the 
exposures of interest (birth weight, season of birth) and it is unlikely to be 
associated with the outcome under study (blood pressure). 
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Issues of confounding are of much greater importance in the analysis of cohort data 
than they are for trial data where, providing randomisation was successful, known 
and unknown confounders should be equally distributed between the trial groups 
[95]. The current dataset suffers from a lack of detailed data on many possible 
confounders. For example, no data on social economic status or on the health of 
women during pregnancy are available, particularly their smoking status although a 
recent study in the region reported no smoking amongst women aged 18-30 [228]. 
Data on growth in infancy are relatively incomplete in this study, which could 
potentially introduce bias into the results under analysis. However, there was no 
difference in systolic blood pressure between individuals who had a weight 
measurement at 12 months of age and those that did not, which suggests that this 
bias may be minimal. Another error inherent in the growth data is that the exact 
age at measurement is not recorded in the database (data are recorded under the 
heading of 3 months, 6 months and so on without an indication of the exact date of 
measurement) and it is therefore not possible to know the margin of error around 
the quoted measurement age in infancy. 
3.5.2.3 Comparison with the literature 
The association between birth weight and blood pressure has been under debate 
for many years [50]; a summary statistic often quoted is that for an increase of 1kg 
in birth weight, systolic blood pressure decreases by 2mmHg [51]. In adolescents, 
the association is much less clear [51], and the lack of overall association between 
birth weight and blood pressure in this study may therefore reflect the timing of 
follow-up. An alternative explanation is that the association between birth weight 
and blood pressure in rural African populations is different from the Western data 
most commonly published. Inverse associations between birth weight and blood 
pressure have been reported for some African populations such as five year old 
children in Soweto, South Africa [229] and school children (6.5 years) in Harare, 
Zimbabwe [230], but the findings have not been universal [56] and there are no 
data from rural populations. Amongst individuals from the intervention arm of the 
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study, birth weight was inversely associated with blood pressure in a similar 
magnitude as is often reported; for every 1kg increase in birth weight, systolic 
blood pressure decreased by 2.17mmHg. 
In the literature, the impact of growth in infancy on later blood pressure has been 
inferred from the stronger association between birth weight and blood pressure 
once the data are adjusted for current size. In the data presented in this thesis, 
individuals who experienced less growth during the first year of life also had lower 
blood pressure in adolescence, although the exposure window did not appear to be 
limited to early infancy as has been previously suggested [136]. 
A life course plot from Brazil depicting the association between growth in early-life 
and blood pressure at age 15 shows a similar pattern to the life course plot 
presented here [121]. In both studies, current weight was the strongest predictor of 
blood pressure but crossing of weight centiles from 42 months to 15 years in the 
Brazil cohort or 36 months to 14.5 years in the current study, was associated with 
raised systolic and diastolic blood pressure in adolescence. It should be 
acknowledged that the timing of measurements in these plots will affect the 
pattern of the observed association. A recent pooled analysis by Adair et al of data 
from five different cohorts in lower income countries reported no association 
between weight gain in infancy and blood pressure in adulthood [123]. However 
the oldest measurement of relative size in this combined analysis was at 48 months 
of age, the pattern of the association between growth after this age and later blood 
pressure may be similar to that reported here and from Brazil. 
3.5.2.4 Implications of findings 
Systolic blood pressure was lowest for individuals who were born in June and July, 
and highest for individuals born in December and January. In rural areas of The 
Gambia such as this one there is a seasonality of farming activity that leads to 
changes in energy balance [198]. The prevalence of small for gestational age babies 
experiences a nadir in June and is thought to reflect more favourable conditions 
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(less farming work) during gestation [198]. The seasonality of birth in relation to 
blood pressure may also reflect this more favourable gestation. It may be that 
individuals born at the middle of the year, after a gestation throughout the harvest 
season, exhibit body systems that have developed to their full potential and thus 
have lower blood pressure. It is important not to over-interpret the graphs of 
seasonality, which utilise smoothed data rather than the raw measurements and 
may therefore appear to be stronger associations than exist in reality. Furthermore, 
a previous observational study in this region found no association between being 
born in the hungry season and blood pressure in young adulthood [148]. In 
addition, in the current study the association was only present for systolic rather 
than diastolic blood pressure. 
The finding that growth in infancy may be an important determinant of later blood 
pressure in the current population is interesting particularly as the importance of 
growth trajectories for cardiovascular disease risk are receiving greater attention 
[231]. Again the findings should not be over-interpreted, especially as the growth 
data are incomplete and there is no information on the exact date of measurement. 
Standardised methods of assessing growth are required to build up a clearer picture 
of the trajectories which confer greatest risk. If faster growth is a determinant of 
increased blood pressure as some of the data suggest, this will have important 
policy implications for developing countries, particularly ones experiencing the 
nutrition transition where the immediate benefits of increased growth may need to 
be balanced against potential long-term consequences [231]. 
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Chapter 4 Follow-up of calcium supplementation trial 
4.1 Forward 
This chapter will describe in detail the results of the statistical analysis investigating 
the impact of maternal calcium supplementation on offspring blood pressure at 5- 
10 years of age in The Gambia. A review of the statistical methods employed has 
been covered in Section 2.5 and should be referred to when interpreting the 
analysis. Regression coefficients appear as ß in the text, standard deviations are 
donated by SD, the chi-squared test statistic as X2 and confidence intervals by Cl. 
4.2 Study participants 
4.2.1 General characteristics 
A total of 389 children (193 born to calcium supplemented mothers and 196 born 
to mothers who received a placebo) were enrolled into the follow-up study, 
representing 86% of those eligible and 71% of the original trial births (Figure 4.1). 
Eligible subjects were offspring still living in West Kiang or those who had moved to 
coastal areas that were within an hour drive from MRC facilities (see Section 2.4.1). 
Recruitment rates were similar between the two arms of the trial: 193 children 
from the calcium supplement arm (71.2% of original trial births) and 196 from the 
placebo supplement arm (71.3%). The main reason for non-recruitment (7.6% of 
calcium supplement children and 7.0% of placebo children) was due to family 
movement within The Gambia, resulting in eligible subjects being unavailable 
during the study period. Two subjects were excluded from the study due to a 
reported mental illness and four percent of parents refused to give consent for 
their child to participate in the follow-up study. 
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Figure 4.1 Flow diagram of offspring eligible for calcium trial follow-up and those 
recruited 
452 
Eligible subjects 
223 
CALCIUM ARM 
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PLACEBO ARM 
11 refused 
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17 missed 
through 
movement 
1 unknown 
location 
193 children measured 
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at follow-up 
There were some differences in available characteristics between those recruited 
and those lost to follow-up (Table 4.1). The mothers of recruited individuals were 
1.8 years older and had slightly lower baseline (20 weeks gestation) systolic blood 
pressure (-1.7mmHg) than the mothers of individuals enrolled into the follow-up 
study. Children enrolled into the follow-up study had been slightly shorter (-0.1cm) 
in length at two weeks of age compared to those lost to follow-up. 
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Table 4.1 Differences between recruited individuals into calcium supplementation 
trial follow-up and those lost to follow-upa 
N 
Recruited 
Mean (SD) 
lost to follow-upa 
N Mean (SD) 
P-valueb 
Maternal age (y) 249 27.9 (7.0) 93 26.1(6.7) 0.03 
Maternal baseline` 387 55.0 (6.8) 156 55.3 (8.1) 0.4 
weight (kg) 
Maternal height 389 160.1 (5.3) 157 159.7 (5.6) 0.6 
(cm) 
Maternal baseline` 389 101.5 (8.7) 157 103.2 (10.0) 0.04 
systolic BP (mmHg) 
Maternal baseline` 389 55.3 (7.6) 157 56.5 (6.9) 0.09 
diastolic BP 
(mmHg) 
Child weight at 385 3.34 (0.50) 136 3.35 (0.56) 0.1 
2wkd (kg) 
Child length at 385 50.7 (2.0) 136 50.8 (2.4) 0.08 
2wkd (cm) 
aLost to follow-up defined as all live, singleton children born during original trial who were not 
recruited into follow-up study (ie: includes those ineligible for current follow-up) 
bP-value refers to a difference in mean values between those recruited and those lost to follow-up 
`Baseline for original supplementation trial was 20 weeks gestation, prior to commencement of 
supplementation 
dAnthropometry at two weeks of age used as a proxy measure for birth weight due to a large 
number of missing data at the earlier age point 
Thirty eight children enrolled (13 calcium, 25 placebo) were classified as having a 
gestational age under 37 weeks (preterm), as assessed by the Dubowitz score [212] 
at delivery and were excluded from the analysis. One blood pressure measurement 
was missing as the child refused to cooperate, leaving a final sample of 350 (171 
born to calcium supplemented mothers and 179 to placebo mothers) for analysis. 
The analysed sample was split equally between girls and boys. Only 13% were 
recruited from the urban/semi-urban areas and there were no differences in 
characteristics (age, sex, intervention arm) between individuals recruited from 
West Kiang and those from urban areas (data not presented). 
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4.2.2 Anthropometry and body composition 
Table 4.2 displays the anthropometric and body composition data for individuals 
included in the analysis. Mean height for girls was 118.0cm (SD: 8.3) and mean 
height for age Z-score was -1.0 (SD: 0.9). Mean height for boys was also 118.3cm 
(SD: 7.6) and their mean height for age Z-score was -1.2 (SD: 0.8). Thirteen percent 
of the sample fell below two Z-scores of the reference population and can therefore 
be regarded as stunted. Mean BMI for girls was 13.9 kg/m2 (SD: 1.2) and for boys 
was 14.1 kg/mz (SD: 1.0). Height and weight increased with age whereas BMI, fat 
(FMI) and lean mass index (LMI) were unrelated to age (data not shown). 
Table 4.2 Anthropometry and body composition of offspring born during Gambian 
calcium supplementation trial 
Mean (SD) 
Girls Boys 
N 175 175 
Height (cm) 118 (9) 118 (8) 
Weight (kg) 19.6 (3.6) 19.9 (3.1) 
Height-for-age Z-scores -1.0 (0.9) -1.2 (0.8) 
BMI (kg/m2) 13.9 (1.2) 14.1 (1.0) 
BMI Z-scores -1.4 (0.9) -1.4 (1.0) 
Body fat (%) 16.3 (2.9)#n-3 12.8 (2.5) #n-4 
Fat mass index (FMI) 2.5(0.6 )#n-2 1.9(0.4 )#n-4 
(kg/m 1.6) 
Lean mass index (LMI) 11.1 (0.8)#n-1 11.7(0.8 )#n-4 
(kg/mz. 3) 
Trunk fat (%) 14.2 (2.8) #n-2 13.6 (2.7) #n-4 
'Compared to UK reference data[214] 
""Denotes sample size which differs from the column header 
4.2.3 Blood pressure 
Mean systolic blood pressure for girls was 98.6mmHg (SD: 8.8) and for boys was 
97.6mmHg (SD: 8.1) (Table 4.3). The variance in blood pressure was similar for boys 
and girls and the analysis was therefore conducted for the sexes combined, 
although adjusted for sex where appropriate. Blood pressure was normally 
distributed when assessed using quantile-quantile plots and the Shaprio-Wilk test 
for normality (systolic P: 0.01; diastolic P: 0.001). 
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Table 4.3 Blood pressure of subjects recruited into calcium trial follow-up 
Mean (SD) 
Girls Boys 
N 175 175 
Systolic (mmHg) 98.6 (8.8) 97.6 (8.1) 
Diastolic (mmHg) 58.7 (7.5) 57.3 (7.3) 
Pulse pressure (mmHg)' 39.9 (5.9) 40.4 (6.6) 
Mean arterial pressure (mmHg)b 72.0 (7.4) 70.7 (6.9) 
Hypertension (%)` 5.1 3.4 
aCalculated as systolic - diastolic blood pressure 
bMean arterial pressure calculated as diastolic + (1/3*pulse pressure) 
`Hypertension defined as systolic blood pressure above the NHBPEP 95% centile for height and age 
[12] 
Using simple linear regression analysis maternal baseline (20 weeks gestation) 
weight was marginally but positively associated with child systolic blood pressure; 
for each kilogram increase in weight, offspring systolic blood pressure increased by 
0.2mmHg (95% CI: 0.03,0.29; P: 0.02). There was a very similar association 
between maternal weight and child diastolic blood pressure (ß: 0.18mmHg; 95% Cl: 
0.08,0.30; P: 0.001). Maternal baseline systolic blood pressure was also marginally 
associated with offspring systolic blood pressure; for each mmHg increase in 
maternal blood pressure, child blood pressure increased by 0.1mmHg (95% Cl: 
0.003,0.208; P: 0.04). Maternal baseline diastolic blood pressure was also positively 
associated with offspring diastolic blood pressure; for each mmHg increase in 
maternal diastolic blood pressure, child blood pressure increased by 0.2mmHg (95% 
Cl: 0.04,0.25; P: 0.01). Maternal parity was not associated with offspring blood 
pressure (data not shown). The antenatal clinic attended during pregnancy (one of 
three) was also not significantly associated with offspring blood pressure but was 
retained in the model for completeness. 
Both systolic (ß: 1.6mmHg; 95% Cl: 0.8,2.3; P: <0.001) and diastolic (ß: 0.9mmHg; 
95% Cl: 0.4,1.6; P: 0.003) blood pressure increased with child age but were 
unrelated to season of birth, or to the location of the individual (rural or urban) at 
follow-up (data not shown). Variables included in the adjusted models were 
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therefore restricted to age, sex, antenatal clinic, maternal baseline weight and 
maternal baseline blood pressure. 
Systolic and diastolic blood pressure were found to be positively associated with 
most measures of body composition, with the exception of percentage body fat for 
systolic blood pressure and percentage trunk fat for both systolic and diastolic 
blood pressure (Table 4.4). Investigating the relative contribution of fat mass index 
(FMI) and lean mass index (LMI) in simultaneous models including both terms 
different patterns were observed for systolic and diastolic blood pressure. In the 
simultaneous model, FMI was no longer associated with systolic blood pressure (ß: 
1.37mmHg; 95% Cl: -0.44,3.18; P: 0.14) but LMI remained associated (ß: 
1.58mmHg; 95% Cl: 0.38,2.78; P: 0.01). For diastolic blood pressure, FMI remained 
associated (ß: 2.70mmHg; 95% Cl: 1.10,4.30; P: 0.001) whereas LMI was no longer 
associated (ß: 0.83mmHg; 95% Cl: -0.23,1.89; P: 0.12). 
Table 4.4 Association between blood pressure and anthropometry/body 
composition for individuals in calcium trial follow-up 
Systolic BP (mmHg) 
Regression P-value 
coefficient 
(95% Cl) 
Diastolic BP (mmHg) 
Regression P-value 
coefficient 
(95% Cl) 
Height (cm) 0.50 <0.001 0.35 <0.001 
(0.31,0.68) (0.18,0.51) 
Weight (kg) 1.10 <0.001 0.90 <0.001 
(0.76,1.44) (0.59,1.20) 
BMI (kg/m2) 1.72 <0.001 1.49 <0.001 
(0.96,2.47) (0.82,2.15) 
Body fat (%) 0.22 0.20 0.45 0.003 
(-0.11,0.55) (0.15,0.74) 
FMI (kg/ml'6) 2.30 0.01 3.19 <0.001 
(0.62,3.98) (1.71,4.67) 
LMI (kg/m2.3) 1.93 0.001 1.53 0.003 
(0.83,3.04) (0.54,2.52) 
Trunk fat (%) 0.02 0.99 0.25 0.10 
(-0.32,0.36) (-0.05,0.56) 
Results are the effect on blood pressure of a one unit increase in explanatory variable, derived from 
linear regression analysis adjusted for age and sex 
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4.3 Maternal calcium supplementation and offspring blood pressure 
4.3.1 Results of intention-to-treat analysis 
Maternal calcium, compared to placebo, supplementation during pregnancy did not 
affect offspring blood pressure at 5-10 years of age (Table 4.5). The maternal 
intervention was unrelated to offspring blood pressure even after adjusting for 
compliance to the intervention and for covariates related to blood pressure (model 
4, Table 4.5). 
Only four percent of children had a systolic blood pressure that was above the 95th 
percentile for their height and age, and the odds of having high blood pressure was 
not related to the maternal calcium intervention (unadjusted OR: 1.1,95% Cl: 0.4, 
3.1, P: 0.86). 
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A potential source of error is the incorrect inclusion of individuals born preterm as 
there were a large number of missing data regarding gestational age (37%). 
However, restricting the analysis only to offspring with a known gestational age did 
not alter the conclusions (Table 4.6). 
Table 4.6 Effect of maternal calcium supplementation on offspring blood pressure 
for individuals with known gestational age (n=221) 
Unadjusted regression P-value 
coefficient (95% Cl) 
Systolic (mmHg) -0.03 0.98 
(-2.26,2.19) 
Diastolic (mmHg) -0.35 0.73 
(-2.34,1.64) 
Pulse pressure 0.32 0.71 
(mmHg) (-1.32,2.00) 
Mean arterial -0.25 0.80 
pressure (mmHg) (-2.17,1.68) 
Results are the difference in mean blood pressure (95% Cl) for individuals born to women receiving 
calcium supplements (coded 1) compared to placebo (coded 0) during pregnancy, derived from 
linear regression analysis. 
The possibility of the intervention effect being modified by covariates was assessed 
by fitting interaction terms into the linear regression models. There was a 
significant interaction between maternal baseline blood pressure and the effect of 
the intervention on childhood systolic blood pressure (Interaction coefficient, ß: 
0.26mmHg; 95% CI: 0.06,0.46; P: 0.01). Figure 4.2 graphically displays this 
interaction; for women with low baseline systolic blood pressure, the calcium 
intervention was associated with lower child systolic blood pressure compared to 
placebo, whereas for women with high blood pressure this association was 
reversed. 
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Figure 4.2 Interaction between calcium intervention and maternal blood pressure; 
effect on child blood pressure 
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The association between maternal calcium supplementation and offspring blood 
pressure was not modified by an interaction with attended antenatal clinic or with 
maternal BMI (data not shown). There was also no interaction with age or sex of 
the offspring (data not shown) but there was a significant interaction between the 
maternal intervention and child height at follow up on offspring systolic blood 
pressure (Interaction coefficient, ß: -0.23mmHg; 95% Cl: -0.44, -0.02; P: 0.03). For 
shorter children, the maternal calcium intervention was associated with higher 
blood pressure compared to placebo, whereas for taller children it was associated 
with lower blood pressure (Figure 4.3). There was also the suggestion of a similar 
relationship for diastolic blood pressure (Interaction coefficient, ß: -0.18mmH; 95% 
CI: -0.37,0.01; P: 0.06) (Figure 4.4). 
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Figure 4.3 Interaction between maternal calcium intervention and child height; 
effect on child systolic blood pressure 
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Figure 4.4 Interaction between maternal calcium intervention and child height; 
effect on child diastolic blood pressure 
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4.2.3 Results of as-treated analysis 
Mean compliance (comprising both intervention and control women) as assessed 
by tablet count and consumption was 98% (range: 75-100%) and there was no 
difference in mean compliance between the calcium and placebo arms of the trial 
(calcium: 98%, placebo: 98%; t-test P-value: 0.43). The mean total number of 
calcium tablets consumed by women in the intervention arm was 422 (range: 267- 
561) and the mean number of placebo tablets consumed was 415 (range: 285-588). 
In the as-treated analysis, there was a suggestion that women who demonstrated 
greater compliance had offspring with higher systolic blood pressure (ß: 
29.92mmHg, 95% Cl: 1.10,58.74, P: 0.04) but this was not related to the amount of 
the calcium supplement consumed (reflected by the 'dose consumed' term) (Table 
4.7). Offspring diastolic blood pressure was also unrelated to the maternal calcium 
dose. 
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4.4 Early life exposures: observational analysis 
4.4.1 Birth weight and later blood pressure 
Weight at two weeks of age was used as a proxy for birth weight. The regression 
coefficient for the association between weight at two weeks and systolic blood 
pressure (adjusted for age, sex and maternal weight and blood pressure) was 
1.31mmHg (95% Cl: -0.64,3.25, P: 0.19) and after adjustment for current weight it 
was -0.89mmHg (95% Cl: -2.89,1.10, P: 0.38). For the association with diastolic 
blood pressure the regression coefficient was 0.11mmHg (95% Cl: -1.59,1.81, P: 
0.90), and adjusted for current weight was -1.64mmHg (95% CI: -3.41,0.12, P: 
0.07). There was no association between weight at two weeks and pulse pressure 
or mean arterial pressure (data not shown). 
Length at two weeks was not related to either systolic (ß: 0.04mmHg; 95% Cl: -0.1, 
0.09; P: 0.08) or diastolic (ß: 0.03mmHg; 95% Cl: -0.01,0.07; P: 0.14) blood pressure 
at follow-up. After additional adjustment for current height there remained no 
association with either systolic (ß: 0.003mmHg; 95% Cl: -0.05,0.05; P: 0.90) or 
diastolic (ß: 0.01mmHg; 95% CI: -0.04,0.05; P: 0.73) blood pressure. There was also 
no association between length at two weeks and pulse pressure or mean arterial 
pressure (data not shown). Unlike the analysis in Chapter 3, there was no 
interaction between maternal supplementation group and the birth weight - blood 
pressure association for the offspring (data not shown). 
4.4.2 Season of birth and later blood pressure 
Season of birth, adjusted for age, sex, maternal blood pressure, maternal weight 
and child height and body composition, was unrelated to systolic (LR text X2: 0.71; 
P: 0.69) or diastolic (LR test x2: 7.93; P: 0.09) blood pressure at 5-10 years of age. 
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4.4.3 Growth in infancy and later blood pressure 
Growth in the first year of life, defined as the change in weight SD score between 
two and fifty-two weeks of age, was unrelated to blood pressure at 5-10 years in 
analysis adjusted for age, sex, maternal weight and maternal blood pressure (Table 
4.8). In contrast, change in weight SD score from one year to the current study was 
positively associated with systolic, diastolic and mean arterial pressure. 
Table 4.8 Relationship between weight change in early-life and blood pressure at 5- 
10 years of age in Gambian children 
Change between 2-52 weeksa Change between 1-7 years° 
Regression P-value Regression P-value 
coefficient (95% Cl) coefficient (95% Cl) 
Systolic BP 0.32 (-0.49,1.13) 0.44 1.12 (0.09,2.15) 0.03 
(mmHg) 
Diastolic BP 0.47 (-0.23,1.18) 0.19 0.92 (0.01,1.82) 0.05 
(mmHg) 
Pulse pressure -0.19 (-0.81,0.43) 0.55 0.21 (-0.58,1.00) 0.60 
(mmHg) 
Mean arterial 0.43 (-0.26,1.11) 0.22 0.98 (0.11,1.86) 0.03 
pressure 
(mmHg) 
Results are the effect on blood pressure at 5-10y of a one unit increase in weight standard deviation 
score between the specified time points, derived from linear regression analysis adjusted for age, 
sex, maternal weight and maternal blood pressure 
aChange in weight SD score between the two and 52 weeks 
bChange in weight SD score between 1 year of age and current follow-up (average 7 years old) 
The pattern of the association between growth and blood pressure at 5-10 years 
was further explored by creating a life course plot [121]. This reveals the 
importance of current weight for current blood pressure but also the positive 
association between growth after one year and blood pressure at follow-up (Figure 
4.5). 
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Figure 4.5 Life course plot of the association between growth at different ages and 
blood pressure at 5-10 years in rural Gambia 
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Change in length SD score between two and 52 weeks was unrelated to systolic (ß: 
0.05mmHg; 95% Cl: -0.80,0.90; P: 0.91) and diastolic (ß: 0.24mmHg; 95% Cl: -0.50, 
0.99; P: 0.52) blood pressure at 5-10 years. There was also no association with pulse 
pressure and mean arterial pressure and length change (data not shown). Change in 
length SD score between one and seven years was similarly unrelated to blood 
pressure at follow-up (data not shown). 
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4.5 Discussion 
4.5.1 Maternal calcium intervention 
4.5.1.1 Summary of findings 
This study has found no evidence that maternal calcium supplementation (1500 mg 
Ca/d) of rural Gambian women during the second half of pregnancy is associated 
with offspring blood pressure at 5- 10 years of age. 
4.5.1.2 Study strengths and limitations 
The original trial was a randomised double-blind, placebo controlled trial of calcium 
supplementation during pregnancy. An intervention study employing this type of 
design may be regarded as the highest quality epidemiological study, with the 
potential to provide findings with the greatest assurance of validity [95]. There was 
excellent compliance (98%) to the study regime and all investigators and 
participants remained blinded to the treatment allocation throughout the original 
study and the follow-up. The recruitment rate into the follow-up study was high 
(86% of all eligible individuals) and there was no differential follow-up between the 
two arms of the trial. In contrast, the only trial to report an overall association 
between maternal calcium supplementation and offspring blood pressure suffered 
losses to follow-up of over 90% [107]. Loss to follow-up was associated with only 
minor differences in characteristics from the original trial for which data were 
available, such as maternal baseline blood pressure and maternal age. The 
recruited sample is therefore representative of the trial offspring as a whole. 
One potential limitation of this study is the age of the children at follow-up. Studies 
that have reported lower offspring blood pressure in relation to maternal calcium 
intake during pregnancy (either trial or observational data) have mainly included 
children aged two years and under [69,71,107], whereas two studies reporting no 
association were in children aged 4-7 [108] and 7-10 years respectively [70]. A study 
in the US reported an inverse association between maternal calcium intake and 
offspring systolic blood pressure at one month of age, which was no longer 
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apparent by twelve months, although recruitment was greatly reduced at the 
second follow-up [69]. It may be that any influence of maternal calcium intake is 
short lived and/or does not track into later childhood. 
Another limitation is the difficulty of measuring blood pressure in children, even 
when an automated device is used. Given the design of the current study this issue 
should be equally distributed between the two random arms of the study and 
would therefore act to obscure any effect of maternal supplementation on 
offspring blood pressure through the additional 'noise' around the measurement of 
blood pressure. Given the small effect size and the tight confidence intervals 
presented in the analysis, it is unlikely that a greater precision of the effect estimate 
would have changed the conclusions of the study. 
4.5.1.4 Comparison with literature 
A number of studies have investigated the effect of maternal calcium intake, during 
pregnancy, on blood pressure in the offspring. These were recently summarised by 
Bergel and Barros [232], in a review that included both observational and 
randomised controlled trial studies. Three observational studies were included in 
the review [69-71], two of which were from the USA and included infants under one 
year of age [69,71]. As outlined above, McGarvey et al observed a negative 
association between maternal calcium intake (from food and personal 
supplements) and offspring systolic blood pressure at one month, a borderline 
association at six months but no association at twelve months of age [69]. Gilman et 
al observed a negative association between maternal calcium intake from 
supplements and offspring systolic blood pressure at six months of age but no 
association with calcium intake from foods [71]. The third observational study was 
from Australia and included children of nine years of age and observed no 
association between maternal calcium intake from supplements and childhood 
blood pressure [70]. There were a number of methodological issues with these 
studies; they suffered from loss to follow-up (of up to 40% for the one year follow- 
up of McGarvey et al [69]) and small sample sizes. In addition, the study by 
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McGarvey et al [69] and the Australian study [70] both used retrospective dietary 
assessment after birth. 
To date, three intervention studies of maternal calcium supplements have 
published follow-up data on offspring blood pressure. These trials are: one 
conducted in the US providing 2g calcium per day [109]; one from Argentina also 
providing 2g/d [110]; and one from Australia providing 1.8g of calcium per day 
[111]. The trial from the US was the only one to find an overall effect of maternal 
calcium supplementation on offspring blood pressure, albeit at only one of the two 
age points measured [107]. At three months of age 47% of targeted offspring were 
recruited and no association between maternal calcium supplementation and 
offspring systolic blood pressure was apparent. At the second follow-up the 
offspring were now two years old, and less than 10% of the original trial offspring 
were recruited but slightly lower systolic blood pressure was observed for children 
born to women receiving the supplement compared to placebo [107]. The follow- 
up of the Australian calcium supplementation trial recruited offspring who were 4-7 
years old and observed no association between the maternal intervention and 
offspring blood pressure [108]. 
Despite no overall effect of maternal calcium supplementation on offspring blood 
pressure at 5-9 years in Argentina, there was a lower risk of having high systolic 
blood pressure (>90th centile for US reference data [12]) for the offspring of calcium 
supplemented women compared to those provided with a placebo [106]. 
Additionally, the Argentinean trial observed an interaction with childhood BMI; for 
individuals with greater BMI at follow-up (above the mean) the intervention was 
associated with lower blood pressure [106]. In the current study from The Gambia 
there was no interaction with BMI and one explanation for this could be that the 
Gambian children were leaner (mean BMI: 14.0kg/m2 ±1.1) than those enrolled into 
the Argentinean follow-up (mean BMI: 16.2kg/m2 ±2.4), which was restricted to 
offspring in the wealthier subgroup. Only seven percent of subjects in the current 
study would be classified as having a BMI in the top two quartiles of the 
Argentinean study [106]. 
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Discrepancies in the results of calcium trials of supplementation with respect to 
hypertensive disorders in pregnancy have been attributed to different baseline 
intakes with a lower risk for women from areas of low habitual intake [233]. It is 
important to acknowledge that different baseline intakes may also explain the 
differences in the findings presented here, with average baseline intakes in the US 
trial of over 1000mg/d [107], compared to 300-400mg/d in The Gambia [195]. 
The four trials of calcium supplementation during pregnancy that have published 
findings on offspring blood pressure can be usefully combined into a forest plot to 
give a clearer indication of the effect of this exposure. A meta-analysis of the 
combined effect may not be appropriate however, due to the different ages of the 
trial offspring and the different concentrations of calcium supplement provided by 
the trials. Taken together, the current evidence suggests that maternal calcium 
supplementation during pregnancy does not affect offspring systolic (Figure 4.6) or 
diastolic (Figure 4.7) blood pressure. 
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Figure 4.6 Forest plot for the effect of maternal calcium supplementation during 
pregnancy on offspring systolic blood pressure 
Stu dy 
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Points represent weighted mean difference (WMD) in systolic blood pressure for children born to 
women taking calcium compared to placebo supplements during pregnancy. Data are from 
unadjusted intention-to-treat analysis reported in the publications. No overall estimate of effect is 
included due to the different study designs of the trials and follow-up studies included. 
Studies are Belizan et al [106] from Argentina, Hatton et al [107] from the US and Hillier et al [108] 
from Australia together with the current analysis (Hawkesworth). 
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Figure 4.7 Forest plot for the effect of maternal calcium supplementation during 
pregnancy on offspring diastolic blood pressure 
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Points represent weighted mean difference (WMD) in diastolic blood pressure for children born to 
women taking calcium compared to placebo supplements during pregnancy. Data are from 
unadjusted intention-to-treat analysis reported in the publications. No overall estimate of effect is 
included due to the different study designs of the trials and follow-up studies included. 
Studies are Belizan et al [106] from Argentina, Hatton et al [107] from the US and Hillier et al [108] 
from Australia together with the current analysis (Hawkesworth). 
This data adds important findings to the question of the impact of maternal calcium 
supplementation on offspring blood pressure, benefitting from a high rate of 
recruitment and being conducted in an area of low habitual intake where it might 
be hypothesised that a greater impact would be observed. The findings suggest that 
the calcium content of the maternal diet during pregnancy does not affect offspring 
blood pressure, at least in this setting and this age group. It could be argued that a 
larger sample size would be necessary to corroborate this finding, as in order to 
detect a 2mmHg difference in blood pressure between the trial arms (assuming 
means and standard deviations similar to those reported in this study) an 
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intervention study would require a sample of 608 individuals. A pooled analysis of 
the available data was not considered appropriate for the studies that have been 
conducted as there is great heterogeneity in study design, especially in the age of 
subjects. However, the forest plots suggest there is no impact of maternal calcium 
supplementation on offspring blood pressure. 
An alternative explanation for the null effect is that the additional calcium provided 
during pregnancy was not transferred to the offspring in utero [234,235]. In an 
analysis of a sub-set of mothers and their infants in the current trial, there was no 
effect of maternal calcium supplementation on fetal growth, bone mineral 
accretion of infants in their first year or on breast milk calcium concentration [195]. 
This suggests that even when habitual calcium intake is extremely low, physiological 
adaptations may operate that override any effects of supplementation and provide 
both the mother and developing fetus with their calcium requirements [195]. 
4.5.2 Observational analysis 
4.5.2.1 Summary of findings 
Relative weight at one year of age and the crossing of weight SD scores from one 
year to the current study were positively associated with systolic blood pressure at 
5-10 years. Neither anthropometry at two weeks of age (used as an indicator of 
birth weight) nor season of birth were associated with blood pressure at seven 
years of age in this group of individuals. 
4.5.2.2 Study strengths and limitations 
The study presented here was designed as a follow-up of a randomised controlled 
trial but it may also represent a useful resource with which to study these 
observational associations. The intervention was not demonstrated to have an 
effect on the exposures under investigation, such as birth weight, or on the 
outcome blood pressure and the data may thus be thought of as a cohort enrolled 
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at birth. Loss to follow-up was relatively low: 71% of individuals born into the study 
were recruited into the follow-up and loss to follow-up was not associated with the 
exposures under investigation (early-life anthropometry, season of birth) and is 
unlikely to be associated with the outcome of interest (blood pressure). An 
advantage of the data is the accuracy of the anthropometric measurements in 
infancy, which were conducted by trained fieldworkers and were adjusted for the 
actual age at measurement. 
Similarly to the data in Chapter 3, the major limitation of using trial follow-up data 
for cohort analysis is a lack of data on well-characterised confounders. Although 
smoking prevalence is known to be low in this region [228], there is no data on 
other important confounders such as social economic status. 
4.5.2.3 Comparison with the literature 
A number of cohort studies have published data on the impact of early postnatal 
growth on later blood pressure, employing many different data analysis techniques 
and presenting conflicting results. The Collaborative Perinatal Project in the US 
reported that a change in weight SD score from birth to four months, four months 
to one year, one to four years and four to seven years were independently 
associated with increased odds of having high blood pressure (>90`h percentile in 
the cohort) at seven years [116]. In the UK, reflecting similar findings to the 
Gambian data, growth (defined as weight SD score change) in the first year of life 
was unrelated to blood pressure at age 22 but growth from one to five years of age 
was positively associated with systolic and diastolic blood pressure at this age [119]. 
In contrast, data from Hong Kong suggests the opposite effect of growth to that 
normally observed; a decrease in ponderal index between six and eighteen months 
of age was associated with increased systolic blood pressure at 30 years [120]. 
A recent analysis of five cohorts from developing countries reported that higher 
than average weight gain between birth and four years was only associated with 
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early adult blood pressure because it predicted later body size, once later height 
and BMI were included in the analysis the association was no longer apparent 
[123]. With such heterogeneity of study designs, particularly the time points 
studied and the method of characterising growth, it is difficult to draw a conclusive 
picture from the literature of the association between early growth and later blood 
pressure. 
4.5.2.4 Implications of findings 
Similar to Chapter 3, the findings presented in this chapter suggest that childhood 
growth is a factor that influences blood pressure in later childhood. Interestingly, 
season of birth was not associated with blood pressure in the children under study 
here although it had been associated with blood pressure in the adolescent 
individuals presented in Chapter 3. This disparity of findings may be related to the 
smaller sample size involved in the analysis of the calcium cohort (350 compared to 
1267). Alternatively it may be that in this region seasonal effects have lessened over 
time so that individual born during the protein-energy trial were exposed to greater 
variation than the more contemporary children from the calcium trial. An 
alternative explanation is that the seasonality effect was not seen because the 
calcium trial (unlike the protein-energy trial) included the core village of Keneba, 
which has been the recipient of the greatest amount of health care in the region 
and may thus be less susceptible to seasonal effects. However, repeating the 
analysis only on children born outside of Keneba only did not reveal an association 
between season of birth and later blood pressure, indicating that this is unlikely to 
be the explanation of the null effect. 
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Chapter 5 Bangladesh study methods 
5.1 Forward 
In 2006, the MRC ING was awarded an MRC Project Grant to collaborate in a follow- 
up study of a multiple micronutrient supplementation trial in Bangladesh. Partner 
institutions included the International Centre for Diarrhoeal Disease Research, 
Bangladesh (ICDDR, B) (PI: Dr Shams Arifeen) and Uppsala University, Sweden (PI: 
Professor Lars-Ake Persson). The collaborators allowed full access to data from the 
original trial, which is described briefly below. SH was employed full-time on this 
grant as a research assistant and subsequently a research fellow responsible for the 
implementation of the study in Bangladesh. SH was also registered as a PhD student 
throughout this period. The design, implementation and management of fieldwork 
insofar as they relate to this PhD will be outlined in this chapter and the results will 
be presented in Chapter 6. 
5.2 Field site 
5.2.1 Bangladesh 
Bangladesh is situated in South Asia, bordering India and Myanmar at the head of 
the Bay of Bengal (Figure 5.1). It is the most densely populated major country in the 
world, having a population in mid 2007 of 158.6 million [236] residing in a country 
of 144,000 km2 (237]. Dhaka is the capital city and is home to over 11 million 
people [237]. Bangladesh is located on the delta of three major rivers, the Ganges, 
Brahmaputra and Meghana and as a result much of the country experiences annual 
flooding during the seasonal monsoon rains. The official language is Bengali and the 
major religion is Islam (89%), with a Hindu minority of around 10% [237]. 
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Figure 5.1 Location of Bangladesh in South Asia 
(reproduced from Trinity College Dublin(regional map) [238] and Map Archive 
(Bangladesh map) [239]) 
JA, IIRIS IAI'1 
., r 
Kabul 
AFGHANISTAN Islamabed 
PAKISTAN 
NEPAL Thimphu 
New Delhi h du "JITAl 
BANGLADESH ', 
acs., . ". ------ ----1 "' 
INDIA YANMI 
fir 
ARABIAN 
SEA 
SRI 
LANKA 
2 cr 
°ý Colombo t 
" Male 
MALDIVES 
µý 
BHUGN 
NEPAL 
Bangladesh 
INDIA 
'". 
± `""y °-" 
DHAýA 
INDIA INDIA 
"., ..... 
n 
r. 
`ýc ýM 
\I 
....! CHITTAGONG 
KHULNA 
A. of 8oopei 
-145- 
Chapter 5: Bangladesh methods 
Bangladesh is lagging behind in economic development compared to its larger 
neighbour India, although annual economic growth and poverty indicators are 
slowly improving. World Bank statistics quote the Gross Domestic Product (GDP) 
per capita of Bangladesh in 2007 as US$42.7 compared to the Indian GDP/capita of 
$1042.5 [236]. Poverty and malnutrition remain widespread and there is an 
increasing gap between the rich and the poor. According to World Bank statistics, 
again for 2007, average life expectancy at birth is 64 years and infant mortality is 
52/1000 live births with a much higher rate (85/1000 live births) in lower income 
groups [236]. 
5.2.2 Mat/ab 
Matlab is a region situated around 55km south-east of Dhaka in the flood plains of 
Bangladesh. In common with the majority of the country, Matlab experiences a 
tropical climate with a hot, humid summer from March to June followed by the 
rains of the monsoon season which fall between July and October. The seasonal 
pattern of the rains is mirrored by changes in the water level and resulting changes 
in farming activities. During the winter season (November to March), the waters 
gradually retreat, revealing large tracts of cultivatable land on extremely fertile 
alluvial soil. The main harvest takes place during the summer months before the 
onset of the monsoon. Once the monsoon starts the water level rapidly rises 
covering the fields and preventing most forms of farming activity, although fishing 
thrives during this time (Figure 5.2). The local community is well adapted to the 
seasonal changing water levels, which rise and fall by an average of two to three 
metres each year. The houses and roads are all built above the level that the floods 
usually reach. The main crops grown in the region are rice (Oryza sativa), maize 
(Zea mays) and potatoes (Solanum tuberosum). 
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Figure 5.2 Annual change in water levels, Matlab Bangladesh 
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5.2.3 ICDDR, B Matlab 
The International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) is a 
health research institution based in Dhaka. Since 1963, ICDDR, B has conducted 
medical research in the Matlab area basing their work around a health clinic. One of 
the consequences of this increased health service provision is a reduced rate of 
infant mortality, which is 30/1000 live births [240] compared to the national 
average of 52/1000 [236]. In addition to clinic activities and various field trials the 
centre has conducted a detailed demographic surveillance study (DSS) of the area 
since 1966, which is the largest longitudinal demographic data collection system in 
a developing country [240]. The DSS area covers sections of Matlab that receive 
health care provided by ICDDR, B (population of 113,128 in 2006) as well as 
contiguous areas outside of ICDDR, B care where residents receive government 
provided health care (population of 111,410 in 2006) [240]. The area of the DSS 
that receives medical care from ICDDR, B, and is included in any large-scale studies 
in the region, comprises four blocks (A, B, C and D) each of which has a small sub- 
centre that is used for outpatient care and as a base for some of the larger research 
projects (Figure 5.3). 
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Figure 5.3 The location of ICDDR, B demographic surveillance survey within the 
district of Matlab 
(reproduced from ICDDR, B [240]) 
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5.3 Original supplementation trial ("MINIMat") 
The Maternal and Infant Nutrition Interventions, Matlab (MINIMat) trial was 
conducted by ICDDR, B between 2000 and 2004 in Matlab, Bangladesh. The study 
was designed to test community interventions aimed at improving birth outcomes 
and infant health. Three interventions targeted pregnancy and a fourth focused on 
postnatal feeding behaviour. The interventions were promotion to access a 
government food supplementation programme either early in pregnancy or at a 
time of the participants' choosing (usual care); a three-arm micronutrient 
supplementation intervention; and two drug treatments for bacterial vaginosis. The 
latter intervention is not relevant to this PhD and will not be discussed further. The 
final intervention involved counselling to promote exclusive breast feeding or 
counselling on other health messages. 
5.3.1 Prenatal nutritional interventions 
Eligible women were identified as part of the established DSS in the region, through 
which community health workers visited households on a monthly basis to ask 
women about their menses. During the study, any women reported as missing a 
menstrual period for two weeks or more was offered a confidential pregnancy test 
and if positive were invited to participate in the MINIMat trial. This system meant 
that eligible women were identified roughly 6-8 weeks after conception. Recruited 
individuals were randomly allocated to the three different interventions at 8-10 
weeks gestation using a computer tracking system where women were assigned to 
one of 12 different blocks (Table 5.1). 
Table 5.1 Randomisation to prenatal interventions in the MINIMat trial, Bangladesh 
E Micronutrient arm 
Tablet A Tablet B Tablet C 
ö Intervention A Al A2 B1 B2 Cl C2 
0 
u- Intervention B D1 D2 El E2 F1 F2 
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The food supplementation arm of the MINIMat trial involved encouragement given 
to participants to attend government sponsored local community nutrition centres 
(CNC). These centres are part of the Bangladesh Integrated Nutrition Programme 
(BINP) and food is usually only available for pregnant and lactating women with a 
BMI <18.5kg/mzto commence at a time of their choosing; average enrolment in the 
program is 17 weeks gestation [241]. For the purposes of this intervention, all 
women were entitled to the supplement (irrespective of BMI) and were randomised 
to an early (8-10 weeks gestation) invitation to attend the CNC or to the usual 
invitation (at a time of their choosing). Women in the early arm of the intervention 
were given strong encouragement to enrol at the CNC as soon as possible. Once 
enrolled, women were eligible to receive the supplement throughout pregnancy 
and for two months post-parturn. The food supplement was made from 80g of fried 
rice powder, 40g of fried pulse powder, 20g of molasses and 12ml of soybean oil 
and it provided 608kcal/day and 17.9g protein/day (6 days/week) [242]. On seven 
defined occasions during pregnancy, women were visited at home by research staff 
and asked about the consumption of food packets received from the CNC, this data 
was therefore available as an estimate of compliance. 
The second nutritional intervention was micronutrient supplementation in tablet 
form. Women were randomised to three groups, either receiving 30mg of iron and 
400pg of folic acid (Fe30F), the usual government provision of 60mg of iron and 
400pg of folic acid (Fe60F), or a supplement containing the UNICEF/UNU/WHO 
preparation of 15 micronutrients at or above the recommended daily allowance 
(RDA) (Table 5.2). The tablets were identical for the three arms of the trial and were 
provided at 14-15 weeks gestation in containers of 200 tablets to last throughout 
pregnancy and for two months post-partum. The tablet containers carried 
equipment in the lid containing a counting device and small microprocessor 
(eDEM®); each time the pill-bottle was opened and closed, the time and date were 
recorded. At the end of the study these pill counts were aggregated and used as an 
indication of maternal compliance to the intervention. 
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Table 5.2 Nutritional content of the three micronutrient supplements provided 
during the MINIMat trial, Bangladesh 
Fe30F 
30mg Iron 
400µg Folic acid 
Supplement group 
Fe60F' 
60mg Iron 
400pg Folic acid 
MuMsb 
30mg Iron 
400µg Folic acid 
800pg RE vitamin A 
2001U Vitamin D 
10mg Vitamin E 
70mg Vitamin C 
1.4mg Vitamin B1 
1.4mg Vitamin B2 
18mg Niacin 
1.9mg Vitamin B6 
2.6µg Vitamin B12 
15mg Zinc 
2mg Copper 
65µg Selenium 
150ug Iodine 
aUsual tablet composition provided to all pregnancy women in Bangladesh 
bUNICEF/UNU/WHO recommended preparation 
5.3.2 Postnatal intervention 
At 30 weeks gestation, women were randomly assigned to the final intervention in 
the program. Participants were either allocated to receive counselling to promote 
exclusive breastfeeding or counselling on different health education messages in 
newborn care. There were seven counselling sessions, which all took place in the 
home: two occurred before delivery, one just after delivery and then again at 1,2,3 
and 5 months postpartum. Breast feeding messages concentrated on emphasising 
the importance of exclusive breastfeeding for six months, whilst the control group 
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received more general health messages about newborn care. Counsellors were 
trained using WHO material modified from a previous intervention study in the 
region, and provided emotional and practical support to the participating women 
and family members [243]. 
5.3.3 Trial protocol and measurements 
Women attended clinic visits for data collection at four time points during their 
pregnancy: baseline at 8-10 weeks gestation, then 14-15 weeks, 19-20 weeks and 
30-31 weeks. After birth, both the participating women and the newborn children 
were seen each month until the child was six months old and every two months 
thereafter until they were one year old. Additional measurements were also taken 
during infancy, including thymic size assessment and child development indices. 
The main outcome measures of the original trial were fetal growth, birth weight 
and maternal haemoglobin and the publication of these findings is in progress. 
Table 5.3 summarises the measurements taken during the original trial. Only some 
of these measurements are of direct relevance to this PhD and are described in the 
sections below. 
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Table 5.3 Measurements conducted in the original MINIMat trial, Bangladesh 
Stage Measure Time point 
Pre- 
pregnancy- 
Pregnancy 
Maternal weight 
Pregnancy identification: urine pregnancy 
test 
Routine DSS 
surveillance 
68 wk gestation 
Fetal ultrasound: gestational age + growth 
Maternal anthropometry (weight, height, 
MUAC) + blood pressure 8-10,14-15,19-20 & 
Maternal urine collection 30-31 weeks 
Maternal morbidity gestation 
Maternal venous blood collection 14-15 & 30-31 wk 
gest 
Maternal dietary intake (recall) and food j 
security 
8-10,22-23 & 30-31 
wk gestation 
Interviews on stress, violence, toxic 
exposures and work load 
Birth Birth anthropometry (weight, length, head 
circumference) Within 72h of birth 
Maternal and newborn health 
Cord blood and placenta samples 
Infancy Infant anthropometry (weight and length) Monthly to 6 mo, 
Infant morbidity (diarrhoea, respiratory tract 
infections) 
then every two 
months until 24 mo 
Infant feeding (recall) 
Infant thymus size by ultrasound 1,8,24 & 52 weeks 
Infant blood sample 6 months 
Breast milk samples 8,24,52 weeks 
Infant motor milestone assessment Monthly from 3-12 
mo 
Infant psycho-motor assessment 7 months 
Infant language assessment 12 months 
Maternal blood sample 12 months 
Maternal anthropometry (weight) 2,6 & 12 mo post- 
partum 
Childhood Child anthropometry (weight and height) 
1-3y Child dietary intake (recall) 15,18,21 & 24 
Child morbidity (diarrhoea and respiratory 
tract infections) 
months 
Child motor milestone assessment 15 & 18 months 
Child psycho-motor assessment 18 months 
Child language assessment 18 months 
Maternal anthropometry (weight) 24 months 
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5.3.3.1 Prenatal measurements 
Maternal weight and height were measured at the baseline clinic visit (8-10 weeks 
gestation) by trained fieldworkers, and additional weight measurements were 
made throughout pregnancy. Weight was measured on electronic scales 
(UNISCALE) to the nearest 100g. Data on maternal age were available from the 
ongoing DSS as was information on parity. Detailed interviews were conducted at 
baseline to collect data on household and personal assets owned and on level of 
parental education. 
Venus blood samples were collected at two different time points during pregnancy; 
14-15 weeks (baseline for micronutrient arm) and 30-31 weeks gestation. At these 
time points, haemoglobin was assessed on all women in the field using a 
haemocue®. Maternal blood pressure was measured at four time points in 
pregnancy (8-10,14-15,19-20 and 30-31 weeks gestation); at these visits a nurse 
made a single assessment of systolic and diastolic blood pressure using a mercury 
sphygmomanometer. 
5.3.3.2 Postnatal measurements 
In total, 4436 women were randomised to take part in the MINIMat trial and 
between May 2002 and June 2004 there were 3267 live singleton births recorded 
(Figure 5.4). Anthropometric measurements were conducted on the infants within 
72 hours of birth, either at the subject's home or the subcentre. Birth weight, 
length, head circumference and knee-heel length were measured at this time by 
fieldworkers. Infant weight and length were also measured every month after birth 
until the child was six months of age and thereafter every two months until they 
were twelve months of age. Up to six months of age, all infant weights (including 
birth weight) were measured by beam scales, which are accurate to 10g. All 
maternal weights and infant weights beyond six months of age were measured with 
electronic scales (UNISCALE), accurate to 100g. Locally manufactured, collapsible 
length boards, which are precise to 1mm, were used to measure the recumbent 
length of the infant. 
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In addition to measurements of infant anthropometry, the post-partum visits also 
involved the administration of a questionnaire to assess infant feeding practices 
both using a 24h recall and questions relating to feeding during the previous seven 
days. This self-report of breast feeding practices was found to have a good level of 
accuracy when compared to infant breast milk consumption measured by the dose- 
to-mother deuterium dilution technique in a sub-sample of the participating 
mother-infant pairs [244]. 
5.4 Follow-up study, methodology 
5.4.1 Subjects 
A detailed follow-up of the children born during the MINIMat trial was conducted 
between May 2007 and February 2009, when they were 4.5 years old. The follow- 
up study was coordinated by ICDDR, B with funding and expertise also provided by 
Uppsala University and LSHTM. All of the 3267 individuals comprising the live 
singleton births during the original trial were eligible for recruitment. Scientific 
approval was granted by the Scientific Research Committee of ICDDR, B and ethical 
approval was provided by the ICDDR, B Ethical Research Committee as well as the 
ethical committees of the participating universities. Full informed consent was 
obtained from the parents or guardians of the children prior to enrolment in the 
study. 
5.4.2 Study protocol 
Children were invited to participate within two weeks of reaching 4.5 years old, 
although if missed at this time point they were invited again at a later date. 
Fieldworkers collected the children and their mother, or guardian, early in the 
morning to bring them to the study sub-centre in a fasted state. Clinic visits were 
conducted in each of the four sub-centers of the Matlab study area, with additional 
questionnaires administered during a home visit. Two teams of fieldworkers, 
supervised by a medical doctor, conducted the clinic visits and alternated on a 
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weekly basis which clinics they were located in. Children born during the first half of 
the MINIMat trial (May 2002 - mid June 2003) comprised 'Group A' and 
participated in a reduced protocol, whilst the remaining children (Group B: June 
2003 - June 2004) participated in a protocol that required two clinic visits (21 days 
apart) with a larger number of assessments at each (Table 5.4). It was not possible 
to conduct the detailed protocol on all offspring due to the costs involved; children 
born in the latter half of the trial were chosen for the detailed study as they had 
also participated in a detailed study at one year old which included assessment of 
thymus size amongst other outcomes. 
Table 5.4 Assessments conducted during MINIMat 4.5 follow-up relating to current 
thesis 
Group A Group B 
Anthropometry xx 
Blood pressure xX (twice') 
Cystatin cxX (sub-sample only) 
Kidney size -x 
Maternal sitting ht -x 
'Conducted on two separate occasions, 21 days apart 
Eligible individuals were identified from their unique DSS number and location 
details, and because they had been extensively followed-up since birth and were 
therefore well known to the fieldworkers. Recorded data were checked by the 
Medical Officer at the end of each visit and sent to Dhaka to be entered by ICDDR, B 
staff at the data records office there. 
5.4.3 Measurements 
5.4.3.1 Blood pressure 
Blood pressure was measured in triplicate using an automated oscillometric device 
(Omron 7051T, Morton Medical ltd), with the cuff placed on the right arm and the 
arm resting on a table at chest height. The first measurement was taken after the 
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subject had been seated at rest for five minutes and there was one minute between 
each subsequent measurement. Group B children were seen on two separate 
occasions, 21 days apart, to gain a more accurate estimate of the habitual blood 
pressure of the subject with blood pressure assessed in the same manner. 
5.4.3.2 Anthropometry, body composition and morbidity 
Anthropometric measurements included height, weight, skinfold thickness, mid- 
upper arm circumference and head circumference. Measurements were taken by 
trained nurses and only four individuals held this post during the study period. 
Height was measured to the nearest 0.1cm with the subject wearing no shoes using 
a daily-calibrated Seca Leicester stadiometer (Chasmors Ltd). Weight was measured 
on a daily-calibrated digital scale (Tanita, Chasmors Ltd) to the nearest 0.1kg, again 
with the subject wearing no shoes. Four skinfold thickness sites were assessed using 
Holtain callipers (Chasmors Ltd): triceps, biceps, superilliac and sub-scapular sites 
were all measured in triplicate to the nearest 1mm. 
Total body composition was assessed using a foot-to-foot bioelectrical impedance 
analyser (Tanita TBF-300MA, Chasmors Ltd). Subjects stood on the scale with bare 
feet after being asked to void their urine. The analyser produces fat mass and fat- 
free mass values that are based on inbuilt equations derived in Caucasian 
populations and for use in children over seven years old. A validation study was 
conducted using deuterium dilution as a reference method to assess the accuracy 
of the analyser in this population. However, the laboratory results are still being 
analysed and in the meantime the raw impedance data has been used (see Section 
5.5.1), as this provides a proxy measure of lean mass that may be more accurate 
than the inbuilt equations in this setting. 
For children in group B only, maternal sitting height was recorded using the same 
stadiometer as for child height but with the stadiometer placed on the seat of a 
hard bench against a wall. Mothers were asked to sit on the base of the 
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stadiometer with as much as possible of their thighs supported and height 
measured in the standard way. 
When children first arrived at the subcentre their parents were asked general 
health questions including whether they were feeling well on the study day and if 
the children had experienced diarrhoeal episodes in the preceding two weeks. Both 
of these were thought to have potential implications for blood pressure 
measurement on the study day and were therefore used in the analysis. 
5.4.3.3 Kidney function 
Plasma Cystatin C (CysC) is a non-glycosylated protein produced in lysosomes and 
cleared exclusively by the kidneys [159]. It has recently been proposed as an 
estimate of glomerular filtration rate that may be more accurate than the more 
commonly used creatinine [245]. It has been suggested that it may be particularly 
useful in studies involving children where creatinine is thought to be less accurate 
due to the variations in body size and muscle mass [159]. In a recent study of 
Colombian children CysC was found to have greater specificity and sensitivity than 
serum creatinine, leading the authors to conclude that CysC was a better indicator 
of kidney function in children [159]. In the current follow-up study, fasted blood 
samples were collected from participating children using lithium heparin treated 
collection tubes for later analysis of a number of biomarkers. Blood samples were 
transported to the Matlab laboratory within two hours of collection for separation 
of plasma by centrifugation at 3000rpm for five minutes. Plasma aliquots were then 
separated and frozen in a -70°C freezer. At the end of the study, frozen plasma 
aliquots were transported to the hospital laboratory in Uppsala, Sweden where 
CysC was analysed using the immunoturbidimetric analysis described by Flodin et al 
[246]. 
Group B children took part in a more detailed protocol at the clinic visits, including 
sonographic assessment of the size of the kidney, liver and spleen (Figure 5.5 and 
5.6). Ultrasonography was conducted using a convex scanner (Toshiba SSA 320A 
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Justavision-200, Toshiba Medical Systems, Japan) at a frequency of 3.5Mhz by two 
highly skilled medical doctors who had undergone extensive training and 
standardisation. Single measurements of kidney size (length, width and depth) and 
two alternative methods of assessing volume were conducted on each participant 
in the vertical dorsal view. Assessments were made on the right kidney first, 
followed by the left. Length was measured as the long axis of the kidney, taking a 
line that passed through the hilus (Figure 5.7). In the same view, width was 
measured as the shortest axis of the kidney. From the length measurement 
position, the probe was turned 90° anti-clockwise and the diameter of the largest 
round section was measured to obtain an estimate of depth. Using the 
measurements of length, width and depth obtained, the internal software of the 
ultrasound machine provided an estimate of kidney volume. As an alternative 
estimate of volume the ellipsoid function was also used; in the length view the 
sonographer placed an ellipsoid shape around the kidney and adjusted the size to 
best fit the kidney shape (Figure 5.7). Again the internal software used these 
dimensions to estimate kidney volume. 
Figure 5.5 Medical officer conducting ultrasound measurements 
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Figure 5.6 Kidney ultrasound image taken during MINIMat 4.5 follow-up 
Image represents the right kidney of a MINIM, it follow-up subject: length, width and ellipsoid 
volume were measured in this view 
Figure 5.7 Diagram of kidney dimension measurement by ultrasound in MINIMat 
trial follow-up 
Ellipsoid 
A----`, volume 
Width 
Probe Depth 
rotated 90" 
Length 
Schematic representation of the different kidney size measurements conducted: length, width, 
depth and ellipsoid volume 
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5.5 Statistical analysis 
All statistical analysis was conducted using Stata 10 (Stata Corporation, College 
Station, Texas, USA). The effects of the prenatal interventions were assessed by 
intention-to-treat analysis and then by an as-treated analysis. Both analyses 
focused on the effect of food and micronutrient supplementation separately and 
together, on blood pressure and then on kidney function outcomes. Analysis of the 
effect of randomisation to counselling for exclusive breast feeding or for other 
health messages was also assessed as an intention-to-treat followed by as-treated 
analysis. An analysis of the observational data of the association between early-life 
factors and later blood pressure and kidney function was also conducted. All of the 
analysis was restricted to infants born at term (>37 weeks gestation) as assessed by 
the timing of their mothers' last menstrual period (LMP method). 
5.5.1 Data manipulation 
Outcome variables and continuous covariates were assessed for the normality of 
their distribution using histograms and quantile-quantile plots. The mean of three 
measurements was taken as the estimate of systolic and diastolic blood pressure. 
Pulse pressure was defined as systolic - diastolic pressure, whilst mean arterial 
pressure (MAP) was defined as diastolic + (1/3 * pulse pressure). Kidney volume 
was defined as total volume of the right and left kidney, and where appropriate was 
adjusted for body surface area calculated from the Haycock formula [247]. 
Glomerular filtration rate was calculated from plasma CysC using a prediction 
equation generated in Swedish patients and applicable for use in children [248]. 
Body mass index (BMI) was calculated as weight(kg)/height(m)2. The raw 
impedance data from the bioelectrical impedance analyser was used to give an 
indication of relative lean mass. An impedance index, defined as 100/impedance, 
was created as this has been shown by Wells et al to have a good correlation with 
lean body mass assessed by the four component model [249]. Skinfold 
measurements were used to give an indication of body fat, again retaining the data 
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in their raw form rather than using prediction equations. For each site (biceps, 
triceps, subscapular and suprailiac) the three measurements were combined into 
an average value. Body fat was then calculated as the sum of the four skinfold sites, 
whilst relative trunk fat was calculated as the ratio of central skinfold thickness 
(subscapular + suprailiac) to limb skinfold thickness (biceps + triceps). 
Socio-economic status (SES) was assessed by the creation of a wealth index using 
principal component analysis in a method described by Filmer and Prichett [250]. 
Variables included in the index were land, construction materials of house walls, 
ownership of household assets, numbers of sarees or shalwer-kameez owned for 
ceremonial use and pairs of shoes or sandals owned. The explanation of these 
variables and a more detailed description of the creation of the wealth index in this 
population is given by Saha et al [251]. The wealth index score (ranging from -6 to 
+4) was kept as a continuous variable for this analysis. 
5.5.2 Intention-to-treat analysis 
Independent t-tests were used to assess any differences in characteristics from the 
original trial between those recruited and those lost to follow-up. Linear regression 
was used to investigate the effect of the maternal interventions on offspring blood 
pressure and kidney function. Variables that were potential correlates of blood 
pressure and kidney function were assessed by simple linear regression analysis and 
those that were associated were included in the adjusted regression models. There 
were three stages of regression models used to investigate the impact of the 
maternal interventions: unadjusted (model 1), adjusted for covariates unrelated to 
the maternal intervention but related to blood pressure/kidney function (model 2), 
as model 2 but additionally adjusted for height, BMI, impedance index, body fat, 
morbidity on the study day and the reporting of diarrhoea in past 2 weeks (model 
3). 
The analysis was firstly conducted to investigate the impact of the food 
intervention, with the variable divided into early or usual start of food 
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supplementation. The micronutrient intervention was assessed in two different 
ways; comparing multiple micronutrient supplementation (MuMs) to iron and 
folate supplementation and comparing high iron dose (60mg) with low iron dose 
(30mg) (Table 5.5). This method of analysis was chosen as the most effective 
method of answering two important research questions: is there an impact of 
multiple micronutrient supplementation and is there an impact of providing a high 
iron dose. The linear regression models were fitted with both terms but the 
coefficients are reported separately in the results. 
Table 5.5 Categorising micronutrient intervention from MINIMat trial for analysis 
Original New code for analysis° 
rancomisation Multiple micronutrients High iron dose 
codea (MuMs) (highFe) 
Fe30F 00 
Fe60F 01 
Mulls 10 
'Original micronutrient arm of the intervention. Fe30F represents women randomised to receive 
30mg iron and 400µg folic acid; Fe60F represents women randomised to receive 60mg iron and 
400µg folic acid; MuMs represents women randomised to receive 15 multiple micronutrients (of 
which iron concentration was 30mg) 
bVariable is recoded to represent multiple micronutrients or high iron dose: individuals coded 0 
('control') or 1 (receiving intervention). 
The combined effect of the food and multiple micronutrient interventions was 
assessed by fitting interaction terms between the food and MuMs interventions 
(food*MuMs) and between the food and iron interventions (food*highFe) together 
in a model. The final analysis investigated the impact of counselling for exclusive 
breast feeding, which was fitted as a binary variable again using linear regression 
analysis and investigating the impact on offspring blood pressure and kidney 
function via the same models as described above. 
Children were defined as having high blood pressure if their systolic blood pressure 
was above the 95th centile for their age and height [12]. The impact of the three 
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interventions on the odds of having high blood pressure was assessed using logistic 
regression adjusted for the same covariates as above. 
Interactions 
For each intervention (food, micronutrient and breast feeding counselling) it was 
also necessary to model potential interactions with co-variates to assess if the 
effects of the interventions were modified by other factors. Interaction terms were 
added in model 2 in a sequential manner to investigate any modification of the 
intervention effect with sex, SES, maternal baseline blood pressure, maternal 
baseline BMI and offspring body composition (height, impedance index, body fat 
and BMI). If an interaction term was found to be significant the relationship was 
investigated graphically to assess how biologically meaningful the association was 
likely to be. 
5.5.3 As-treated analysis 
The number of food packets consumed by participating women was available from 
home visits conducted at weeks 14,18,19,22,26,30 and 34 of gestation. The total 
number of packets consumed during pregnancy was calculated from this data 
based on maternal recall at each visit. A linear regression analysis was conducted to 
investigate the association between total food packets consumed and offspring 
blood pressure with a separate analysis to investigate any effect on offspring kidney 
function. The as-treated analysis was conducted using the same models (1-3) as the 
intention-to-treat analysis described above. 
For the micronutrient intervention the total number of tablets consumed was 
available from the pill count provided by the eDEM® lid technology. Although 
women had been provided with micronutrient tablets that lasted for two months 
post partum the level of encouragement they had been given to take the tablets 
after birth was unclear. It therefore did not seem appropriate to define compliance 
as observed/expected tablet consumption. Instead, the effect of tablet 
consumption (irrespective of randomisation) on later blood pressure was modelled 
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by linear regression analysis using total pill consumption as the exposure variable. 
The effect of the micronutrient dose (multiple micronutrient tablets compared to 
iron and folate only or high compared to low iron tablets) was then included in the 
same model by fitting an interaction between the number of tablets consumed and 
the randomisation variable. Again, the analysis was conducted first as an 
unadjusted model and then adjusting the model for co-variates related to blood 
pressure and finally adjusting for body size and composition. 
Data on breast feeding practices and on the provision of other foods and liquids to 
the child were available from monthly interviews conducted until the children were 
six months of age and bimonthly from six to twelve months. At each visit, 
researchers asked about feeding practices in the preceding month in 15 day 
intervals. Breast feeding was then categorised in line with WHO recommendations 
into exclusive breast feeding (breast milk only), predominant breast feeding (breast 
milk plus other liquids including water and juice) and partial breast feeding (breast 
milk plus foods and other milks) [252]. The as-treated analysis utilised this 
categorical variable on infant feeding practices as the exposure variable and 
different models (unadjusted and adjusted) were fitted as before. Breast feeding 
practices changed markedly between four and size months of age, falling from 60% 
to 30% of women reporting to be exclusively breast feeding. Thus the as-treated 
analysis of the effect of different infant feeding types was conducted for both of 
these time points separately. 
5.5.4 Observational analysis 
5.5.4.1 Maternal growth in childhood 
Maternal leg length can be used as a proxy indicator of the mother's own 
nutritional exposures in early-life as leg growth is affected to a much greater degree 
than trunk length [253]. Maternal leg length was calculated as height-sitting height 
and the association between maternal leg length and offspring blood pressure and 
kidney function was assessed using linear regression analysis. Firstly an unadjusted 
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analysis was conducted, followed by analysis adjusting for variables associated with 
the outcome of interest. 
5.5.4.2 Maternal micronutrient status 
The only maternal micronutrient status data that was available on the majority of 
women was haemoglobin concentration, as this had been assessed in the field at 
weeks 14 and 30 gestation. The association between maternal haemoglobin 
concentration in pregnancy, separately for each time point, and offspring blood 
pressure and kidney function was assessed using linear regression analysis. Firstly 
an unadjusted analysis was conducted followed by analysis adjusted for factors 
associated with current blood pressure and kidney function. As the iron 
intervention may have directly impacted on maternal haemoglobin by week 30 
gestation, an interaction between the intervention and maternal haemoglobin on 
offspring blood pressure and kidney function was assessed for this time point by 
fitting an interaction term. An additional analysis was conducted to investigate the 
association between anaemia during pregnancy (defined as haemoglobin <11g/dl) 
and offspring blood pressure and kidney function. Again this analysis was 
conducted for both time points (week 14 and week 30) separately. 
5.5.4.3 Birth anthropometry 
The association between birth weight and length and later blood pressure and 
kidney function was assessed using linear regression analysis. Two models were 
fitted, with the first adjusted for confounders (age, sex, SES and maternal blood 
pressure) and the second also adjusted for current weight or current height. 
5.5.4.4 Season of birth 
A further analysis was conducted to investigate the effect of season of birth on 
blood pressure and kidney function in childhood. Season of birth was defined by 
fitting Fourier terms (sin, cos, sin 2, cost) in the same manner as for the analysis of 
the Gambian data (Chapter 2). Linear regression models were fitted with factors 
relating to current blood pressure and this model was then compared, using a 
likelihood ratio test, to one also containing season of birth terms. This analysis was 
repeated for the association of season of birth and child kidney function. 
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5.5.4.5 Growth in infancy 
Anthropometric data on infant weights and lengths were available monthly from 
birth until the child was six months old and every two months until they were two 
years old. Weight and length standard deviation scores (SD scores) were calculated 
in comparison to the WHO reference data [254]. Due to the large number of data it 
was felt more appropriate to restrict the analysis to two time points. Growth was 
therefore defined as the change in weight and length SD score from birth to one 
year of age and from one to two years of age. The impact of this early growth 
pattern on blood pressure at 4.5 years was assessed using linear regression analysis 
adjusted for confounders. In addition, the association between the more complete 
growth data and later blood pressure was visualised by using life course plots [121]. 
A similar analysis was conducted to investigate the impact of early growth on later 
kidney function. Any relationship between growth and kidney volume was explored 
with the outcome variable unadjusted for current body surface area as this was 
would be closely related to early size and to growth. 
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Chapter 6 Follow-up of maternal food, micronutrient and 
breast feeding interventions 
6.1 Forward 
This Chapter presents the analysis of the effect of three interventions during 
pregnancy and lactation on offspring blood pressure and kidney function at 4.5 
years of age in rural Bangladesh. The interventions were: an invitation to enroll in a 
food supplementation programme early in pregnancy or at the usual time (around 
17 weeks gestation); a tablet-based multiple micronutrient or iron and folate 
supplement; and randomisation to receive counselling. for exclusive breast feeding 
or for other health messages. A review of the statistical methods has been covered 
in Section 5.5 and should be referred to when interpreting the analysis. Regression 
coefficients appear as ß in the text, standard deviations are denoted by SD, the chi- 
squared test statistic by X2 and confidence intervals by Cl. 
6.2 Study participants 
6.2.1 General characteristics 
The follow-up study successfully recruited 2526 children, representing 77% of the 
live, singleton individuals born during the trial (Figure 6.1). Recruitment rates were 
similar across the six supplement arms of the trial, and the reasons for loss to 
follow-up were also similar in their distribution. The main cause of loss to follow-up 
was individuals who could not be located during the follow-up study, accounting for 
39% of the losses. Refusal by the parents or guardians of the children, primarily due 
to concerns about the taking of blood, accounted for 28% of losses. Out-migration 
(between birth and the follow-up) accounted for 22% of the losses and the further 
11% of individuals had died in the period between birth and 4.5 years of age. 
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Chapter 6: Bangladesh results 
Amongst those individuals enrolled into the follow-up, maternal baseline 
characteristics remained equally distributed between the six nutritional 
supplementation arms of the trial (Table 6.1). There were small differences in 
characteristics between mothers whose children were recruited into the study and 
those lost to follow-up. Children lost to follow-up were more likely to have been the 
first born (X2: 34.6; P: <0.001). There was also a small difference in maternal age and 
years spent at school; women whose children were lost to follow-up were on 
average around nine months younger (mean difference: -0.8y; 95%Cl: -1.2, -0.5; P: 
<0.001) and had spent six months longer in education (mean difference: 0.5y, 
95%Cl: 0.3,0.7; P: <0.001), than women whose children were recruited. 
Gestational age was estimated from the mother's last menstrual period (LMP 
method) and 191 individuals had been recruited who were deemed to have been 
born before 37 weeks (pre-term). These subjects were excluded from the analysis 
resulting in a sample size of 2335 that forms the basis of all subsequent results. 
6.2.2 Anthropometry and body composition 
The mean age at follow-up was 4.6 years (range: 4.5,5.4) and 50.5% of recruited 
subjects were boys. The anthropometric characteristics of the recruited individuals 
are displayed in Table 6.2. Lean mass (or fat-free mass) was estimated by the 
impedance index (100/impedance) as recommended by Wells et al [249]. There 
were occasional technical faults with the Tanita technology, primarily as it was 
designed for use in older (7y+) well nourished children; impedance data are 
therefore missing for 224 children. The sum of four skinfold sites is reported as an 
estimate of body fatness, whist the ratio of trunk to limb skinfolds is reported as an 
estimate of fat distribution. 
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Table 6.2 Anthropometry and body composition of offspring born during the 
MINIMat trial, Bangladesh 
Mean (SD) 
Girls Boys 
N 1157 1178 
Age (years) 4.6 (0.1) 4.6 (0.1) 
Height (cm) 99.9 (26.8) 100.5 (4.3) 
Weight (kg) 13.4 (1.6) 14.1 (1.7) 
BMI (kg/m2) 13.6 (1.0) 13.9 (1.0) 
Impedance index 0.13 (0.01)#"-171 0.14 (0.01)#"-53 
(100/R) 
Height-for-age z- -1.69(0.87 )#n-10 -1.53(0.95 )#n-ii 
score (HAZ)a 
Weight-for-height z- -1.33 (0.80)#"-10 -1.29(0.87 )#n-11 
score (WHZ)a 
BMI-for-age z-score -1.25(0.77 )#n-10 -1.14(0.85 )#n-11 
(BMIZ)a 
Whole body fatb 23.2(4.5 )#n-11 21.5(4.2 )#n-10 
Trunk fat` 0.86(0.13 )#n-11 0.83(0.13 )#n-10 
Triceps-for-age z- -0.71(0.8 )#n-19 -0.47(0.85 )#n-18 
scorea 
Subscapular-for-age -0.70(0.92 )#n-18 -0.70(1.03 )#n-18 
z-scorea 
"-"Sample size differs from column total by x amount 
"Compared to WHO Multicentre Growth Reference Study data [254] 
bCalculated as the sum of four skinfold thickness measurements (biceps, triceps, subscapular and 
suprailiac) 
`Calculated as the ratio of central skinfolds (subscapular and suprailiac) : limb skinfolds (biceps and 
triceps) 
The height-for-age (HAZ) and weight-for-height (WHZ) Z-scores demonstrate that 
this is a marginally nourished population; 34% of recruited children were stunted 
(<-2 HAZ) and 19% were categorised as wasted (<-2 WHZ) compared to WHO 
standards [254]. The skinfold thickness Z-scores however, indicate these individuals 
may have relatively more body fat for their size, as the values are less reduced 
relative to the reference population than those for height. 
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6.2.3 Blood pressure 
Blood pressure was normally distributed and the first, second and third readings 
were highly correlated (r: >0.65). The mean of the three readings was used as an 
estimate of average blood pressure. Twenty three subjects had missing blood 
pressure measurements as the child had failed to cooperate with the medical team, 
leaving a sample size of 2312 for all subsequent analysis. Mean systolic blood 
pressure was 91. lmmHg (SD: 7.5) for girls and 91.4mmHg (SD: 7.7) for boys. Mean 
diastolic blood pressure was 55. OmmHg (SD: 6.4) for girls and 53.8mmHg (SD: 6.5) 
for boys (Table 6.3). Half of the individuals (n=1058) recruited into the follow-up 
had triplicate blood pressure readings taken on two separate occasions, 21 days 
apart (explained in Section 5.4.3). The correlation coefficient between mean systolic 
blood pressure at the first and second visit was r: 0.59, and for diastolic blood 
pressure it was r: 0.52. For the remainder of this section, blood pressure will refer 
to that measured on the first visit only as this involves the greater sample size, 
returning to the issue of additional measurements in Section 6.3. 
Table 6.3 Blood pressure of subjects recruited into the MINIMat trial follow-up 
Mean (SD) 
Girls Boys 
N 1140 1172 
Systolic BP (mmHg) 91.1 (7.5) 91.4 (7.7) 
Diastolic BP (mmHg) 55.0 (6.4) 53.8 (6.5) 
Pulse pressure (mmHg)' 36.1 (5.5) 37.6 (5.8) 
Mean arterial pressure (mmHg)b 67.0 (6.3) 66.3 (6.3) 
Hypertension (%) 3.4 1.7 
'Calculated as systolic - diastolic blood pressure 
bMean arterial pressure calculated as diastolic + (1/3*pulse pressure) 
`Hypertension defined as systolic blood pressure above the NHBPEP 95% centile for height and age 
(12] 
Blood pressure was unrelated to maternal age, maternal height or early (week 8 
gestation) pregnancy BMI in simple linear regression analysis (data not shown). 
Systolic, but not diastolic, blood pressure was positively associated with maternal 
wealth index: for each point increase in wealth index, systolic blood pressure 
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increased by 0.18mmHg (95%Cl: 0.04,032; P: 0.01). Systolic blood pressure also 
increased marginally with tertiles of maternal systolic blood pressure (ANOVA: 6.55; 
P: 0.002), but there was no association between maternal and child diastolic blood 
pressure (ANOVA: 1.37; P: 0.25) (Figure 6.2). 
Figure 6.2 Association between maternal and child blood pressure in MINIMat trial 
follow-up 
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Bars: mean offspring blood pressure for each tertile of maternal blood pressure 
Error bars: ±2xS. E 
Both systolic and diastolic blood pressure at 4.5 years were positively associated 
with current height and weight and with estimates of lean and fat mass (Table 6.4). 
The one exception was that no association was observed between diastolic blood 
pressure and impedance index. 
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Table 6.4 Association between blood pressure and anthropometry/body 
composition for individuals in the MINIMat trial follow-up 
Systolic BP (mmHg) 
Regression 
coefficient 
(95% Cl) 
P-value 
Diastolic BP (mmHg) 
Regression P-value 
coefficient (95% 
Cl) 
Height (cm) 0.27 <0.001 0.16 <0.001 
(0.19,0.34) (0.10,0.22) 
Weight (kg) 0.96 <0.001 0.58 <0.001 
(0.78,1.15) (0.43,0.74) 
BMI (kg/m2) 1.36 <0.001 0.81 <0.001 
(1.05,1.68) (0.55,1.08) 
Impedance 35.1 0.01 -4.1 0.70 
index (100/R) (10.8,59.2) (-25.1,16.8) 
Whole body 0.20 <0.001 0.20 <0.001 
fata (mm) (0.13,0.27) (0.14,0.26) 
Trunk fatb 3.32 0.01 4.36 <0.001 
(mm) (0.95,5.70) (2.34,6.38) 
Results are the effect on blood pressure of a one unit increase in explanatory variable, derived from 
linear regression analysis adjusted for age and sex 
a Calculated as the sum of four skinfold thickness measurements (biceps, triceps, subscapular and 
suprailiac) 
bCalculated as the ratio of central skinfolds (subscapular and suprailiac) : limb skinfolds (biceps and 
triceps) 
Again using simple linear regression, children reporting (via maternal interview) to 
be unwell on the study day had higher diastolic blood pressure (mean difference: 
0.79mmHg; 95% Cl: 0.27,1.32; P: 0.003) than those reporting to be well. In 
contrast, systolic blood pressure was unrelated to reported health on the study day 
(data not shown). Children reporting to have had diarrhoea in the past two weeks 
had lower systolic (mean difference: -1.15mmHg; 95% CI: -2.07, -0.24; P: 0.01) and 
diastolic (mean difference: -0.81mmHg; 95% Cl: -1.59, -0.03; P: 0.04) blood pressure 
than children reporting no illness. This appeared to be partly explained by the lower 
weight exhibited by these children; once the association between diarrhoea and 
systolic blood pressure was adjusted for current weight it became weaker (mean 
difference: -0.81; 95% Cl: -1.71,0.08; P: 0.08). 
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6.2.4 Kidney function 
There were 1077 individuals recruited into the study visits that included ultrasound 
measurements. Of these children, eight failed to cooperate sufficiently to have 
ultrasound performed and one had measurements that were greater than four SDs 
of the mean and were therefore regarded as a recording error. This resulted in a 
sample size of 1068 that forms the basis of the kidney size analysis. Kidney volume 
(right plus left kidney) measured by the length, width, depth method was highly 
correlated with kidney volume measured by the ellipsoid method (r: 0.92), 
suggesting that using either method in further analysis would be appropriate. The 
results from the ellipsoid measurement have been used in all further analysis. Total 
kidney volume was higher for boys (65.2cm3; SD: 11.3) compared to girls (63.1cm3; 
10.8) (P: 0.002). 
In simple linear regression analysis kidney volume was unrelated to maternal 
baseline BMI, maternal height or wealth index (data not shown). All estimates of 
anthropometry and body composition were positively associated with kidney 
volume, with the exception of trunk fat (Table 6.5). 
Table 6.5 Association between kidney volume and anthropometry/body 
composition for individuals in the MINIMat trial follow-up 
Kidney volume (cm3 ) 
Regression coefficient P-value 
(95% CI) 
Height (cm) 1.25 (1.11,1.39) <0.001 
Weight (kg) 3.29 (2.94,3.65) <0.001 
BMI (kg/rn2 2.89 (2.23,3.56) <0.001 
Impedance index (100/R) 169.4 (115.2,223.7) <0.001 
Whole body fata(mm) 0.35 (0.20,0.50) <0.001 
Trunk fatb (mm) -0.78 (-6.37,4.80) 0.78 
Results are the effect on kidney volume of a one unit increase in explanatory variable, derived from 
linear regression analysis adjusted for age and sex 
a Calculated as the sum of four skinfold thickness measurements (biceps, triceps, subscapular and 
suprailiac) 
bCalculated as the ratio of central skinfolds (subscapular and suprailiac) : limb skinfolds (biceps and 
triceps) 
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Kidney volume was adjusted for body surface area (kidney volume/BSA) calculated 
from the Haycock formula [247]; adjusted kidney volume was 103.8 (SD: 15.5) 
cm3/m2 for boys and 104.0 (SD: 15.9) cm3/m2 for girls. This estimate of kidney 
volume was used in all further analysis with the exception of certain observational 
associations (Section 6.7). Adjusted kidney volume was not associated with either 
systolic (ß: 0.002mmHg; 95% Cl: -0.12,0.13; P: 0.97) or diastolic (ß: -0.12mmHg; 
95% Cl: -0.28,0.03; P: 0.12) blood pressure. Adjusted kidney volume was also 
unrelated to reporting to be unwell on the study day or to have experienced 
diarrhoea in the preceding two weeks (data not shown). 
Glomerular filtration rate (GFR), calculated from plasma Cystatin C (CysC), was used 
as an alternative estimate of kidney function. CysC had been measured on 
individuals recruited into the first half of the study protocol, n: 1225. One child had 
a CysC measurement that was more than four SDs of the mean, and therefore 
deemed to be a recording error, which was removed from further analysis leaving 
1224 individuals. Using simple linear regression, GFR was not related to maternal 
height or baseline BMI (data not shown). GFR was associated with wealth index; for 
each point increase in wealth index, GFR increased by 1.15ml/min/1.73m2 (95% Cl: 
0.31,2.00; P: 0.01). GFR was unrelated to age (data not shown) or sex in simple 
linear regression analysis; mean GFR for boys was 159.7 (SD: 36.0) ml/min/1.73 m2 
and for girls it was 157.1 (34.1) ml/min/1.73m2 (P: 0.19). GFR was positively 
associated with both height and weight and marginally negatively associated with 
impedance index (Table 6.6). There was no association between GFR and reporting 
to be unwell on the study day or to have had recent diarrhoeal episodes (data not 
shown). GFR was also unrelated to systolic and diastolic blood pressure (data not 
shown). 
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Table 6.6 Association between glomerular filtration rate and anthropometry/body 
composition for individuals in the MINIMat trial follow-up 
Glomerular filtration rate 
(ml/min/1.73m2) 
Regression coefficient P-value 
(95% Cl) 
Height (cm) 0.54 (-0.09,0.99) 0.02 
Weight (kg) 1.21(-0.004,2.42) 0.05 
BMI (kg/r2) 0.40 (-1.66,2.46) 0.71 
Impedance index (100/R) -131.4 (-278.6,15.9) 0.08 
Whole body fata (mm) 0.10 (-0.38,0.58) 0.69 
Trunk fat' (mm) 3.73 (-11.77,19.22) 0.64 
Results are the effect on GFR of a one unit increase in explanatory variable, derived from 
linear regression analysis adjusted for age and sex 
'Calculated as the sum of four skinfold thickness measurements 
(biceps, triceps, subscapular and suprailiac) 
bCalculated as the ratio of central skinfolds (subscapular and suprailiac): 
limb skinfolds (biceps and triceps) 
Due to the design of the follow-up study into two separate groups, only a small 
number of individuals (n=143) had measurements of both kidney size and of GFR. 
For these individuals there was a weak correlation between the two proxy 
measures of kidney function, r: 0.28. For every 1cm3/m2 increase in kidney volume, 
2 GFR increased by 0.12ml/min/1.73m (95% CI: 0.05,0.19; P: 0.001). 
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6.3 Maternal nutritional interventions and offspring blood pressure 
6.3.1 Invitation to food supplementation 
6.3.1.1 Intention-to-treat analysis 
The invitation to food supplementation intervention was successful in producing 
two groups of women who received different amounts of food during pregnancy. 
Mean food packet consumption in the early invitation group was 95 (SD: 41) 
compared to 64 (SD: 35) packets in usual invitation arm. Information on food 
packet consumption was taken at regular intervals throughout pregnancy and 
women in the early food invitation arm appeared to access the food service earlier 
than their counterparts in the usual invitation arm (Table 6.7). 
Table 6.7 Percentage of women reporting to have never received food packets 
during the MINIMat trial, at different time points in pregnancy 
Early invitation (%) Usual invitation (%) 
(N=1173)a (N=1162)a, b 
Week 14 gestation 31 92 
Week 18 gestation 12 57 
Week 22 gestation 6 24 
Week 26 gestation 5 15 
Week 30 gestation 4 12 
Week 34 gestation 3 10 
aData only refers to those individuals whose children were recruited into the follow-up study, 
although the data are representative of the entire cohort 
The invitation to attend the government food supplementation programme early in 
pregnancy was associated with lower diastolic and mean arterial blood pressure in 
the offspring (Table 6.8). In unadjusted analysis, early invitation to food 
supplementation was associated with a 0.58mmHg lower diastolic blood pressure 
at 4.5 years of age. The timing of the food invitation was not associated with 
systolic or pulse pressure in the offspring. Adjusting the analysis for co-variates did 
not alter the results significantly. 
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Only 2.5% of individuals had a systolic blood pressure above the 95`h percentile for 
their height and age [12]. There was no difference in the proportion of individuals 
with high blood pressure in the early or usual food invitation groups (adjusted odds 
ratio: 1.47; 95% Cl: 0.86,2.49; P: 0.16). 
Half of the recruited offspring had a more reliable estimate of their habitual blood 
pressure because they were measured in triplicate on two separate occasions, on 
average 21 days apart. Restricting the analysis to only those individuals who had 
these two measures of blood pressure, produced a less significant association with 
diastolic and mean arterial blood pressure, albeit with a reduced sample size (Table 
6.9). 
Table 6.9 Effect of MINIMat food intervention on child blood pressure measured on 
two separate occasions (n=1064) 
Unadjusted regression P-value 
coefficient (95% Cl) 
Systolic (mmHg) 0.58 0.15 
(-0.22,1.37) 
Diastolic (mmHg) 0.62 0.07 
(-0.05,1.30) 
Pulse pressure -0.04 0.88 
(mmHg) (-0.60,0.52) 
Mean arterial 0.61 0.08 
pressure (mmHg) (-0.06,1.27) 
Results are the difference in mean blood pressure (95% Cl) for individuals born to women invited to 
receive food supplements early in pregnancy (coded 0) compared to the usual time (coded 1), 
derived from linear regression analysis 
Interactions 
The potential for the effect of the food intervention to be modified by covariates 
was assessed on the entire dataset by fitting interaction terms between the 
intervention variable and relevant covariates. The effect of the food intervention 
was not modified by sex, wealth index, maternal baseline BMI, child impedance 
index, body fat or height for any of the blood pressure measures. There was a 
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significant interaction between the food intervention and child BMI for the effect 
on diastolic blood pressure (Interaction coefficient, ß: -0.67mmHg; 95% Cl: -1.26, - 
0.08; P: 0.03), although the graphical representation reveals this to be of 
questionable biological significance (Figure 6.3). 
Figure 6.3 Interaction between food intervention and child BMI in the MINIMat 
trial: effect on child diastolic blood pressure 
Early food imitation 
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Lines are lines of best fit from linear regression analysis plotted for early and usual food invitation 
arms separately 
The mean number of food packets consumed during pregnancy in the early 
intervention arm was 95 (range: 0-156) and in the usual invitation arm was 64 
(range: 0-141) (mean difference: 30 packets; 95% Cl: 27,33; P: <0.001). Using the 
number of food packets consumed as the exposure variable, rather than 
randomisation to food intervention, there was no association with offspring blood 
pressure (Table 6.10). 
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6.3.2 Micronutrient tablet intervention 
6.3.2.1 Intention-to-treat analysis 
The micronutrient intervention was judged separately as a multiple micronutrient 
compared to iron and folic acid intervention, and a higher (60mg) compared to 
lower (30mg) iron intervention (Table 6.11). 
Table 6.11 Categorising the MINIMat micronutrient intervention for analysis 
Original New code for analysis 
randomisation Multiple micronutrients High iron dose 
code a (MUMS) 
Fe30F 00 
Fe60F 01 
Mulls 10 
aoriginal micronutrient arm of the intervention: Fe30F represents women randomised to receive 
30mg iron and 400µg folic acid; Fe60F represents women randomised to receive 60mg iron and 
400µg folic acid; MuMs represents women randomised to receive 15 multiple micronutrients (of 
which iron concentration was 30mg) 
bVariable is recoded to represent multiple micronutrients or high iron dose: individuals 
coded 0 ('control') or 1 (receiving intervention). 
In unadjusted analysis there was no association between the maternal 
randomisation to multiple micronutrient supplementation and offspring blood 
pressure (Table 6.12). In an analysis adjusted for factors relating to offspring blood 
pressure, including current body composition, there was an effect of the multiple 
micronutrient intervention on diastolic blood pressure with 0.65mmHg (95%Cl: 
0.06,1.24; P-value: 0.03) higher diastolic blood pressure compared to children 
whose mothers had received iron and folate only. There was no effect of maternal 
supplementation with high compared to low iron during pregnancy on offspring 
blood pressure in either unadjusted or adjusted analysis (Table 6.13). 
The proportion of individuals with systolic blood pressure above the 95th percentile 
for their height and age [12] was not different between the two multiple 
micronutrient groups (adjusted odds ratio: 1.11; 95% Cl: 0.65,1.92; P: 0.70) or 
between the high or low iron groups (adjusted odds ratio: 0.88; 95% Cl: 0.50,1.54; 
P: 0.65). 
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Chapter 6: Bangladesh results 
Looking only at individuals who had blood pressure measured on two separate 
occasions there remained no association between either of the micronutrient 
interventions and offspring blood pressure (Table 6.14). 
Table 6.14 Effect of MINIMat micronutrient intervention on child blood pressure 
measured on two separate occasions (n=1064) 
MuMs interventiona Fe intervention" 
Unadjusted P-value Unadjusted P- 
regression regression value 
coefficient (95% coefficient 
Cl) (95% Cl) 
Systolic (mmHg) 0.02 (-0.96,1.00) 0.98 -0.39 (-1.36,0.58) 0.43 
Diastolic (mmHg) 0.06 (-0.77,0.89) 0.89 -0.24 (-1.06,0.59) 0.57 
Pulse pressure -0.04 (-0.73,0.64) 0.90 -0.15 (-0.83,0.53) 0.66 
(mmHg) 
MAP (mmHg) 0.04 (-0.78,0.87) 0.92 -0.29 (-1.10,0.53) 0.49 
Results are mean difference (95% Cl) in blood pressure between individuals whose mothers received 
the micronutrient intervention compared to iron and folate only (MuMs intervention) or the 
difference in blood pressure between individuals whose mothers received a high iron (60mg) 
compared to low iron (30mg) dose during pregnancy (Fe intervention) 
aMuMs: multiple micronutrient supplement compared to iron and folate only 
bFe: high (60mg) iron supplement compared to low (30mg) iron supplement 
Interactions 
The effects of the multiple micronutrient and iron interventions on offspring blood 
pressure were not modified by any of wealth index, maternal baseline BMI, child 
height, impedance index, body fat or BMI (data not shown). No interaction of the 
multiple micronutrient intervention was observed for sex and systolic (Interaction 
coefficient, ß: -0.36mmHg; 95% Cl: -1.92,1.20; P: 0.65) or diastolic (Interaction 
coefficient, ß: 1.00mmHg; 95% Cl: -0.33,2.33; P: 0.14) blood pressure. However, 
the effect of the multiple micronutrient intervention on offspring pulse pressure 
was different for boys and girls (Interaction coefficient, ß: -1.36mmHg; 95% Cl: - 
2.52, -0.19; P: 0.02). For girls the intervention was associated with a decrease in 
pulse pressure whilst for boys there was no effect (Figure 6.4). 
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Figure 6.4 Effect of maternal multiple micronutrient intervention during pregnancy 
on offspring pulse pressure at 4.5 years differs by sex 
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Points are the difference in mean pulse pressure for individuals whose mothers received a multiple 
micronutrient supplement during pregnancy compared to those whose mothers received iron and 
folate only, derived from unadjusted linear regression and plotted for the sexes separately. 
Error bars: ±2xS. E. 
Combined interventions 
The effect of the food and micronutrient interventions combined was assessed by 
adding two interaction terms, one between the food and MuMs intervention and 
one between the food and Fe intervention. There appeared to be no interaction 
between the interventions in relation to offspring blood pressure (Table 6.15). 
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Table 6.15 Interaction between maternal food and micronutrient interventions on 
child blood pressure in MINIMat follow-up 
MuMs*food intervention Fe*food intervention 
Interaction term P-value Interaction term P-value 
regression regression 
coefficient coefficient 
(95% CI)a (95% CI)a 
Systolic (mmHg) -0.18 0.78 -0.01 0.98 
(-1.50,1.13) (-1.32,1.30) 
Diastolic (mmHg) -0.89 0.12 0.71 0.21 
(-2.01,0.23) (-0.40,1.83) 
Pulse pressure 0.71 0.16 -0.73 0.15 
(mmHg) (-0.28,1.70) (-1.71,0.26) 
Mean arterial -0.66 0.24 0.47 0.40 
pressure (mmHg) (-1.75,0.44) (-0.62,1.56) 
Results are the interaction term coefficient (MuMs*food or Fe*food), derived from linear regression 
analysis 
6.3.2.2 As-treated analysis 
Obtained pill count, from the electronic pill bottle lid technology known as eDEM®, 
was used for the as-treated analysis of the micronutrient intervention. The mean 
number of tablets consumed for women in the Fe30F group was 81 (range: 5-163), 
for women in the Fe60F group it was 80 (range: 0-176) and for women in the MuMs 
arm it was slightly lower at 76 (range: 0-143) (ANOVA: 4.12; P: 0.02). Again there 
was no association with offspring blood pressure in relation to the number of 
multiple micronutrient or iron-folate tablets consumed during pregnancy (Table 
6.16). 
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Chapter 6: Bangladesh results 
6.3.3 Breast feeding counselling intervention 
6.3.3.1 Intention-to-treat analysis 
Of the 2526 individuals recruited into the follow-up study, 43% had been born to 
mothers receiving counselling for exclusive breast feeding (Figure 6.5). Loss to 
follow-up was equally distributed between the two arms of the trial and there were 
no differences in baseline characteristics between individuals who were given 
counselling on general health messages and those who were given counselling 
promoting exclusive breast feeding (Table 6.17). 
Figure 6.5 Flow of participants into the MINIMat 4.5 follow-up by maternal 
counselling intervention arm 
3267 live 
singleton 
births 
Health Counselling EBF Counselling 
1850 1417 
91 out- 71 out- 
migrated migrated 
160 not 127 not 
located located 
114 93 
refused refused 
51 died 34 died 
1434 1092 
recruited recruited 
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Table 6.17 Baseline characteristics for MINIMat trial follow-up individuals by 
maternal breast feeding counselling intervention arm 
Health message EBF counselling 
counselling 
N 1434 1092 
Maternal age (y) 26.6 (5.9) 26.7 (6.1) 
Maternal height (cm) 150.0(5.3 )#n-2 149.8(5.3 )#n-2 
Maternal weight, 8 wk 45.4(6.9)#n-5 45.0 (6.7)#n-3 
gestation (kg) 
Maternal BMI (kg/mz) 20.1 (2.6)#n-5 20.2(2.7 )#n-4 
Maternal education 7.3(2.7 )#n-462 7.2 (2.6)#n-346 
(years) 
Wealth index 0.01(2.33 )#n-59 -0.11(2.25 
)#n-54 
Primiparous mothers (%) 30.9 29.5#n-1 
Values are means (SD) or percentages 
#n-Xsample size differs from column header by x amount 
The breast feeding counselling intervention was successful in promoting exclusive 
breast feeding amongst women in the intervention arm. Although the percentage 
of women reporting to exclusively breast fed declined with child age, the 
proportion was consistently higher in the intervention arm (Figure 6.6). 
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Figure 6.6 Effect of breast feeding counselling on the adoption of this practice post- 
partum 
100 
90 
w SO 
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Q 30 
20 
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i ý3ar, 
Month post-partum 
Bars: percentage of women reporting to provide only breast milk at each time point 
Data derived from questionnaires asking about breast feeding and the provision of other foods and 
liquids in the preceding month. 
Data presented only for individuals recruited into the current follow-up 
There was no impact of counselling for exclusive breast feeding compared to 
counselling for other health messages on child blood pressure at 4.5 years of age 
using intention-to-treat analysis (Table 6.18). There was also no difference between 
the two counselling intervention groups in the proportion of individuals with 
systolic blood pressure above the 95`h percentile for their height and age [12] 
(adjusted odds ratio: 1.08; 95% Cl: 0.64,1.85; P: 0.77). 
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Chapter 6: Bangladesh results 
Investigating the effect of the breast feeding intervention only on those individuals 
for whom blood pressure was measured on two separate occasions there remained 
no association with blood pressure (Table 6.19) 
Table 6.19 Effect of breast feeding counselling intervention on child blood pressure 
measured on two separate occasions (n=1064) 
Unadjusted regression P-value 
coefficient (95% Cl) 
Systolic (mmHg) -0.04 (-0.83,0.76) 0.95 
Diastolic (mmHg) -0.002 (-0.68,0.67) 0.99 
Pulse pressure (mmHg) -0.03 (-0.59,0.52) 0.90 
MAP (mmHg) -0.01 (-0.68,0.65) 0.97 
Results are the difference in mean blood pressure (95% Cl) for individuals born to women receiving 
counselling for exclusive breast feeding (coded 1) compared to women receiving counselling for 
general health messages (coded 0), derived from linear regression analysis 
Interactions 
There were no interactions between the breast feeding counselling intervention 
and sex, maternal baseline BMI, child height, impedance index, BMI or body fat on 
the effect on child blood pressure (data not shown). There was a suggestion that 
the effect of the intervention on offspring systolic blood pressure was modified by 
maternal wealth index (Interaction coefficient, ß: -0.28mmHg; 95% CI: -0.56,0.003; 
P: 0.05). However, graphical representation of this interaction revealed it to be of 
limited biological significance (data not shown). There was also a suggestion that 
child impedance index modified the effect of the breast feeding counselling 
intervention on offspring systolic blood pressure (Interaction coefficient, ß: - 
55.7mmHg; 95% Cl: -105.0, -6.4; P: 0.03), although again the graphical 
representation failed to reveal a biologically meaningful association (data not 
shown). 
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6.3.3.2 As-treated analysis 
Data on infant feeding practices were collected in 15 day intervals from birth to 12 
months of age. At each time point, women were asked if they had breast fed and if 
they had provided other liquids and foods to their infants in the preceding 15 days. 
Feeding practice was categorised according to WHO guidelines as exclusive (breast 
milk only), predominant (breast milk plus other liquids such as water or juice) or 
partial (breast milk plus food or other milk) [252]. At four months of age 60% of 
individuals were still being exclusively breast fed whereas this proportion fell to 
30% at six months of age. The analysis was therefore conducted for both time 
points as practices diverged so much between these ages, despite 
recommendations to continue to exclusively breast feed until six months of age. 
There was no difference in blood pressure between those who were exclusively or 
predominantly breast fed at four months of age (Table 6.20). There was a 
suggestion that individuals who were only partially breast fed at four months of age 
had lower systolic and mean arterial blood pressure than those who were 
exclusively breast fed. However, once the analysis was adjusted for co-variates 
relating to blood pressure this association was no longer apparent. 
There was no association between infant feeding at six months of age and blood 
pressure at 4.5 years in either unadjusted or adjusted analysis (Table 6.21). 
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6.4 Maternal food and micronutrient supplementation and offspring 
kidney function 
6.4.1 Invitation to food supplementation 
6.4.1.1 Intention-to-treat analysis 
The maternal food intervention (early pregnancy vs usual invitation to join the food 
supplementation programme) was not associated with kidney volume or 
glomerular filtration rate (GFR) in the offspring at 4.5 years of age in unadjusted or 
adjusted analysis (Table 6.22). 
Interactions 
The effect of the food intervention on kidney function was not modified by any of 
the variables tested: sex, maternal baseline BMI, wealth index, season of birth, 
height, impedance index, body fat or BMI (data not shown). 
6.4.1.2 As-treated analysis 
The number of food packets consumed during pregnancy were also unrelated to 
offspring kidney function at 4.5 years of age, in both unadjusted and adjusted 
analysis (Table 6.23). 
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6.4.2 Micronutrient tablet intervention 
6.4.2.1 Intention-to-treat analysis 
Maternal multiple micronutrient supplementation was also not associated with 
offspring kidney function (Table 6.24). Maternal high iron compared to low iron 
dose was not associated with kidney volume but there was a suggestion of an 
association with glomerular filtration rate, albeit only in the adjusted analysis (Table 
6.25). Individuals whose mothers had received 60mg of iron during pregnancy had, 
on average, a 4.98ml/min/1.73m2 (95% Cl: 0.30,9.67; P: 0.04) higher GFR at 4.5 
years of age than those whose mothers received 30mg of iron in analysis adjusted 
for co-variates related to GFR but unrelated to the maternal intervention. 
Interactions 
The effect of the maternal micronutrient interventions on offspring kidney function 
were not shown to be modified by any of the variables tested: sex, wealth index, 
maternal baseline BMI, season of birth, height, body fat, impedance index or BMI 
(data not shown). 
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Combined intervention 
There was no interaction between the maternal food and micronutrient 
interventions in relation to offspring kidney function (Table 6.26). 
Table 6.26 Interaction between food and micronutrient interventions on child 
kidney function in MINIMat follow-up 
MuMs*food intervention Fe*food intervention 
Interaction P-value Interaction P-value 
regression regression 
coefficient coefficient 
(95% CI)a (95% CI)a 
Kidney volume -0.89 0.66 -2.80 0.17 
(cm3/m2) (-4.90,3.11) (-6.76,1.17) 
GFRa -1.88 0.66 1.02 0.81 
(mI/min/1.73m2) (-10.28,6.52) (-7.28,9.32) 
Results are the interaction term coefficient (MuMs*food or Fe*food), derived from linear regression 
analysis 
aGFR: glomerular filtration rate 
6.4.2.2 As-treated analysis 
There was a small negative effect of maternal consumption of multiple 
micronutrient tablets on offspring kidney volume (Table 6.27). Displayed graphically 
however, it is apparent that there is very little association, either for the iron and 
folate only or multiple micronutrient groups (Figure 6.7). 
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Figure 6.7 Graphical representation of the effect of maternal micronutrient 
intervention on offspring kidney volume: as treated analysis 
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6.4.3 Breast feeding counselling intervention 
Counselling for exclusive breast feeding was not associated with offspring kidney 
function (Table 6.28). There was a slight suggestion of an effect on glomerular 
filtration rate, which was lost after adjustment for co-variates. 
Interactions 
The effect of the breast feeding counselling intervention on kidney function was not 
modified by any of the following covariates: sex, wealth index, season of birth, 
maternal baseline BMI, child BMI, height, body fat or impedance index (data not 
shown). 
There was no association between the type of infant feeding (exclusive breast 
feeding, predominant breast feeding or partial breast feeding) at four (Table 6.29) 
or six (Table 6.30) months of age and kidney function at 4.5 years. 
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6.6 Early life exposures and later blood pressure: observational 
analysis 
The impact of early-life factors on later blood pressure and kidney function for 
children in the MINIMat trial follow-up will be assessed in the following sections. 
Maternal factors (leg length and haemoglobin during pregnancy) will be assessed 
first, followed by birth anthropometry and season of birth, finally focusing on the 
impact of infant growth. 
6.6.1 Maternal sitting height 
There was no association between maternal leg length, used as a proxy indicator of 
maternal early-life nutritional exposures [255], and child blood pressure at 4.5 years 
of age (Table 6.31). 
Table 6.31 Association between maternal leg length and child blood pressure at 4.5 
years in Bangladesh 
Unadjusted P-value Adjusted P-value 
regression regression 
coefficient (95% coefficient 
Cl) (95% CI)a 
Systolic pressure 0.09 0.24 0.03 0.79 
(mmHg) (-0.06,0.23) (-0.18,0.23) 
Diastolic pressure 0.04 0.52 0.01 0.91 
(mmHg) (-0.09,0.17) (-0.17,0.19) 
Pulse pressure 0.05 0.42 0.02 0.85 
(mmHg) (-0.07,0.16) (-0.15,0.18) 
Mean arterial 0.06 0.37 0.02 0.85 
pressure (mmHg) (-0.07,0.18) (-0.16,0.19) 
Results are the effect on child blood pressure of a one centimeter increase in maternal leg length, 
derived from linear regression analysis 
a Model adjusted for age, sex, wealth index, season of birth, thirds of maternal blood pressure, 
maternal schooling, feeling well on study day, diarrhoea in past 2 weeks, height, BMI, body fat and 
100/R 
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6.6.2 Maternal haemoglobin 
Maternal haemoglobin levels at baseline (week 14 gestation) were positively 
associated with childhood blood pressure, both before and after adjustment for 
appropriate confounders (Table 6.32). In adjusted analysis, for each 1g/dI increase 
in maternal haemoglobin, childhood systolic blood pressure increased by 
0.42mmHg (95%CI: -0.09,0.75; P: 0.01) and a similar association was apparent for 
diastolic blood pressure. 
Table 6.32 Association between maternal haemoglobin during pregnancy (week 14 
gestation) and offspring blood pressure at 4.5 years in Bangladesh 
Unadjusted 
regression 
coefficient (95% Cl) 
P-value Adjusted 
regression 
coefficient (95% CI)a 
P-value 
Systolic pressure 0.24 0.06 0.42 0.01 
(mmHg) (-0.01,0.50) (0.09,0.75) 
Diastolic pressure 0.31 0.01 0.45 0.002 
(mmHg) (0.09,0.53) (0.16,0.73) 
Pulse pressure -0.07 0.50 -0.02 0.86 
(mmHg) (-0.26,0.13) (-0.28,0.23) 
Mean arterial 0.29 0.01 0.44 0.002 
pressure (mmHg) (0.07,0.50) (0.16,0.71) 
Results are the effect on child blood pressure of a 1g/dl increase in maternal haemoglobin, derived 
from linear regression analysis 
'Model adjusted for age, sex, wealth index, season of birth, thirds of maternal blood pressure, 
maternal schooling, feeling well on the study day, diarrhoea in past 2 weeks, height, BMI, body fat 
and 100/R 
In later pregnancy (week 30 gestation) there was still the suggestion of a positive 
association between maternal haemoglobin and offspring systolic blood pressure, 
but this was lost after adjustment for confounding variables (Table 6.33). There was 
no interaction between maternal high or low iron supplementation and 
haemoglobin at 30 weeks gestation on offspring blood pressure (data not shown). 
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Table 6.33 Association between maternal haemoglobin (week 30 gestation) during 
pregnancy and offspring blood pressure in Bangladesh 
Unadjusted P-value Adjusted P-value 
regression regression 
coefficient (95% Cl) coefficient (95% CI)a 
Systolic pressure 0.28 0.04 0.26 0.15 
(mmHg) (0.01,0.54) (-0.09,0.61) 
Diastolic pressure 0.17 0.14 0.13 0.39 
(mmHg) (-0.06,0.40) (-0.17,0.43) 
Pulse pressure 0.11 0.31 0.13 0.36 
(mmHg) (-0.10,0.31) (-0.15,0.40) 
Mean arterial 0.21 0.07 0.17 0.24 
pressure (mmHg) (-0.02,0.43) (-0.12,0.46) 
Results are the effect on child blood pressure of a 1g/dl increase in maternal haemoglobin, derived 
from linear regression analysis 
'Model adjusted for age, sex, wealth index, season of birth, thirds of maternal blood pressure, 
maternal schooling, feeling well on the study day, diarrhoea in past 2 weeks, height, BMI, body fat 
and 100/R 
Twenty-nine percent of individuals had a haemoglobin concentration below 11g/dl 
at week 14 gestation, suggesting anaemia according to WHO guidelines [256]. 
Children born to mothers that were anaemic during pregnancy had lower systolic 
(mean difference ß: -1.23mmHg; 95% Cl: -2.17, -0.29; P: 0.01) and diastolic (ß: - 
1.10mmHg; 95% Cl: -1.91, -0.29; P: 0.01) blood pressure than those born to non- 
anaemic women, in analyses adjusted for appropriate confounders. Anaemia at 30 
weeks gestation was not associated with offspring blood pressure (data not shown). 
6.6.3 Birth anthropometry 
Neither birth weight nor birth length were associated with blood pressure at 4.5 
years of age until adjustment for current weight (Table 6.34). Once this variable was 
added to the model there became a strong inverse association between birth 
weight and both systolic and diastolic blood pressure and between birth length and 
systolic blood pressure. There was no interaction between the food or 
micronutrient interventions and the impact of birth weight or length on later blood 
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pressure (data not shown). Adjusting birth weight and length for gestational age 
produced very similar results (data not shown). 
Table 6.34 Association between birth anthropometry and childhood blood pressure 
at 4.5years for individuals born during the MINIMat trial 
Systolic BP (mmHg) Diastolic BP (mmHg) 
Regression P-value Regression P-value 
coefficient coefficient 
(95% Cl) (95% Cl) 
Birth weight -0.63 0.17 0.23 0.55 
(kg) (-1.51,0.26) (-0.52,0.98) 
Adjusted birth -2.53 <0.001 -1.02 0.01 
weight (kg)' (-3.46, -1.60) (-1.82, -0.22) 
Birth length -0.07 0.34 0.03 0.67 
(cm) (-0.21,0.07) (-0.10,0.15) 
Adjusted birth -0.23 0.002 -0.09 0.18 
length (cm)b (-0.38, -0.08) (-0.22,0.04) 
Results are the effect on child blood pressure of a one unit increase in birth weight or length, 
derived from linear regression analysis adjusted for age, sex wealth index and maternal blood 
pressure 
aAdditionally adjusted for weight at follow-up 
bAdditionally adjusted for height at follow-up 
6.6.4 Season of birth 
Season of birth was associated with offspring systolic blood pressure (LR test x2: 
14.94; P: 0.001), adjusted for age, sex, wealth index, maternal blood pressure, BMI, 
height and impedance index. Systolic blood pressure was highest for those born 
during May and June and lowest for those born in November and December (Figure 
6.8). There was only a very minimal and borderline association between month of 
birth and diastolic blood pressure (LR test X2: 6.77; P: 0.03) (Figure 6.9). 
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Figure 6.8 Variation of systolic blood pressure in Bangladesh children aged 4.5 years 
in relation to their month of birth 
Bold middle line represents the fitted line for the variation in systolic blood pressure with month of 
birth. Upper and lower lines represent fitted 95% confidence interval. 
Figure 6.9 Variation of diastolic blood pressure in Bangladesh children aged 4.5 
years in relation to their month of birth 
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Bold middle line represents the fitted line for the variation in diastolic blood pressure with month of 
birth. Upper and lower lines represent fitted 95% confidence interval. 
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6.6.5 Infant growth 
Infant weight and length had been measured at monthly visits from birth to one 
year, and bimonthly to two years of age, providing substantial data with which to 
investigate the association between early infant growth and systolic blood pressure 
in childhood. Change in weight SD score between birth and one year of age was 
positively associated with systolic and diastolic blood pressure at 4.5 years of age, 
even after adjustment for current BMI (Table 6.35). In contrast, change in weight 
SD score between one and two years was not associated with either systolic or 
diastolic blood pressure. 
Table 6.35 Association between growth in infancy and blood pressure at 4.5 years 
in Bangladesh 
Systolic BP (mmHg) Diastolic BP (mmHg) 
Growth time period Regression P-value Regression P-value 
coefficient coefficient 
(95% Cl) (95% Cl) 
0-12 months 0.88 (0.58,1.17) <0.001 0.60 (0.35,0.85) <0.001 
0-12 months plus 0.40 (0.09,0.72) 0.01 0.27 (0.01,0.54) 0.05 
current sizea 
12-24 months 0.35 (-0.26,0.97) 0.26 -0.20 (-0.72,0.33) 0.46 
12-24 months plus 0.19 (-0.42,0.79) 0.54 -0.32 (-0.84,0.20) 0.23 
current sizes 
Results are the effect on blood pressure of a one unit increase in weight standard deviation score 
(calculated relative to WHO standards [254]) between the specified time points, derived from linear 
regression analysis adjusted for age, sex, wealth index and tertiles of maternal blood pressure 
aAnalysis additionally adjusted for BMI and height at 4.5 years 
The association between growth in infancy and blood pressure at 4.5 years of age 
can be visualised by plotting the regression coefficients for the association between 
weight SD score and blood pressure against age in a life course plot [121]. These 
plots (Figure 6.10 and 6.11) indicate that early increase in weight SD score (before 
six months of age) is positively associated with blood pressure in later childhood. 
They also indicate that there is a relatively flat relationship between growth in the 
second year of life and blood pressure in later childhood. 
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Figure 6.10 Life course plot for the association between growth in infancy and 
systolic blood pressure at 4.5 years of age in Bangladesh 
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Points are regression coefficient (±2 x SE plotted as error bars) for the association between systolic 
blood pressure at 54 months and weight SD score (compared to WHO reference data [254]) at 
different ages 
Figure 6.11 Life course plot for the association between growth in infancy and 
diastolic blood pressure at 4.5 years of age in Bangladesh 
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Points are regression coefficient (±2 x SE plotted as error bars) for the association between diastolic 
blood pressure at 54 months and weight SD score (compared to WHO reference data [254] at 
different ages 
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Change in length SD score between birth and one year of age was also positively 
associated with systolic (ß: 0.71mmHg; 95% Cl: 0.39,1.02; P: <0.001) blood 
pressure even after adjustment for current height (ß: 0.43mmHg; 95% Cl: 0.09, 
0.77; P: 0.01). Diastolic blood pressure was similarly associated with change in 
length SD score between birth and one year (ß: 0.47mmHg; 95% Cl: 0.20,0.74; P: 
0.001), but the association became borderline once it was adjusted for current 
height (ß: 0.25mmHg; 95% Cl: -0.04,0.54; P: 0.09). In common to the weight change 
pattern there was no association between change in length SD score from one to 
two years for both systolic (ß: 0.01mmHg; 95% Cl: -0.60,0.62; P: 0.98) and diastolic 
(ß: -0.25mmHg; 95% Cl: -0.77,0.27; P: 0.34) blood pressure. This was again due to 
the flatter relationship between length gain and later blood pressure in the second 
year of life (Figure 6.12). 
Figure 6.12 Life course plot for the association between linear growth in infancy 
and systolic blood pressure at 4.5 years of age in Bangladesh 
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Points are regression coefficient (±2 x SE plotted as error bars) for the association between systolic 
blood pressure at 54 months and length SD score (compared to WHO reference data [254] at 
different ages 
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6.7 Early life exposures and later kidney function: observational 
analysis 
6.7.1 Maternal leg length 
There was no association between maternal leg length and child kidney volume at 
4.5 years of age in either unadjusted analysis (ß: 0.16cm3/m2; 95% Cl: -0.15,0.48; P: 
0.31) or in models adjusted for age, sex and wealth index (ß: 0.14cm3/m2; 95% Cl: - 
0.20,0.48; P: 0.43). It was not possible to test the association between maternal leg 
length and glomerular filtration rate (GFR) due to missing data on maternal sitting 
height from the first half of the study period, which corresponds to the same 
individuals for whom GFR was measured. 
6.7.2 Maternal haemoglobin 
Maternal haemoglobin during pregnancy was unrelated to measures of kidney 
function in their offspring at 4.5 years of age in either unadjusted or adjusted 
analysis (Table 6.36 and 6.37). In addition, maternal anaemia (Hb: <11g/dI) at 14 or 
30 weeks gestation was not associated with kidney volume or GFR (data not 
shown). 
Table 6.36 Association between maternal haemoglobin (week 14 gestation) during 
pregnancy and offspring kidney function at 4.5 years in Bangladesh 
Unadjusted P-value Adjusted P-value 
regression regression 
coefficient (95% Cl) coefficient (95% Cl)' 
Kidney volume -0.48 0.23 -0.23 0.64 
(cm3/m2) (-1.27,0.31) (-1.20,0.74) 
GFRb -0.89 0.27 -0.35 0.76 
(ml/min/1.73m2) (-2.47,0.69) (-2.55,1.86) 
Results are the effect on child kidney function of a 1g/dl increase in maternal haemoglobin, derived 
from linear regression analysis 
: models adjusted for age, sex, wealth index, season of birth, height, BMI 100/R and body fat 
GFR: glomerular filtration rate 
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Table 6.37 Association between maternal haemoglobin during pregnancy (week 30 
gestation) and offspring kidney function at 4.5 years in Bangladesh 
Unadjusted P-value Adjusted P-value 
regression regression 
coefficient (95% Cl) coefficient (95% CI)a 
Kidney volume 0.19 0.65 -0.44 0.40 
(cm3/m2) (-0.63,1.02) (-1.44,0.57) 
GFRb 1.57 0.07 0.02 0.99 
(mI/min/1.73m2) (-0.14,3.28) (-2.38,2.42) 
Results are the effect on child kidney function of a 1g/dl increase in maternal haemoglobin, derived 
from linear regression analysis 
amodels adjusted for age, sex, wealth index, season of birth, height, BMI, 100/R and body fat 
bGFR: glomerular filtration rate 
6.7.3 Birth anthropometry 
Kidney volume, unadjusted for body surface area, was positively associated with 
birth weight and length both before and after adjustment for current size (Table 
6.38). In contrast, glomerular filtration rate was not associated with either birth 
weight or length, either before or after adjustment. 
Table 6.38 Association between birth anthropometry and kidney function at 4.5 
years for individuals born during the MINIMat trial, Bangladesh 
Kidney volume Glomerular filtration rate 
(cm) (mI/min/1.73m2) 
Regression P-value Regression P-value 
coefficient coefficient 
(95% Cl) (95% Cl) 
Birth weight 7.37 <0.001 4.23 0.13 
(kg) (5.50,9.25) (-1.21,9.68) 
Adjusted birth 2.59 0.01 3.48 0.25 
weight (kg)' (0.77,4.41) (-2.46,9.42) 
Birth length 1.41 <0.001 0.52 0.22 
(cm) (1.07,1.75) (-0.31,1.35) 
Adjusted birth 0.52 0.002 0.30 0.51 
length (cm)b (0.18,0.86) (-0.59,1.18) 
Results are the effect on child kidney function of a one unit increase in birth weight or length, 
derived from linear regression analysis adjusted for age, sex and wealth index 
'Additionally adjusted for weight at follow-up 
bAdditionally adjusted for height at follow-up 
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6.7.4 Season of birth 
Season of birth, adjusted for age, sex, height, BMI, body fat and impedance index, 
was associated with kidney volume at 4.5 years of age (LR test Xz: 58.3; P: <0.001). 
Kidney volume was highest for individuals born in August and lowest for those born 
in February (Figure 6.13). 
Figure 6.13 Variation of kidney volume in Bangladesh children aged 4.5 years in 
relation to their month of birth 
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Bold middle line represents the fitted line for the variation in kidney volume with month of birth. 
Upper and lower lines represent fitted 95% confidence interval. 
A mirror image pattern was seen for the association between glomerular filtration 
rate and month of birth (LR test X2: 48.7; P: <0.001). Individuals born in February 
and March had the highest GFR, whilst those born in August and September had 
the lowest (Figure 6.14). 
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Figure 6.14 Variation of glomerular filtration rate in Bangladesh children at 4.5 
years of age in relation to their month of birth 
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Bold middle line represents the fitted line for the variation in glomerular filtration rate with month 
of birth. Upper and lower lines represent fitted 95% confidence interval. 
6.7.5 Child growth 
Relative kidney volume, adjusted for body surface area, at 4.5 years of age was not 
associated with change in weight SD score between birth and one year of age 
(Table 6.39). Weight change between one and two years of age was positively 
associated with later kidney volume however, even after adjustment for current 
BMI (ß: 2.27cm3/m2; 95% Cl: 0.21,4.30; P: 0.03). Change in length SD score 
between birth and one year of age (ß: -0.57cm3/m2; 95% CI: -1.17,0.56; P: 0.32) or 
between one and two years of age (ß: 1.18cm3/m2; 95% Cl: -0.86,3.22; P: 0.26) was 
not associated with kidney volume at 4.5 years. GFR was also not associated with 
change in length SD score in early-life (data not shown). 
-223- 
Chapter 6: Bangladesh results 
Table 6.39 Association between growth in infancy and kidney function at 4.5 years 
in Bangladesh 
Kidney volume Glomerular filtration rate 
(cm3/m2) (ml/min/1.73m2) 
Growth time Regression P-value Regression P-value 
period coefficient coefficient 
(95% Cl) (95% Cl) 
0-12 months -0.80 0.09 0.68 0.48 
(-1.71,0.11) (-1.23,2.60) 
12-24 months 2.29 0.03 -1.92 0.32 
(0.24,4.33) (-5.69,1.86) 
Results are the effect on kidney function of a one unit increase in weight standard deviation score 
(calculated relative to WHO standards [254]) between the specified time points, derived from linear 
regression analysis adjusted for age, sex and wealth index 
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6.8 Discussion 
This Chapter reported the impact of three separate maternal nutritional 
interventions provided perinatally in a rural area of Bangladesh on offspring blood 
pressure and kidney function. In the following sections, the results of the three 
interventions will be discussed separately, followed by a discussion of the 
observational analyses. 
6.8.1 Maternal food intervention 
6.8.1.1 Summary of findings 
An invitation to receive food supplements earlier in pregnancy than is the usual 
practice was associated with lower diastolic and mean arterial blood pressure in the 
offspring at 4.5 years of age. The same intervention was not associated with 
offspring systolic blood pressure or with kidney volume or glomerular filtration rate 
(GFR). 
6.8.1.2 Study strengths and limitations 
This was a large follow-up study where 77% of individuals born during the maternal 
trial were successfully recruited. Loss to follow-up was evenly distributed between 
the six prenatal nutritional intervention arms (two food intervention arms and 
three micronutrient tablet arms). There were only very marginal differences in 
characteristics measured during the original trial between individuals who were 
recruited and those who were lost to follow-up. As a result, the recruited sample 
should be representative of the trial offspring as a whole. The sample size of the 
follow-up study (n=2312 for blood pressure analysis; n=1068 for kidney volume; 
n=1224 for GFR) was relatively large and the resulting effect estimates exhibited 
tight confidence intervals, promoting confidence in the results reported. 
Researchers in the original trial and the follow-up study were blind to the treatment 
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allocation of participating women, although it was not possible to keep allocation 
from the participants themselves due to the nature of this intervention. 
During the follow-up, the measurement of outcome variables was conducted by 
fully-trained staff using standard operating protocols that were created to maximise 
accuracy in the setting. For the measurement of blood pressure an automated 
oscillometric device was used, and measurements were made in triplicate following 
the manufacturer's guidelines. Just over half of the individuals recruited had an 
additional blood pressure estimate, again in triplicate, on average 21 days after the 
first measurement. This provided an estimate of habitual blood pressure that 
should be more accurate than that obtained on a single occasion. Estimates of 
kidney size and volume were conducted by trained sonographers who had 
extensive practice and standardisation prior to the commencement of the 
fieldwork. 
A particular strength of this study was the measurement of kidney function in 
addition to blood pressure assessment. The blood pressure system is tightly 
regulated by the renal system and alterations in kidney size and function have been 
suggested as one of the mechanisms linking suboptimal conditions during 
development to raised blood pressure in later life [160,257,258]. It is difficult to 
compare the kidney volumes for children in this study with the wider literature as 
there are no published reference data for kidney volumes in this age group. In 
agreement with a Danish study of ten year old children, gender differences in 
kidney volume were explained by differences in body size and there was a strong 
association between lean body mass and kidney volume [259]. Kidney volumes of 
children in this study were similar to those of 18 month old infants in Copenhagen, 
Denmark (n=631) that were on average 63.7cm3 [260]. Kidney volume/body surface 
area ratio was similar to healthy 28 month old children in Turkey, which were 
reported to be on average 109cm3/m2 [261]. 
The main limitation with the original study design is that women were only 
randomised to encouragement to access food provision, rather than provided with 
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the food supplement itself. Some women would therefore be unlikely to access the 
supplement at all, although only 54 individuals reported not to have had a single 
food packet during their pregnancy and the majority (76%) of these were in the 
usual food invitation arm. The intervention design had been adopted as a method 
of evaluating the existing government nutritional provision during pregnancy, but 
as a result lacked a true 'control' arm. However, the data on food packet 
consumption during pregnancy did demonstrate that the intervention successfully 
created two distinct groups; women in the early invitation arm accessed the service 
much earlier in pregnancy and consumed on average 30 more packets during 
pregnancy. One packet provided 608 kcal and 17.9g of protein that, provided the 
food was consumed by the participating women, would have led to a substantial 
difference in nutritional intake per day between the two groups. This leads us to 
another limitation of the design, although women were asked whether they had 
consumed food packets at regular time points during their pregnancy the food was 
not consumed in the presence of field staff and could therefore have been given to 
family members or added to family meals. 
In addition to the limitations of the original trial, the follow-up study also had some 
inherent limitations that affect the ability to correctly interpret the findings 
presented here. As with the other studies presented in this thesis, the age of 
follow-up represents a limitation of the design. The children may be too young to 
observe any differential effects on blood pressure and/or kidney function. In 
common with the Gambian studies reported in Chapters 4 and 5 it could also be 
argued that in a rural area of Bangladesh, where the children experience a high 
degree of wasting and stunting, it would be unlikely that the interventions would 
result in demonstrable effects on cardiovascular risk factors such as blood pressure. 
Any effect may thus only become apparent if these individuals are exposed to more 
'Western' lifestyles as they develop. 
A limitation of the design of the follow-up study in relation to kidney function is 
that only a small number of individuals (n=143) had estimates of both kidney 
volume and GFR. Initially the analysis of Cystatin C (CysC) was planned for the entire 
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sample but due to cost constraints a smaller number of samples were analysed, and 
the choice of these individuals was the responsibility of the original trial Pis, who 
conducted the CysC analysis in combination with other markers. The original Pis 
required data on certain individuals who were born between 2001 and 2002, which 
resulted in only a small overlap in these markers of kidney function as the 
ultrasound estimates were mainly conducted on individuals born between 2002 
and 2003. The main consequence of this decision is the difficulty of interpreting 
effects observed on one aspect of kidney function that are not seen on the other, 
which may merely reflect the different individuals involved. However, the 
randomised design of the intervention should minimise any potential differences in 
children born earlier rather than later in the trial, suggesting that this concern may 
have only minimal impact on the results. For the individuals for whom both 
measurements were available there was only a marginal correlation between these 
markers, suggesting that they are measuring different aspects of kidney function, as 
would be expected. 
Another major challenge of the follow-up design is the correct interpretation of 
differences in GFR between individuals as a result of the intervention. According to 
the hyperfiltration theory proposed by Brenner et al, fetal undernutrition resulting 
in a reduced number of nephrons will initially cause the remaining nephrons to 
have an increased load in compensation [155]. It is therefore debatable what the 
overall effect on total GFR would be in this model, particularly in childhood. Indeed 
Bagby has suggested that single nephron hyperfiltration will initially lead to 
increased total GFR [160], although no human data exists with which to test this 
hypothesis. Thus although GFR was chosen as a useful marker of kidney function 
and one that is used commonly to detect early renal disease [262], its applicability 
as a marker of kidney function response to altered prenatal nutrition may be 
questioned in this age group. Kidney volume relative to body size may thus be a 
more robust marker of any functional alterations experienced in the kidney in 
response to early-life conditions. It should be noted that whilst this limitation is of 
academic interest it does not affect the interpretation of the results presented here 
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as there was no association (either reduced or enhanced) between invitation to 
food supplementation and offspring GFR. 
6.8.1.3 Comparison with the literature 
It is challenging to compare the finding that a maternal invitation to enter a food 
supplementation program early in pregnancy was associated with lower diastolic 
blood pressure with the wider literature due to the specific design of this particular 
trial, including the lack of a control group. The impact of protein-energy 
supplementation during pregnancy on offspring blood pressure has been discussed 
elsewhere in this thesis (Section 3.5.1.3) and has in general been shown to have no 
effect [97,99,213]. However, these designs are not directly comparable with the 
study presented here. 
One of the factors that suggest caution in the over-interpretation of this finding is 
that the number of food packets consumed during pregnancy was not associated 
with offspring diastolic or mean arterial pressure. Whilst there are well-established 
limitations of as-treated analyses, primarily the loss of randomisation, it would be 
assumed that the intervention effect would operate through a greater consumption 
of food packets. Furthermore, the effect seen in the intention-to-treat analysis was 
only of weak significance which, given the large sample size, suggests that any real 
effects are very subtle. 
The lack of an association between the invitation to access the food 
supplementation programme and offspring kidney function is also difficult to 
compare with the wider literature as no published studies have investigated the 
impact of the maternal diet on these parameters in humans. The majority of animal 
data focus on the effects of nutrition restriction during fetal development on 
subsequent renal function, rather than enhanced nutrition, and may not be directly 
relevant to the human situation. In addition, most of the animal data use models of 
protein restriction during pregnancy followed by a normal postnatal diet [79,263]. 
Hoppe et a/ investigated the impact of a low protein diet in rats that was provided 
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throughout gestation and for 135 days postnatally, postulating that this may be 
more reflective of the human diet in marginally nourished populations [132]. The 
resulting offspring had a reduced number of nephrons but their mean arterial 
pressure was lower, rather than higher, than rat pups exposed to a normal protein 
diet [132]. In contrast, the data presented in this chapter has revealed lower mean 
arterial pressure for individuals exposed to higher protein intake, but no effects on 
the markers of kidney function studied. Again in contrast to the null effect on 
kidney volume reported here, animal studies have demonstrated changes in kidney 
weight relative to body weight in response to protein-calorie restriction [257]. 
Cross-species comparisons are challenging due to the inherent biological 
differences and the specific techniques that can be used, which could explain the 
conflicting findings. For example, estimation of kidney volume via ultrasound in 
humans has a greater error associated with it than the direct measurement of 
organ weight possible in animal experiments. 
6.8.1.4 Implications of findings 
The potential effect of the intervention on offspring blood pressure was not 
reflected in altered kidney function, suggesting that changes were operating 
outside of the renal system or that the estimates of renal function used in this study 
were not able to pick up subtle differences between intervention groups. 
Early invitation to access the food supplementation programme was associated 
with only a 0.58mmHg decrease in diastolic blood pressure. Thus, even if this result 
is robust, the effect size is too small to have large public health implications. 
Although it could be argued that this small difference will become larger in 
magnitude as the participants age [48]. If additional health benefits were found for 
this intervention then the potential advantageous effect on blood pressure would 
represent an added benefit. However, a recent cost-effectiveness analysis of the 
Bangladesh Integrated Nutrition Programme revealed the food provision to be of 
debatable value for money [264]. The authors demonstrated that the cost of the 
food supplement alone was around US$0.20 per participant per day, arguing that 
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from a purely cost-per-calorie standpoint it would be possible to purchase over 
three times as many calories from the local market for the same price [264]. Their 
analysis thus questions the sustainability of this government nutrition programme, 
and the lack of any large benefit in terms of offspring blood pressure would also 
discourage the roll-out of the intervention to target this aspect of cardiovascular 
health. 
6.8.2 Maternal micronutrient intervention 
6.8.2.1 Summary of findings 
Maternal supplementation with multiple micronutrients during pregnancy, 
compared to supplements containing iron and folate only, was associated with 
raised offspring diastolic blood pressure at. 4.5 years of age in the analysis 
presented here. However, the association was only strongly apparent in the 
adjusted analysis and was not observed in the analysis involving two repeat 
measurements of blood pressure, even though the sample size remained greater 
than 1000, suggesting the finding may be a chance occurrence. Maternal multiple 
micronutrient supplementation was not related to systolic blood pressure but there 
was a suggestion that for girls only, the supplement was associated with lower 
pulse pressure. Supplementation with 60mg of iron compared to 30mg of iron 
during pregnancy was not associated with offspring blood pressure 
The maternal multiple micronutrient supplement was not associated with offspring 
kidney volume or GFR. There was a suggestion that providing a high (60mg) versus 
lower (30mg) iron dose during pregnancy resulted in raised offspring GFR, although 
the finding was of very borderline significance. 
6.8.2.2 Study strengths and limitations 
In addition to the general study strengths outlined in Section 6.8.1.2, the 
micronutrient arm of the trial benefitted from being a true, double blind 
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intervention. The original trial and follow-up researchers, field staff and participants 
remained blind as to the treatment allocation of participating children. 
A limitation specific to the micronutrient intervention is the absence of a true 
control group provided with a placebo. This design was used because it is 
Bangladesh Government policy to provide 60mg of iron and 400µg of folic acid to 
pregnant women and it would therefore be unethical to provide a true placebo 
arm. Similar designs have been adopted in other trials [103], which allows the 
results presented here to be directly comparable with the literature. The design of 
the intervention is further compromised by its unbalanced design; there is no 
multiple micronutrient arm that also contains 60mg of iron (Table 6.40). As a 
consequence, any effect of the MuMs arm could be confounded by the iron 
treatment arm and it is not possible to look at the interaction between these 
different treatments. 
Table 6.40 Unbalanced design of the MINIMat intervention 
400µg folate MuMs 
30mg iron 
60mg iron 
Yes 
Yes 
Yes 
No 
An additional limitation from the original trial is the pill-count data that was derived 
from the bottles themselves, which recorded each time the lid was opened. It has 
been assumed in the analysis that this pill count accurately reflects the intake of 
participating women, whereas the tablets could have been shared with other 
members of the family or the lid merely opened and closed to generate data. 
6.8.2.3 Comparison with the literature 
Two studies have to date published directly comparable follow-up data on the 
blood pressure of offspring born during a maternal multiple micronutrient 
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supplementation trial. Both of these trials were set in Nepal: one conducted by 
Osrin et al compared the UNICEF/UNU/WHO preparation of 15 micronutrients (of 
the same concentrations as in the current Bangladesh study) with 60mg of iron and 
400µg of folate [101], whilst the second was a follow-up of a five-arm 
supplementation trial conducted by Christian et al [102]. This second study 
provided different combinations of micronutrients to the participating women: the 
control group received vitamin A (1000µg retinol retinol equivalents) only, in 
addition to vitamin A the intervention groups received either folic acid (400µg); folic 
acid and iron (60mg); folic acid, iron and zinc (30mg); or these four micronutrients 
with an additional ten (10µg vitamin D, 10mg vitamin E, 1.6mg thiamine, 1.8mg 
riboflavin, 2.2mg vitamin B6,2.6µg vitamin B12,100mg vitamin C, 64µg vitamin K, 
20mg niacin, 2mg copper and 100mg of magnesium) [102]. Both supplementation 
trials demonstrated an increase in birth weight and a reduction in low birth weight 
(proportion of infants <2500g) for women in the multiple micronutrient arms of the 
trial [101,102]. However, the trial by Christian et al also found a beneficial effect on 
birth weight of folic acid and iron in comparison to vitamin A and no demonstrable 
additional benefit of the multiple micronutrient supplement [102]. 
Both trials were recently followed-up and the cardiovascular health of the offspring 
was assessed [103,104]. For the trial conducted by Osrin et al the offspring were 
2.5 years of age at follow-up and 83% (n=917) of the original live singleton born 
individuals were recruited [103]. At follow-up there remained a significant 
difference in weight between the two groups and systolic blood pressure was found 
to be on average 2.5mmHg lower in children born to women in the multiple 
micronutrient arm compared to the iron and folate arm [103]. 
The follow-up of the trial conducted by Christian et al enrolled individuals who were 
now 6-8 years old and recruited 85% (n=3524) of live born individuals from the 
original trial [104]. There was no difference in systolic or diastolic blood pressure 
between the five groups of the trial [104]; findings that are in line with the analysis 
presented in this chapter. 
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All three micronutrient supplementation trials (two from Nepal and the data from 
Bangladesh presented here) are large, well conducted intervention studies with 
high rates of follow-up and it is therefore important to consider explanations for 
the different findings observed. Firstly the current study participants and the 
participants in the follow-up of the Christian et al trial were older than those in the 
first Nepalese trial and it is possible that any effects of maternal nutritional 
supplementation on offspring blood pressure are only short-lived. Another 
explanation could be a difference in the populations as the Osrin et al trial recruited 
women from a more urban environment than the rural Bangladesh setting and the 
more rural setting of the second Nepalese study. An explanation for the null effects 
of the Bangladesh trial could be that the supplement was less effective in this 
setting; there was no effect of the multiple micronutrient supplement on birth 
weight for example (Persson, unpublished). However, both Nepalese trials were 
shown to impact on birth weight [101,102]. Finally it could be that the reduction in 
infant blood pressure observed in the first Nepalese study was due to chance. 
The authors of the first Nepalese trial follow-up suggest that the beneficial effect of 
multiple micronutrient supplementation on blood pressure could be due to the 
difference in iron composition of the two tablets, 60mg compared to 30mg in the 
MuMs tablet [103]. They suggest that the high iron dose may be detrimental, 
leading to raised blood pressure in this group. The design of the MINIMat trial 
allows this hypothesis to be investigated and the analysis has shown no effect of 
high compared to low iron dose on offspring blood pressure or kidney function in 
this population. Two large cohort studies have investigated the impact of the 
general diet during pregnancy, including iron intake, on offspring blood pressure at 
three years [72] and 7.5 years respectively [73]. In the US, maternal iron intake 
from personal supplements, but not from food, was positively associated with 
offspring systolic blood pressure at three years whereas in the UK there was no 
association between iron intake (from foods or iron-only supplements) in 
pregnancy and offspring blood pressure at 7.5 years [73]. It should be noted that 
these studies are not directly comparable with each other; the UK researchers 
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restricted their analysis to iron-supplements whereas the US study included iron 
from multiple micronutrient supplements. 
As stated previously, there is very little human data on the association between 
maternal nutritional interventions or maternal diet during pregnancy and offspring 
kidney function. However, the follow-up of the second Nepalese multiple 
micronutrient trial, originally conducted by Christian et al, contained urinary 
measurements of the microalbumin: creatinine ratio in the offspring [104]. 
Microalbuminuria (microalbumin: creatinine ratio 23.4mg/mol) is an established 
marker of kidney dysfunction [265], but in Bangladesh the analysis of both 
microalbumin and creatinine in urine have been hampered by the highly dilute 
nature of the urines collected in this region (Vahter, pers. comm. ). In the Nepalese 
study, there was no difference in the mean microalbumin: creatinine ratio for 
individuals born to women in any of the intervention arms but there was a lower 
risk of microalbuminuria (microalbumin: creatinine ratio >_3.4mg/mol) for 
individuals whose mothers had received folic acid in addition to vitamin A or folic 
acid, iron and zinc in addition to vitamin A compared to controls (vitamin A alone) 
[104]. Interestingly there was no difference in the odds of microalbuminuria in the 
other two intervention arms which both contained folic acid, iron and vitamin A. 
A few animal studies have focused on the impact of vitamin A as this is known to 
be essential for organogenesis [266]. Studies have demonstrated that retinoic acid, 
the metabolically active form of vitamin A, is fundamental to mammalian 
nephrogenesis [267]. Even a relatively mild (50%) vitamin A deficiency in pregnant 
rats leads to a 20% reduction in nephron number in their offspring [268]. In protein- 
restricted rats (restricted throughout pregnancy and lactation), the administration 
of retinoic acid during gestation prevented the loss of nephrons associated with the 
low protein diet [269], suggesting that it might have been possible to witness an 
interaction between the food and micronutrient interventions here, although none 
were observed. However, the direct relevance of the animal data to human studies 
is questionable as many additional factors must be considered when investigating 
the impact of a community-based supplementation trial. In particular, the 
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prevalence of vitamin A deficiency (VAD) in this population is not known; a recent 
survey from a northern rural district in Bangladesh reported that 18.5% of pregnant 
women had VAD (serum retinol <0.70µmol/l) [270]. There are no studies of vitamin 
A status and nephron number in humans but a recent pilot study from Bangalore, 
India failed to find a correlation between maternal retinol levels during pregnancy 
and offspring kidney volume ascertained within two days of birth [271], which is 
more in line with the findings presented in this thesis. 
6.8.2.4 Implications of findings 
This study corroborates the findings of a multiple micronutrient supplementation 
trial in Nepal, suggesting that there is no effect on offspring blood pressure [104]. A 
separate Nepalese trial did observe an impact of multiple micronutrient 
supplementation on offspring blood pressure, albeit in a younger age group [103]. 
There do not appear to be any effects of high iron compared to a low iron dose in 
this setting in terms of offspring blood pressure and kidney function. The impact of 
micronutrient supplementation on offspring kidney function requires further 
research; data presented in this thesis suggests no effect whilst one of the Nepalese 
trials reported a reduction in microalbuminuria [104]. 
6.8.3 Breast feeding intervention 
6.8.3.1 Summary of findings 
Maternal randomisation to receive counselling for exclusive breast feeding, 
compared to counselling for general health messages, was not associated with 
offspring blood pressure or kidney function. The as-treated analysis suggested that 
individuals who were partially breast fed (foods and other milks in combination to 
breast milk) at four months of age had lower systolic blood pressure at 4.5 years, 
although the association was lost after adjustment for confounders. 
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6.8.3.2 Study strengths and limitations 
In addition to the general MINIMat trial design strengths and limitations outlined in 
Section 6.8.1.2, the main strength of the breast feeding counselling intervention is 
the randomised nature of the trial; the majority of the literature relies on 
observational data. Again, the follow-up sample size was large, recruitment rates 
were similar between both arms of the intervention and loss to follow-up was not 
associated with any baseline characteristics. The intervention was successful in 
promoting breast feeding practices in the targeted women with 61% still exclusively 
breast feeding four months after birth compared to 37% in the control group. 
A limitation of the intervention is that it would be unethical to randomly assign 
women not to breast feed and therefore the trial focussed on counselling that 
promoted exclusive breast feeding, which is one step removed from the hypothesis 
being tested. 
6.8.3.3 Comparison with the literature 
The lack of an effect of breast feeding counselling on offspring blood pressure is in 
accordance with the follow-up of the Promotion of Breastfeeding Intervention Trial 
(PROBIT) in Belarus [138]. This was a large multicentre cluster-randomised 
controlled trial using the steps of the WHO and UNICEF-developed Baby-Friendly 
Hospital Initiative and targeting more than 17,000 women [137]. The intervention 
was successful at increasing the rate of breast feeding, with infants in intervention 
areas more likely to be breastfed exclusively at three and six months compared to 
infants in control areas [137], but there was no difference in blood pressure 
between these two groups of children at 6.5 years of age [138]. A small trial of 
preterm infants in the UK randomly assigned to receive banked breast milk or 
formula milk also revealed no difference in blood pressure at 7.5-8 years of age 
[135]. However, when the same subjects were followed-up at 13-16 years of age, 
those in the breast milk group had on average 3.2mmHg lower diastolic blood 
pressure and 4.1mmHg lower mean arterial pressure than those in the preterm 
formula group, although it should be noted that only 25% (n: 130) of the original 
- 237 - 
Chapter 6: Bangladesh results 
trial participants were recruited into this second follow-up [134]. The disparity in 
the results between these trials could suggest that an association between breast 
feeding and lower blood pressure will become apparent in the PROBIT and 
MINIMat trial offspring once they reach adolescence. Alternatively the difference 
between the trials could reflect the target individuals, with the Belarus and 
Bangladesh trials being more representative of their wider populations than a small 
trial recruiting pre-term infants. 
There has been an ongoing debate in the literature on the effect of breast feeding 
on long-term blood pressure, with the majority of data derived from cohort studies. 
A systematic review and meta-analysis published in 2003 by Owen et al identified 
25 studies for inclusion that compared exclusively breast fed with exclusively bottle 
fed individuals, and reported a small protective effect of breast feeding on systolic 
blood pressure from their meta-analysis (-1.10mmHg; 95% Cl: -1.79, -0.42) [124]. 
However, the authors also found some evidence of publication bias with smaller 
studies (<300 individuals) showing a stronger association and studies with over 
1000 subjects showing a non-significant association [124]. In 2005, Martin et al 
published a review that included only studies reporting blood pressure after 12 
months of age and identified 15 studies to include [125]. Again there was a small 
protective effect of breast feeding in infancy on later systolic blood pressure (- 
1.4mmHg; 95% Cl: -2.2, -0.6). Only four studies included in the review had more 
than 1000 participants and again the effect was much smaller for these studies and 
only of borderline significance (-0.4mmHg; 95% Cl: -0.9,1.0) [125]. 
The most recent review and meta-analysis of this topic was conducted by Horta et 
a/ for the WHO and published in 2007 [126]. The review included 30 studies and the 
analysis suggested that there was a small protective effect of breast feeding on 
both systolic (-1.21 mmHg; 95% CI: -1.72, -0.70) and diastolic (-0.49 mmHg; 95% Cl: 
-0.87 to -0.11) blood pressure [126]. In addition to issues of publication bias related 
to study size, the authors raised concerns that residual confounding may explain 
the results, as the effect estimates were often attenuated after adjustment for 
measured confounders [126]. Randomised controlled trial data, such as that 
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presented here, may provide more valid results as the data should be independent 
of confounding both by known and unknown factors [95]. 
The reviews of the predominantly observational literature include very few studies 
from developing countries, which could explain the differences between these 
findings and the data from Bangladesh. One large cohort from a semi-urban area in 
Brazil recently reported that breast feeding was not associated with systolic or 
diastolic blood pressure at 15 years [272]. The comparison between exclusively 
breast fed and exclusively bottle fed infants, which is most common in the 
literature, is also not directly comparable with the situation in rural Bangladesh 
where very few infants do not receive any breast milk at all. From the Bangladesh 
data it was possible to investigate the separate effects of different categories of 
breast feeding, from exclusive to predominant to partial feeding. Interestingly it 
appeared that the individuals with lower systolic blood pressure at follow-up were 
those who were already receiving foods and other milks in combination with breast 
milk by four months of age. Singhal et a/ have proposed that formula fed infants will 
grow faster than their breast fed counterparts and that this difference explains the 
higher blood pressure often reported for these individuals [136]. In rural 
Bangladesh it may be that exclusive and predominantly breast fed individuals 
exhibit increased growth compared to partially breast fed infants due to the quality 
of complementary foods that are introduced. Therefore this difference in growth 
profiles (which is the opposite to individuals in developed country settings) may 
explain the differences in blood pressure revealed by this study. 
Very few studies have investigated the impact of infant feeding on kidney function. 
A small Danish study observed a non-significant trend towards increased kidney 
volume (adjusted for current body surface area) from fully breast fed to partially 
breast fed and then formula fed individuals at three months of age [260]. However, 
a second follow-up in the same cohort revealed there was no longer an association 
between feeding type at three months and kidney volume at 18 months of age 
[260]. 
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6.8.3.4 Implications of findings 
These data add to the debate on the long-term health benefits of breast feeding. 
Data from the two community-based randomised trials in this field suggest that 
duration of exclusive breast feeding may not be related to blood pressure in later 
childhood. Concerns regarding residual confounding have been an issue for 
observational studies in this area and the trial data are therefore particularly 
valuable to investigate the impact of breast feeding on long-term cardiovascular 
health. 
6.8.4 Observational analysis 
6.8.4.1 Summary of findings 
A number of early-life factors were found to be associated with blood pressure and 
kidney function at 4.5 years of age. Maternal baseline haemoglobin (week 14 
gestation) was positively associated with offspring systolic and diastolic blood 
pressure. Birth weight and length were inversely associated with kidney volume but 
not with GFR. Systolic and diastolic blood pressure were inversely associated with 
birth weight only after adjustment for current size. Season of birth was also 
associated with systolic blood pressure, kidney volume and GFR. Increased growth 
(weight and length) in the first year of life was positively associated with blood 
pressure and kidney volume but not with GFR. 
6.8.4.2 Study strength and limitations 
In common with The Gambian studies it should be recognised that this 
observational data comes from the follow-up of a randomised trial, which was not 
established as a cohort study. However, with this caveat in mind, the data can 
usefully be viewed as a cohort enrolled at birth and followed-up 4.5 years later. The 
maternal interventions were not associated with the early-life exposures that have 
been studied, such as maternal baseline haemoglobin or season of birth. To date, 
the preliminary trial analysis has also revealed no association between the maternal 
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interventions and birth anthropometry (Persson, unpublished). As has been 
demonstrated in this chapter, there was also little effect of the maternal 
interventions on offspring blood pressure and kidney function, suggesting that it is 
appropriate to conduct these observational analyses without taking the treatment 
allocation into account. 
One of the strengths of this data set from the standpoint of cohort analysis is that 
there is available information on potential confounding factors such as wealth index 
that was missing from The Gambian studies presented earlier in this thesis. 
6.8.4.3 Comparison with the literature 
Maternal leg length has been suggested as a useful proxy indicator of a mother's 
own nutritional exposures as a child, and thus a way of investigating 
intergenerational effects of sub-optimal nutrition [253]. Maternal leg length has 
been shown to be positively associated with the birth weight of her children in two 
retrospective cohort studies based in the UK [255,273]. In the analysis presented in 
this thesis, the association between maternal leg length and offspring blood 
pressure was used to investigate the impact of maternal nutritional experiences in 
early-life on the development of offspring body systems, but no association was 
observed. 
There was a strong positive association between maternal haemoglobin in early 
pregnancy and offspring systolic and diastolic blood pressure. In analysis adjusted 
for confounders, for every 1g/dl increase in maternal haemoglobin at week 14 
gestation, offspring systolic blood pressure increased by 0.42mmHg (95% Cl: 0.09, 
0.75). In addition, anaemia at 14 weeks gestation (but not at 30 weeks) was 
associated with lower blood pressure in the offspring. In line with this finding, data 
from the ALSPAC cohort in the UK suggested that anaemia in pregnancy may be 
associated with lower offspring systolic blood pressure at seven years of age, 
although the association was lost after adjustment for confounders [73]. In Project 
Viva in the US, there was no association between haemoglobin concentration in 
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pregnancy and offspring blood pressure, despite a positive association between 
iron intake from supplements and offspring systolic blood pressure [72]. In contrast, 
experiments in rats have demonstrated that iron deficiency in pregnancy is 
associated with raised offspring blood pressure [89,274,275]. Interestingly, two of 
these rat experiments initially observed lower blood pressure in the offspring of 
anaemic dams at three [274] and six [89] weeks postpartum, but that in the longer- 
term persistently higher blood pressure was observed. It could therefore be that a 
later follow-up of this cohort would reveal a different relationship to the one 
reported here. Potential mechanisms to explain the link between iron deficiency in 
pregnancy and offspring blood pressure remain unclear. Anaemia induced at the 
final stages of pregnancy in sheep has been shown to have dramatic effects on the 
fetal coronary tree, increasing the coronary blood flow and maintaining this 
adaptation into adulthood [276]. It is possible that permanent changes in cardiac 
output as a result of anaemia during fetal development could have long-term 
implications for blood pressure. 
The observed inverse association between birth weight and later blood pressure is 
in close agreement with the literature. The effect size for the association was a 
2.5mmHg decrease in systolic blood pressure for every 1kg increase in birth weight, 
which reflects the often-quoted average association of -2mmHg for a 1kg increase 
[51]. The inverse relationship was only apparent after adjustment for current size, 
which has been interpreted as suggesting that the change in size between birth and 
the current time point is the more important exposure, rather than size at birth 
[53]. Indeed this is revealed in the analysis of the effect of changing weight 
standard deviation scores in the first year of life and in the life course plots, which 
emphasised the positive association between crossing weight centiles in early 
infancy and blood pressure at 4.5 years. As discussed in previous chapters, there is 
currently little consensus in the literature on how best to characterise growth. A 
recent pooled analysis from five cohorts based in developing countries investigated 
the effect of conditional weight (an indication of an individual's deviation from their 
expected size at a given age) in childhood on later blood pressure [123]. The 
analysis initially revealed a positive association with conditional weight at different 
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time points and early adult blood pressure although this was lost after adjustment 
for current BMI, which indicated that early growth only predicted adult blood 
pressure through its association with adult size [123]. In contrast, the association 
between growth in infancy and blood pressure in this Bangladesh study remained 
even after adjustment for current size. 
The association between birth weight and kidney function has been reported for a 
number of studies, with conflicting results. Low birth weight Aboriginal children in 
Australia had lower kidney volume than normal birth weight children [172], a 
finding in agreement with the analysis presented here of the positive association 
between birth weight and kidney volume. In contrast, birth weight was not 
associated with kidney volume or glomerular filtration rate in Swedish children 
[277]. A recent systematic review by White et al investigated the association 
between birth weight and chronic kidney disease (CKD) [174]. From the 31 
identified eligible studies, half reported an association between low birth weight 
and risk of CKD whilst half reported no association [174]. It is therefore currently 
difficult to draw firm conclusions from the existing literature. 
Season of birth can be used as a proxy indicator of suboptimal conditions during 
development in areas where there are marked changes in food availability and 
farming activities. A previous analysis of the effect of season of birth on survival in 
this region of Bangladesh was conducted by Moore et al and revealed no 
association with adult mortality, in contrast to similar data from The Gambia [278]. 
The analysis presented in this thesis however, suggests that subtle health 
differences may occur between individuals in relation to their month of birth. 
Interestingly, the observed pattern between the month of birth and systolic blood 
pressure was almost the direct opposite of that reported in Section 3.4.3 for the 
Gambian data. This could be explained by the different pattern of food and activity 
in these two countries. In Bangladesh, the greatest farming activity occurs in the 
middle of the year before the monsoon starts in June and July, whilst in The Gambia 
the farming peak is from June to October. Variations in maternal BMI and in birth 
weight in these areas reflect the different patterns of activity; women joining the 
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MINIMat trial exhibited the lowest BMI when they were enrolled just after the peak 
farming activities (Figure 6.15). In The Gambia the lowest birth weights (no data on 
maternal early pregnancy BMI is available) occur just after the peak in farming 
activities. 
Figure 6.15 Seasonal pattern of farming activities, maternal BMI and birth weight in 
rural Gambia and Bangladesh 
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Lines represent the fitted line for the variation in birth weight in The Gambia (grey line) and early 
pregnancy BMI in Bangladesh (black line) with month of the year 
The Gambia: birth weight restricted to control group from protein-energy supplementation trial only 
[194), pre-intervention maternal BMI was not available from this dataset 
Bangladesh: maternal BMI represents anthropometry recorded at week eight gestation, prior to the 
implementation of the intervention. Birth weight was considered inappropriate for this trial as it 
may have been influenced by the maternal food intervention inasmuch as the effect of seasonality 
could have been reduced by the intervention 
Interestingly, the seasonal pattern of maternal BMI variation in Bangladesh reflects 
the association between season of birth and blood pressure in the offspring of 
these women (Figure 6.16). Individuals born in the middle of the year may exhibit 
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the highest systolic blood pressure at follow-up as they have been born in the 
'hardest' part of the year as evidenced by the variation in maternal BMI. 
Figure 6.16 Seasonal variation in maternal BMI and in blood pressure in relation to 
month of birth 
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offspring systolic blood pressure in relation to season of birth (grey line) 
Maternal BMI represents anthropometry recorded at week eight gestation, prior to the 
implementation of the intervention 
Offspring systolic blood pressure was measured at 4.5 years 
It should be acknowledged that the use of Fourier terms to model the effect of 
seasonality as an exposure by necessity smoothes the raw data so that the pattern 
may appear more robust than the reality. In addition, the actual size of the 
association between month of birth and blood pressure reported here is very small 
with the 95% confidence interval only spanning 1mmHg, which again cautions 
against the over-interpretation of these intriguing patterns. 
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6.8.4.4 Implications of findings 
The observational analyses presented in this Chapter emphasise the importance of 
early-life factors in determining later blood pressure and kidney function. It is 
interesting that these factors are important despite the limited impact of the 
maternal interventions in this setting, suggesting that focusing on the maternal diet 
may obscure other interesting exposures that can affect long-term health. The 
strong association with growth highlights the importance of this exposure for later 
health, something that is currently gaining recognition in the literature [123,231]. 
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Chapter 7 General discussion, implications and future 
research 
7.1 Forward 
This Chapter will summarise the main findings from this PhD thesis, focusing on 
results that span all three follow-up studies. The data will be interpreted and future 
research suggested before a final discussion of the importance of this data in the 
wider context of the Developmental Origins of Health and Disease (DOHaD) 
research field. 
7.2 Summary of results 
7.2.1 Intervention analysis 
The purpose of this PhD was to investigate the impact of maternal nutritional 
interventions during pregnancy on offspring blood pressure. The research question 
falls under the general umbrella of DOHaD, specifically on the importance of 
nutrition in early-life for later cardiovascular health. Historically, this research field 
has relied heavily on observational data reporting the association between birth 
weight and later health [45,49] and on animal experiments that may not be directly 
relevant to the human situation [77,79]. In contrast, the research presented in this 
thesis utilised trials that were originally conducted to improve maternal and infant 
health, in order to investigate the impact of the maternal diet on offspring blood 
pressure from the standpoint of a randomised trial. Intervention data such as these 
provide two main advantages over the conventional literature, producing effects 
that should be independent of confounding, including by possible genetic effects, 
and removing the necessity to assess maternal nutritional intake using dietary 
assessment techniques that are often prone to error. 
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The data presented were from follow-up studies of protein-energy 
supplementation in The Gambia, calcium supplementation also in The Gambia and 
a large multifaceted intervention of food, micronutrient supplementation and 
breast feeding counselling in Bangladesh (the MINIMat study). Each trial provided a 
different study design with which to investigate the impact of the maternal diet. 
The Gambian protein-energy trial follow-up involved older individuals who could be 
hypothesised to be more likely to demonstrate any long-term effects, but there 
were interpretation issues with the original trial design as the 'control' participants 
received supplements during lactation. The calcium trial provided the most robust 
data; recruiting offspring from a randomised double-blind placebo-controlled trial 
and with a number of directly comparable studies already in the literature. The 
follow-up of the MINIMat trial in Bangladesh enabled the hypothesis to be tested in 
a different setting and allowed for the exploration of kidney function (volume and 
glomerular filtration rate (GFR)) effects that were postulated to exist even in the 
absence of any effect on blood pressure. In addition, the Bangladesh study 
provided data on a breast feeding intervention that added another interesting 
angle to the PhD research. 
Overall, the results revealed little evidence that any of these interventions 
influenced offspring blood pressure or kidney function, with the exception of a 
slight decrease in diastolic blood pressure in response to an invitation to access 
food supplementation early in pregnancy in rural Bangladesh (Table 7.1). 
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Chapter 7: general discussion 
7.2.2 Observational analysis 
The observational analyses were conducted as a secondary aim to utilise the data 
to their full potential, allowing comparisons of these populations with the wider 
literature and exploring exposures other than prenatal nutrition. This was felt to be 
particularly valid as the interventions did not affect the exposures under 
investigation, with the exception of an increase in birth weight associated with 
protein-energy supplementation in The Gambia that was accounted for in the 
analysis. 
There was some heterogeneity in the observational findings from these studies 
(Tables 7.2 and 7.3). Season of birth was associated with systolic blood pressure for 
adolescents in The Gambia and for the Bangladesh cohort, although there were 
distinct patterns of association in each setting. Birth weight and length unadjusted 
for current size were not related to later blood pressure in any of the three groups. 
However, once birth weight was adjusted for current weight there was a strong 
inverse association for individuals in Bangladesh and the suggestion of an 
association for adolescents in The Gambia. This implicates postnatal growth as an 
important exposure and indeed the change in weight standard deviation score from 
birth to one year was found to be positively associated with later systolic blood 
pressure in both Bangladesh and the older Gambian cohort. Change in length SD 
score was also positively associated with systolic blood pressure in Bangladesh. 
None of the exposures relating to birth weight or the first year of life were 
associated with systolic or diastolic blood pressure for the younger Gambian 
children but this may reflect the smaller sample size (n=350) of this group. 
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Table 7.2 Summary of observational analyses relating early-life exposures to later 
systolic blood pressure (mmHg) 
Regression coefficient P-value 
(95% Cl) 
Maternal 
Maternal leg length Bangladesh 4.5y 0.03 (-0.18,0.23) 0.79 
(cm) 
Maternal hb, wk14 Bangladesh 4.5y 0.42 (0.09,0.75) 0.01 
(g/dl) 
Birth 
Birth weight (kg) 
Birth weight (kg) 
adjusted for current 
weight 
Birth length (cm) 
Birth length (cm) 
adjusted for current 
height 
Season of birth 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
-0.52 (-1.72,0.68) 
1.31 (-0.64,3.25) 
-0.63 (-1.51,0.26) 
-1.13 (-2.31,0.04) 
-0.89 (-2.89,1.10) 
-2.53 (-3.46, -1.60) 
0.19 (-0.06,0.43) 
0.04 (-. 01,0.09) 
-0.07 (-0.21,0.07) 
0.06 (-0.18,0.30) 
0.00 (-0.05,0.05) 
-0.23 (-0.38, -0.08) 
LR test X2: 6.69a 
LR text X2: 0.713 
LR test X2: 14.94a 
0.39 
0.19 
0.17 
0.06 
0.38 
<0.001 
0.13 
0.08 
0.34 
0.63 
0.90 
0.002 
0.04 
0.69 
0.001 
Infant 
Change in weight The Gambia, 11-16y 0.73 (0.27,1.19) 0.002 
SDS The Gambia, 5-10y 0.32 (-0.49,1.13) 0.44 
from 0-12m Bangladesh, 4.5y 0.88 (0.58,1.17) <0.001 
Change in length The Gambia, 11-16y 0.27 (-0.39,0.92) 0.43 
SDS The Gambia, 5-10y 0.05 (-0.80,0.90) 0.91 
from 0-12m Bangladesh, 4.5y 0.71 (0.39,1.02) <0.001 
Results are the effect on systolic blood pressure of a one unit increase in the explanatory variable, 
derived from linear regression analysis adjusted for appropriate confounders 
'Results of likelihood ratio tests comparing models with or without season of birth as an exposure 
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Table 7.3 Summary of observational analyses relating early-life exposures to later 
diastolic blood pressure (mmHg) 
Regression coefficient P-value 
(95% Cl)' 
Maternal 
Maternal leg length Bangladesh, 4.5y 0.01 (-0.17,0.19) 0.91 
(cm) 
Maternal Hb, wk14 Bangladesh 4.5y 0.45 (0.16,0.73) 0.002 
(g/dl) 
Birth 
Birth weight (kg) 
Birth weight (kg) 
adjusted for current 
weight 
Birth length (cm) 
Birth length (cm) 
adjusted for current 
height 
Season of birth 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
The Gambia, 11-16y 
The Gambia, 5-10y 
Bangladesh, 4.5y 
-0.004 (-1.03,1.02) 
0.11 (-1.59,1.81) 
0.23 (-0.52,0.98) 
-0.40 (-1.14,0.62) 
-1.64 (-3.41,0.12) 
-1.02 (-1.82, -0.22) 
0.11 (-0.10,0.32) 
0.03 (-0.01,0.07) 
0.03 (-0.10,0.15) 
0.05 (-0.16,0.26) 
0.01 (-0.04,0.05) 
-0.09 (-0.22,0.04) 
LR test X2: 4.51a 
LR test X2: 7.93a 
LR test x2: 6.77a 
0.99 
0.90 
0.55 
0.44 
0.07 
0.01 
0.31 
0.41 
0.67 
0.64 
0.73 
0.18 
0.10 
0.09 
0.03 
Infant 
Change in weight The Gambia, 11-16y 0.32 (-0.08,0.72) 0.12 
SDS The Gambia, 5-10y 0.47 (-0.23,1.18) 0.19 
from 0-12m Bangladesh, 4.5y 0.60 (0.35,0.85) <0.001 
Change in length The Gambia, 11-16y 0.36 (-0.22,0.93) 0.22 
SDS The Gambia, 5-10y 0.24 (-0.50,0.99) 0.52 
from 0-12m Bangladesh, 4.5y 0.47 (0.20,0.74) 0.001 
Results are the effect on diastolic blood pressure of a one unit increase in the explanatory variable, 
derived from linear regression analysis adjusted for appropriate confounders 
aResults of likelihood ratio tests comparing models with or without season of birth as an exposure 
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For the Bangladesh cohort only it was possible to investigate the impact of early-life 
factors on later kidney function (Table 7.4). Kidney volume was positively 
associated with birth weight, length and the crossing of weight or length centiles in 
the first year of life. Glomerular filtration rate was unrelated to any of the factors 
studied with the exception of season of birth. 
Table 7.4 Summary of observational analyses relating early-life exposures to kidney 
function at 4.5 years 
(data from Bangladesh only) 
Regression coefficient 
(95% Cl) 
P-value 
Maternal leg length (cm) 0.14 (-0.20,0.48) 0.43 
Maternal Hb, wk14 (g/dl) -0.23 (-1.20,0.74) 0.64 
Birth weight (kg) 7.37 (5.50,9.25) <0.001 
Birth weight (kg) adjusted for 2.59 (0.77,4.41) 0.01 
current weight 
ö ^'E Birth length (cm) 1.41 (1.07,1.75) <0.001 
T M Birth length (cm) adjusted for 0.52 (0.18,0.86) 0.002 
current height 
Season of birth LR test Xz: 58.3a <0.001 
Change in weight SDS from 0- 1.05 (0.41,1.69) 0.001 
12m 
Change in length SDS from 0- 1.64 (0.85,2.43) <0.001 
12m 
Maternal Hb (g/dl) -0.35 (-2.55,1.86) 0.76 
Birth weight (kg) 4.23 (-1.21,9.68) 0.13 
Birth weight (kg) adjusted for 3.48 (-2.46,9.42) 0.25 
C N current weight 4 m Birth length (cm) 0.52 (-0.31,1.35) 0.22 
Birth length (cm) adjusted for 0.30 (-0.59,1.18) 0.51 
`~ c 
current height 
Season of birth LR test X2: 48.7a <0.001 
E Change in weight SDS from 0- 0.68 (-1.23,2.60) 0.48 
12m 
Change in length SDS from 0- 1.24 (-0.63,3.11) 0.20 
12m 
Results are the effect on kidney function of a one unit increase in the explanatory variable, derived 
from linear regression analysis adjusted for appropriate confounders 
°Results of likelihood ratio tests comparing models with or without season of birth as an exposure 
-253- 
Chapter 7: general discussion 
7.3 Interpretation and future research 
7.3.1 Prenatal nutrition 
7.3.1.1 Interpretation 
In the main, the findings suggest that prenatal nutrition, at least those aspects 
studied here, does not affect offspring blood pressure. The three follow-up studies 
had large sample sizes, good rates of follow-up and experienced no differential loss 
to follow-up. Therefore we can be fairly sure that the results reported are not due 
to chance or bias and it is important to consider alternative explanations for these 
null results, some of which are diagrammatically summarised in Figure 7.1. 
Firstly, there may be general limitations of the design of this PhD research that 
could explain the null results of the interventions. The lack of a true control group is 
an issue for all of the studies with the exception of the calcium supplementation 
trial, which thus represents the data with greatest validity. It could also be that the 
supplements were provided too late in pregnancy to affect the development of 
body systems. Both the Gambian interventions provided supplements after 20 
weeks gestation, whilst the Bangladesh food intervention could be accessed from 8- 
10 weeks gestation. In humans, nephrogenesis occurs throughout gestation [257] 
however, suggesting that nutritional insults operating up until the process is 
complete at 34 weeks could be expected to have an effect. 
The timing of the interventions in the longer perspective of the maternal life course 
may also not be the most appropriate for long-term health implications in the 
offspring. Fetal nutrition is affected by maternal nutrient stores and placental 
function, which are in turn influenced by the mother's own lifetime nutritional 
exposures. This concept has been illustrated by studies investigating 
intergenerational effects of diet restriction during pregnancy. A number of 
experiments in rats have shown that the effects of a low-protein diet during 
pregnancy lead to raised blood pressure [279,280] and reduced nephron number 
[280] in the second, as well as the first, generation. In this thesis the impact of 
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maternal leg length was used as a proxy estimate of maternal nutritional exposures 
in early life, but was not found to be associated with offspring blood pressure or 
kidney function. 
There are two other key limitations of the follow-up studies presented in this thesis 
that have been discussed in previous chapters. The first is the age of the subjects at 
follow-up, who may be too young to reveal differences in blood pressure between 
the trial arms. The second is the setting of the studies in rural areas of developing 
countries where the subjects are, in the main, not exposed to the constituents of a 
'Western' lifestyle that may be important for any disease susceptibility to appear. 
Authors in the animal field have suggested that the 'thrifty phenotype' 
programmed by undernutrition in utero is associated with an increased appetite as 
well as structural changes in organ systems [160]. The effects on appetite control in 
humans are not fully understood, but the relatively poor diet quality in these rural 
settings may nullify any inherent differences in appetite and hence partly explain 
the similarity of risk factor profiles between the trial arms. 
Gluckman and Hanson have proposed the "Predictive Adaptive Response" theory to 
bring together the importance of exposures operating both pre- and post-natally 
[193]. According to this theory, the developing fetus will utilise cues from the 
uterine environment to predict the environment that will be experienced after birth 
and will use this information to take the appropriate developmental pathway [193]. 
Only if there is a mismatch between the uterine information and conditions 
experienced postnatally, does an increased susceptibility to disease occur [193]. In 
the three intervention studies presented here it could be argued that maternal 
supplementation during pregnancy provides conditions that are better than those 
experienced postnatally in these rural farming communities. Applying the predictive 
adaptive response theory, children in the intervention arm of the trial could 
therefore be at risk of raised blood pressure as there will be a mismatch between 
the expected conditions and those experienced. However, no difference in blood 
pressure was demonstrated and it may be that a mismatch in this direction will not 
incur disease susceptibility as organ systems have merely developed to a fuller 
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potential than is required. Again this lack of effect may point to the timing of the 
supplement; as highlighted by Kuzawa it is unlikely that the maternal diet during 
pregnancy is an important cue to the developing fetus as this exposure is variable 
and influenced by temporary changes in the environment that will not provide 
information on habitual conditions to be experienced after birth [281]. 
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Another possible explanation for the null findings is that the interventions 
themselves may not have significantly altered the maternal diet. Although the 
Gambian protein-energy supplement did improve birth weight [194], no effect of 
the calcium intervention was observed on breast milk calcium concentrations, birth 
weight or infant bone mineral status in the sub-set of participants studied [195], 
and neither the Bangladesh food or micronutrient interventions impacted on 
maternal weight gain in pregnancy or birth weight (Persson, unpublished). Whilst 
randomised controlled trials represent the 'gold-standard' study design in 
epidemiological research [95], there are many logistical issues that can impact on 
their effectiveness in a community setting. For example, individuals provided with 
food supplements may simply add these to their family's meal rather than consume 
them themselves (although this possibility was absent in the Gambian trials). 
Alternatively, they may consume less of their normal diet in response to being given 
a supplement. If a nutritional intervention is ineffective, for whatever cause, its 
usefulness as a design with which to investigate the impact of the maternal diet on 
offspring blood pressure can be questioned. 
In general, trials of nutritional supplementation during pregnancy have 
demonstrated disappointingly modest effects on birth weight, which has often 
been the primary outcome. A recent systematic review and meta-analysis of the 
effect of multiple micronutrient supplementation during pregnancy on birth 
outcomes included eight studies that compared multiple micronutrients (MuMs) 
with iron and folate only [282]. The analysis revealed a positive effect of MuMs 
compared to iron and folate on birth weight and a reduction in the proportion of 
individuals born low birth weight [282]. However, the effect was of fairly modest 
size, with a weighted mean increase in birth weight of 54.02g (95% Cl: 36.22, 
71.83), and there was some heterogeneity in the results with three out of the eight 
studies (the review did not include the MINIMat data) showing no effect [282]. One 
explanation for the small effect size of these large interventions could be that the 
micronutrients are not fully available in tablet form and that a food-based 
supplement may be more effective [283]. Trials of protein-energy food 
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supplementation have also been shown to have only a modest impact on birth 
weight [284], with the exception of the Gambian trial that was the basis of one of 
the chapters in this thesis [194]. This has led some researchers to suggest that a 
food-based fortified supplement also containing a number of micronutrients may 
be the most effective method of improving nutrition during pregnancy [283]. This 
hypothesis was recently tested by Huybregts et a/ in Burkina Faso where pregnant 
women were provided with a food-based supplement fortified with the same 15 
multiple micronutrients that were provided in the MINIMat trial [283]. 
Disappointingly, the fortified food-based supplement was found to increase birth 
length, but there was no difference in birth weight between intervention arms 
[283]. 
As described in Chapter 1, the observational data on the impact of the diet during 
pregnancy on offspring blood pressure is limited and often reports conflicting 
results [63,65-68]. In contrast, the large amount of animal data in this field has 
consistently shown that reduced nutrition in utero, including global undernutrition, 
a restricted protein diet and iron deficiency, leads to raised offspring blood 
pressure in a range of species [75-80]. It is therefore interesting to consider why the 
human data presented here have shown no effect of manipulating the maternal 
diet. There are clearly some challenges for extrapolating from one species to 
another and it may not be surprising that the findings do not translate. Moreover, 
animal experiments occur in a tightly controlled environment whereas human 
interventions are placed in a real world setting where other factors operate to 
dilute any potential effect of the intervention. Another key difference between the 
human and animal interventions is that the latter have focussed on restricting 
nutrients, whereas studies of human pregnancy are designed to increase intake 
relative to control or placebo, therefore making the results difficult to compare. 
Finally, the incremental nutrient requirements for human reproduction are very low 
compared to other species, and the developing fetus is protected by a number of 
evolved adaptations [94]. It may not therefore be surprising that it does not appear 
possible to replicate the animal findings in the human situation using the tools of 
epidemiology. 
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7.3.1.2 Future research 
The conceptual diagram in Figure 7.1 helps to visualise the various proposed 
explanations for the null effect of the interventions. In order to explore these ideas 
further, additional research projects should be conducted. Firstly it would be 
interesting to follow these same cohorts of children into the future when they are 
themselves adults to see if differences in risk factors are apparent at a later age. An 
important aspect to study in these individuals as they develop will be the pace of 
rural development and/or the choice to remain in the rural area or to travel to 
more urban environments where they will be increasingly influenced by 'Western' 
diet and physical activity patterns. An increasing dichotomy of exposures may 
reveal any underlying differences in body systems that are not visible in the current 
study, where individuals in the control groups remain 'matched' to their 
environments. An inherent challenge would be that the more distant the subjects 
are from the original study site the harder they will be to trace and recruit into 
future research projects, creating major logistical difficulties. 
To investigate the concept that the supplement was not provided at a time point 
that would optimally affect offspring body systems it would be interesting to study 
children whose mothers had received supplements at a different time. The simplest 
study design would be to focus on the periconceptual period as a number of trials 
have investigated this time point, including one in the West Kiang region of The 
Gambia [ISRCTN 13687662] [285]. It would also be interesting to look at individuals 
who were born to women who had been provided with supplements earlier in their 
life course, perhaps during their own childhood, in order to investigate the 
intergenerational cycle of improved nutrition. 
This thesis has only focused on one aspect of offspring health that could potentially 
be affected by maternal nutrition during pregnancy. It will be important to look at 
other aspects of disease susceptibility such as body composition, lipid profiles, 
immune response, cognitive development and human capital in these children. The 
follow-up of the Gambian trials have to date revealed no effect of either the 
protein-energy or calcium interventions on body composition [216] [Goldberg, 
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unpublished] and the analysis of other outcomes is ongoing. Currently only two 
publications have reported the impact of the MINIMat interventions on offspring 
health; one revealing a small positive impact of the maternal nutritional 
interventions on offspring motor skills in infants born to women of low BMI only 
[286], whilst the second reported no impact on offspring thymic size as an indicator 
of immune development [287]. Follow-up studies of other maternal nutritional 
interventions have provided some evidence for long-term effects on outcomes 
other than blood pressure. For example, the Guatemalan protein-energy 
intervention (INCAP) has been associated with taller stature and enhanced 
cognitive performance in individuals from villages that received the 'Atole' 
compared to 'Fresco' supplement [98]. The Indian protein-energy intervention was 
also associated with taller stature at follow-up of subjects aged 13-18 years and 
with more favourable measures of insulin resistance [99]. 
7.3.2 Growth 
7.3.2.1 Interpretation 
The lack of an association between prenatal nutrition and later blood pressure 
forces us to consider alternative explanations for the apparent inverse associations 
between birth weight and blood pressure that are so prevalent in the literature and 
are generally interpreted as relating to inadequate fetal nutrition [49]. Lucas et al 
proposed that it was the change in size between birth and later life that was the 
explanatory factor, rather than fetal growth restriction per se [53]. Recently there 
has been increasing research focused on the impact of early postnatal growth rates 
on the development of cardiovascular disease in later life and on the potential for 
increased understanding to inform prevention strategies [231]. In this thesis, 
relative change in weight emerged as a predictor of later blood pressure in all three 
studies. This is a relatively new area of research, which currently remains hampered 
by methodological issues of how best to define growth and how to interpret an 
exposure that is fundamentally related to later size, and therefore to later blood 
pressure. 
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Despite these research issues a number of observational studies have now reported 
an association between growth in early life and later blood pressure [117,119,122, 
288-292], although the different statistical methods employed and the time points 
studied act to obscure any coherent pattern of association. Recently, Ben-Shlomo 
et al published an analysis where the impact of early growth was modelled in detail 
by creating individual growth curves based on 14 separate measurements of weight 
and length between birth and five years [122]. The analysis revealed that weight 
gain between 0-5 months and between 1.9-5 years was independently and 
positively associated with systolic blood pressure at 25 years, independent of adult 
adiposity [122]. Using the same data set but conducting an analysis that utilised 
relative weight at three time points (3mo, 1.5y and 5y) only, no association with 
later blood pressure was observed [122]. This highlights a common methodological 
issue in the literature where studies contain only a few measurements of size in 
infancy at arbitrarily chosen time points, making it difficult to interpret any null 
results reported. 
The majority of data that has investigated the impact of early growth on later blood 
pressure has been derived from developed countries where there may be very 
different implications for catch-up growth. A recent analysis of data from five 
developing cohorts provides a valuable addition to the field; the association 
between relative weight in early to mid-childhood (48 months) in these cohorts and 
early adult blood pressure was entirely explained by the contribution of early 
weight to later size [123]. This study did suggest however, that weight gain after 
mid-childhood may be important for later raised blood pressure [123]. This 
highlights an important issue within the growth data, namely that there may be 
different disease patterns associated with weight gain at different time points, 
which, if proven, would have important policy implications. Some studies have 
reported that weight gain in the first year of life is associated with later raised blood 
pressure [122,291], whilst others suggest that the aetiologically important period 
may be in later childhood [123,290]. 
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Even if growth in early life emerges as an important risk factor for later 
cardiovascular disease, the implications are challenging. This is particularly true in 
developing countries where poor early growth, manifested by low birth weight 
and/or wasting in the first few years of life, has been shown to be associated with 
infant mortality and morbidity and with reduced human capital in later life [293- 
295]. The implication is that catch-up growth for individuals who are born small is 
therefore beneficial, although the direct evidence on the benefits of early catch-up 
growth is limited [296]. If catch-up growth is beneficial in the short-term but may 
confer later disease risk, the issue of growth promotion may become one of 
priority, as discussed by Victora and Barros [296]. For example, should programmes 
intervene to promote growth in early life for the short-term improvements in 
health, if there are known long-term consequences in terms of cardiovascular 
disease risk factors such as hypertension and obesity? A related issue is that 
countries, and regions within those countries, are at different stages along the 
nutrition transition [297], which will make a global strategy difficult to define. 
7.3.2.2 Future research 
The impact of early growth on later health outcomes is in need of further well- 
designed studies in order to understand the phenomenon further. One of the first 
steps should be agreed standard methods for characterising growth as an exposure, 
whether this be to utilise life-course plots as recommended by Cole [121] or more 
complex modeling of growth trajectories as suggested by Ben-Schlomo et al [122]. 
Without standardised measures it is very challenging to interpret any null results 
that are published and to build up a picture of the pattern of growth that may 
confer the greater or lesser risk. 
In order to further understand the apparent association between growth and later 
blood pressure it will be important to develop intervention designs that can test 
this hypothesis from the standpoint of a randomised controlled trial. Some 
preliminary data has been obtained from a trial of infant feeding, which was shown 
to impact on growth [136]. Infants born at term but small for gestational age in five 
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UK hospitals were randomly assigned to receive standard formula or a nutrient- 
enriched formula (with 28% more protein) until they were nine months old [136]. 
Those receiving the enriched formula experienced a greater increase in weight Z- 
score, between enrolment and nine months, than those on standard formula and 
also had raised diastolic blood pressure at 6-8 years, although there was no 
difference in systolic blood pressure [136]. It would be interesting to follow-up 
other intervention trials that have impacted on growth, either via infant feeding or 
other mechanisms, in more representative populations in order to investigate the 
association with later blood pressure. 
Most studies in the literature have focused on the effects of weight change rather 
than linear growth and it will be important to be able to investigate both in future 
research in this area. In this thesis linear growth appeared to have either no effect 
or a reduced effect on later blood pressure compared to change in weight. Some 
studies have provided suggestive evidence that the timing of weight gain may be 
related to different patterns of body composition with early growth promoting lean 
mass and later growth promoting fat gain [298-300]. A greater understanding of the 
implications of the type and timing of growth will be important and requires further 
research. 
In regions that have undergone rapid nutrition transitions such as the Indian sub- 
continent and South America, there is emerging a pattern of adult body shape that 
has been termed "stunted-obese" [296]. In these regions, intergenerational and 
early-life nutritional deprivation have promoted a high prevalence of stunting, 
whereas recent nutritional improvements are manifest in the laying down of fat, 
particularly centrally-distributed fat [231]. Indian babies have been shown to be 
small but with relatively well preserved fat mass compared to UK infants, a 
phenotype that researchers have termed the 'thin-fat' baby [301]. If linear gain is 
shown to be associated less with later disease risk than early weight gain this may 
have important policy implications for these settings as it may represent an 
opportunity to break the intergenerational cycle of stunting. It will be important to 
develop interventions that are able to promote linear growth in the absence of 
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inappropriate weight gain, which will themselves require research into the 
appropriate diets, delivery and target age. 
Currently there is very little understood about the potential mechanisms linking 
growth rate in infancy and later blood pressure and this area also requires further 
research [122]. It may be that different underlying mechanisms are operating in 
different settings; individuals born low birth weight who experience rapid postnatal 
catch-up growth may be more susceptible to disease as their organ systems are not 
developed to their full potential and can therefore not process the increased 
demand that greater size provides [302]. For individuals born appropriate for their 
gestational age and with well developed organ systems there may be different 
mechanisms operating that explain the link between growth and blood pressure. 
Given the association between rapid weight gain in early childhood and increased 
risk of being overweight [303,304], this could also explain the link to increased 
blood pressure. However, the association with obesity is unlikely to entirely explain 
the phenomenon as some data reveal an association with infancy weight gain that 
is independent of later adiposity [122]. 
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7.4 The wider context 
The null effect of maternal supplementation on offspring blood pressure reported 
in this thesis provides important information on the effect of fetal environment on 
long-term cardiovascular health. It suggests that either the maternal diet is not an 
important feature of the early-life environment that influences disease 
susceptibility or that the chosen study designs were too simplistic to answer what is 
fundamentally a more complex research question. These results should stimulate 
research into what other factors of the early-life environment (nutritional or other) 
might be operating that do have a marked effect on the disease profile of an 
individual. 
In general, the field of DOHaD has helped to highlight the importance of the fetal 
and early postnatal life as a key stage in the life course that can have long-term 
implications for health. These concepts are important to public health and they are 
beginning to filter through to key stakeholders and to influence public health policy, 
albeit mainly in the developed countries where the majority of studies have been 
conducted. For example, the British Medical Association recently published a report 
on the importance of early-life nutrition that will help to inform medical 
practitioners in the UK on the most recent research in this field [305]. A recent 
survey of European Government stakeholders in infant nutrition found a high level 
of recognition and understanding of the concept of nutritional programming, 
although this knowledge had yet to filter through to relevant policy changes [306]. 
Funding bodies are also increasingly recognising the need for further research into 
early-life impacts, such as the European Union funded Early Nutrition Programming 
project and the World Cancer Research Fund call for proposals on the impact of the 
early-life period on cancer risk. 
Whilst the DOHaD literature has helped to highlight the importance of critical 
windows of development in the aetiology of disease, it is important to remember 
that these exposures do not operate in isolation but are also affected by exposures 
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throughout the life course. The discipline of life course epidemiology is currently 
undergoing a revival in popularity and can be a useful tool for understanding the 
complex causes of disease that encompass both biological and social exposures in a 
temporal relationship [307]. If we consider the impact of the maternal diet during 
pregnancy on the development of adult hypertension through a life course 
perspective it becomes apparent that we have only focused on a very narrow 
pathway within a very complex web of exposures (Figure 7.2). Even this simplistic 
diagram does not take into account intergenerational effects or the wider social 
context and underlying causes. Unraveling the complex association between fetal 
development and the exposures that both feed into it and built on it in terms of 
later health outcomes will require multi-disciplinary research including trial data, 
such as those presented here, together with well-conducted observational studies 
and animal experiments in order to investigate potential mechanisms. Only with 
the entire complement of these, and with a life course perspective, will it be 
possible to build a complete disease model and to use this to accurately inform 
public health policy. 
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7.5 Conclusion 
This thesis has demonstrated that there is no robustly detectable impact of protein- 
energy, calcium or multiple micronutrient supplementation provided during 
pregnancy on offspring blood pressure and kidney function amongst children and 
adolescents in The Gambia and children in Bangladesh. These data have a high 
degree of validity as they were derived from follow-up studies of randomised 
controlled trials of maternal supplementation. The null findings may question the 
importance of the maternal diet in influencing offspring disease risk although 
aspects of the studies, such as the age of the subjects and the rural setting, may 
have acted to obscure any real effect. An intervention providing counselling for 
exclusive breast feeding in Bangladesh was also unrelated to offspring blood 
pressure and kidney function, which feeds into the important debate on the long- 
term effects of infant feeding. Overall the data presented in this thesis have helped 
to highlight the complexities of this research field and the importance of viewing 
exposures throughout the life course. 
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